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ABSTRACT
The carbapenems belong to the P-lactam antibiotics and are known to have an
unrivalled antibacterial spectrum. An expanding number of different carbapenem-
hydrolysing P-lactamases is increasingly being identified, especially in geographical
areas where the carbapenems have been employed widely. These carbapenemases
can be divided into two groups according to whether they are metallo-P-lactamases
or serine P-lactamases.
Recently, there have been several reports from Japan of carbapenem-resistant isolates
that produce a transferable metallo-P-lactamase designated IMP-!. In this thesis
sixty-one clinical Pseudomonas aeruginosa isolates were acquired from hospitals
within Japan and fifty-one of these strains were resistant to imipenem and/or
meropenem (MIC >4mg/l). Neither IMP-1 nor a novel carbapenemase could be
detected in any of these strains; instead synergism between a cephalosporinase and
lowered outer membrane permeability was found to be the most prevalent
mechanism of imipenem resistance.
The carbapenem-hydrolysing metallo-P-lactamases produced by members of the
genus Aeromonas have in the past few years demanded attention from a clinical and
enzymological point of view. Two imipenem-resistant Aeromonas veronii biovar
sobria strains 13 and 99 were isolated from a water source in South India. An
imipenem-based detection method applied after isoelectric focusing revealed that a
P-lactamase with a pi of 5.84 was responsible for carbapenem hydrolysis in strains
13 and 99 and unlike previously reported Aeromonas metallo-P-lactamases this
enzyme could be detected with nitrocephin. Purification of this novel enzyme,
nominated AVS-1, further demonstrated the unusual properties of this
carbapenemase, most notably its insensitivity to EDTA. A metallo-P-lactamase gene
was amplified from/4, veronii bv. sobria strains 13 and 99 by PGR. Sequencing of
the PGR product revealed that these two strains possess a metallo-p-lactamase gene
that is closely related to the metallo-P-lactamase gene imiS previously identified in
an isolate of A. veronii bv. sobria. Therefore, minor amino acid substitutions may
account for the extended substrate specificity and unusual inhibitor profile of AVS-1.
Two non-carbapenem-hydrolysing P-lactamases were also cloned from A. veronii bv.
sobria strain 13. One of these P-lactamases a clavulanic acid sensitive P-lactamase
was found to be an ampS-like penicillinase. The other cloned p-lactamase could
unfortunately not be sequenced.
Biochemical studies have previously shown that the metailo-P-lactamases produced
by Stenotrophomonas maltophilia are a heterogeneous group of enzymes. In this
thesis heterogeneity was investigated at the molecular level by PCR. Seven S.
maltophilia strains that produce biochemically different metallo-P-lactamases, were
subjected to PCR with intragenic primers designed from the known nucleotide
sequences of the S. maltophilia metallo-P-lactamase genes blau and b/aS. A 561
base pair nucleotide sequence was determined from each of the PCR products
amplified from the seven strains tested. The 187 amino acid residues deduced from
the nucleotide sequence demonstrated that the metallo-P-lactamases from seven
different strains share >88.2 % homology with one another and >88.3 % homology
with the metallo-(3-lactamases encoded by blciu and b/aS. Therefore, the metallo-P-
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1.1 Introduction to antibiotic resistance
The discovery of antibiotics in the earlier half of this century could be cited as one of
the great landmarks in the history of medicine and the fight against infectious
disease. However, seventy years after Alexander Fleming observed the antibacterial
properties of penicillin (Fleming, 1929) we are now moving towards a situation
where some bacteria are resistant to all commonly employed antibiotics (Spratt and
Duerden, 1997).
Bacteria have been subjected to intense selection pressures through the widespread
use of antibiotics in medicine and farming, and as a consequence bacterial resistance
mechanisms can now be identified against every clinically available agent.
Advances in medical technology, the use and misuse of antibiotics and poor hospital
infection control procedures are all factors contributing to the problem of antibiotic
resistance which is currently most acute in hospital intensive care units (Amyes and
Thomson, 1995).
1.2 P-Lactam antibiotics
The P-lactam family is the largest of all the antibiotic groups. P-Lactams have
dominated the antibiotic arena since the general introduction of antibiotics into
clinical use in the mid 1940s. The successful nature of the P-lactam antibiotics is
1
reflected by their selective toxicity, strong bactericidal activity and the ability to
modify and improve their activity by chemically altering the P-lactam (Livermore,
1996). The four membered P-lactam ring is the structural feature that all P-lactams
share in common and is also the point of attack for the P-lactamases (Figure 1.1). P-
Lactamases hydrolyse the amide bond of the P-lactam ring to produce an
antibacterially inactive acidic product (Figure 1.1).
Figure 1.1 P-Lactamase hydrolysis of a carbapenem
1.3 Mode of P-lactam action
The mechanism of P-lactam action is known to involve the inhibition of
peptidoglycan biosynthesis and the activation of endogenous autolytic enzymes
leading to cell death (Tomasz, 1979). Both Gram-positive and Gram-negative
bacteria possess a lattice of peptidoglycan in their cell envelope that maintains the
cell shape and protects against osmotic forces (Figure 1.2).
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The peptidoglycan molecule consists of long polysaccharide chains made of
alternating N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues
(Figure 1.3). Pentapeptide chains are attached to the NAM groups and it is through
the covalent cross-linking of pentapeptides that adjacent polysaccharide chains are
connected to form the peptidoglycan matrix (Barnikel et al., 1983). In
Enterobacteriaceae the pentapeptide initially consists of L-alanine, D-glutamic acid,
diaminopimelic acid (DAP) and two terminal D-alanine residues. During the cross-
linking reaction (transpeptidation) the D-alanyl-D-alanine bond is cleaved, providing
energy for coupling of the carboxyl group of the penultimate D-alanine to the free
amino group of DAP in the pentapeptide of an adjacent strand (Barnikel el a/., 1983).
In actively dividing bacteria P-lactams primarily inhibit the enzymes that catalyse
transpeptidation reaction (D-alanyl-D-alanine transpeptidases). The amide group
(0=C-N) in the p-lactam ring (Figure 1.1) is conformationally similar to the peptide
link of the two terminal D-alanyl-D-alanine residues of the peptidoglycan
pentapeptides, thereby, causing the transpeptidases to mistake the drug for their
natural substrates (Tipper and Strominger, 1965; VVaxman et a/., 1980). The
enzymes lose their catalytic activity once the P-lactam has bound.
The p-lactam target enzymes occur on the cytoplasmic membrane and are
collectively known as the penicillin binding proteins (PBPs). There are several
distinct PBPs that demonstrate functional roles other than involvement in
transpeptidation (Livermore and Williams, 1996). The ability to penetrate the cell
wall and the degree of affinity to these PBPs determines the activity of the P-lactam
on the bacterium. Although PBPs have been best studied in Escherichia coli,
virtually all Gram-negative rods give identical patterns of seven PBPs, these are
numbered la, lb, 2, 3, 4, 5, and 6 in order of descending molecular weights
(Georgopapadakou and Liu, 1980; Noguchi et a/., 1979). Some P-lactams bind
almost exclusively to PBPs 2 or 3, although most bind to PBPs 1-3. PBPs 1-3 of
Gram-negative bacteria are essential for peptidoglycan manufacture and inhibition of
these components by P-lactams is lethal (Spratt, 1977).
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1.4 Mechanisms of resistance to the (3-lactams
Bacterial P-lactam resistance is often a multi-factorial event and thus can arise by
one or more of the following mechanisms:
1.4.1 Modification of the penicillin binding protein targets
Modification of PBPs as a mechanism of P-lactam resistance is most important in
Gram-positive cocci and the fastidious Gram-negatives Haemophilus influenzae,
Neisseria gonorrhoeae and Neisseria meningitidis (Spratt, 1994). In other Gram-
negative pathogens, PBP-mediated resistance is not such an important mechanism,
although, it has been reported for example in Pseudomonas aeruginosa (Malouin and
Bryan, 1986).
1.4.2 Impermeability
Impermeability of a p-lactam is a resistance mechanism associated with Gram-
negative bacteria only, because Gram-negative bacteria, unlike Gram-positives,
possess an outer membrane external to the cell wall that protects the PBPs (Figure
1.2). Certain hydrophilic semi-synthetic P-lactams can cross the outer membrane by
passive diffusion through pores composed of porin proteins. The properties and
numbers of the porins and the characteristics of the P-lactam (charge, size and
hydrophobicity) determine the rate of uptake (Livermore, 1991). Reduced porin
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expression has been associated with insusceptibility especially when the organism
possesses a (3-lactamase (see Section 1.10.1)
1.4.3 Efflux
There is increasing evidence that active efflux (active pumping out of an antibiotic
entering the cell) plays a significant role in P-lactam resistance (Nikaido, 1994). In
P. aeruginosa, for example, the over expression of an operon (mexAmexBoprM) that
encodes an efflux system confers cross resistance to P-lactams, quinolones,
tetracycline and chloramphenicol (see Section 1.10.1.1).
1.4.4 Production of a P-lactamase
The production of P-lactam inactivating enzymes is the most prevalent mechanism of
resistance to the P-lactams amongst clinical bacteria (Medeiros, 1997). Gram-
positive organisms release P-lactamases into the environment, whereas, the P-
iactamases produced by Gram-negative bacteria are secreted into the periplasmic
space between the cytoplasmic and outer membrane. The list of P-lactamases that
have so far been identified from bacterial isolates is extensive and the number of
uniquely described P-lactamases now exceeds more than 250 (Karen Bush - personal
communication). The various P-lactamases will be discussed in more detail in
Section 1.6.
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1.5 Classification of the (3-lactams
The confusingly large group of P-lactam antibiotics is often divided into four
different classes: the penicillins, cephalosporins, monobactams and carbapenems.
Changing patterns of infection and resistance have driven the development of
successive P-lactam generations.
Figure 1 4 shows the chemical structures of the four |3-lactam classes. The P-lactam
ring of the penicillins and carbapenems is fused to a five-membered (thiazolidine)
ring, whereas, the cephalosporins possess a P-lactam/six membered (dihydrothiazine)
ring structure. The monobactams are monocyclic compounds, a feature that
distinguishes them from the other P-lactams. With all of these compounds the P-
lactam ring is essential for antimicrobial activity and it is the R-side chains that
determine the spectrum of antibacterial activity and also the pharmacokinetic
properties of the P-lactam
A fifth group of important p-lactam agents are the P-lactamase inhibitors, which
unlike the other four classes generally demonstrate little or no antibacterial activity.
These P-lactamase inhibitors are able to bind to P-lactam hvdrolysing enzymes and



















The penicillin class covers a wide spectrum of antibacterial activity and can be
divided into five groups according to a structure-activity relationship (adapted from
Wright and Wilkowske, 1991). The five different penicillin subclasses are listed in
Table 1.1 along with representatives from each subclass. Examples of some of the
K\ penicillin side chains are shown in Figure 1.5.































Natural narrow spectrum penicillins were the first (3-lactams to be made clinically
available. Benzylpenieillin, isolated as a product of Penicillium notatum (Fleming,
1929), was initially manufactured by adding maize extract rich in phenylacetic acid
to the fermentation process (Raper et al1944; Mover and Coghill, 1946). In a
similar fashion phenoxyacetic acid could be added to the procedure to yield
phenoxymethylpenicillin. The main difference between these two penicillins resides
in their stability to gastric acid. Phenoxymethylpenicillin is acid stable, unlike
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benzylpenicillin and can therefore can be administered orally (Wright and
Wilkowske, 1991).
In 1959 it was found that benzylpenicillin could be treated with an acylase to yield 6-
aminopenicillanic acid (6-APA), this was an important discovery because 6-APA
could then be substituted with various side chains to produce derivatives with
improved oral absorption and a broader spectrum of activity (Rolinson, 1988). A
further aim at this time was to develop penicillins active against penicillinase
producing Staphylococcus aureus, which had emerged as a serious clinical problem
(Barber and Whitehead, 1949). Methicillin was the first penicillin stable to the
staphylococcal penicillinase and was followed by the appearance of the isoxazolyl
penicillins (oxacillin, cloxacillin, dicloxaciilin and flucloxacillin). These penicillins
were stable to the staphylococcal penicillinase because they carry a bulky R] side
chain which sterically inhibits the enzyme action (Figure 1.5) (Doyle et al., 1961;
Knudsen et at., 1962; Sutherland et al., 1970).
Ampicillin was the first penicillin to be active against many common Gram-positive
and Gram-negative pathogens and involved adding an amino group as a side chain to
the basic benzylpenicillin molecule (Figure 1.5). Amoxycillin is closely related to
ampicillin in structure and function but demonstrates improved oral absorption.
Carbenicillin was the first penicillin to show significant activity against P.
aeruginosa. Replacing the amino side chain group of ampicillin with a carboxyl
group (Figure 1.5) produced Carbenicillin Carbenicillin and ticarcillin are both
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examples of carboxypenicillins. The ureidopenicillins (azlocillin, mezlocillin and
piperacillin) are P. aeruginosa active ampicillin derivatives and have somewhat
better activity than the carboxypenicillins against P. aeruginosa (Nathwani and
Wood, 1993). Both the carboxypenicillins and ureidopenicillins can only be
administered parenterally.
Temocillin is a derivative of ticarcillin and is the only penicillin to show general P-
lactamase stability (Slocombe et al., 1981). It is a 6-a-methoxy (OCH3) group of
Temocillin that makes it resistant to bacterial P-lactamases. The disadvantage of
temocillin is its narrow-spectrum of activity, which is restricted to the
Enterobacteriaceae (Wright and Wilkowske, 1991).
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The successful discovery of penicillin promoted the search for other antibiotic-
producing microorganisms. The fungus Cephalosporium cicrentomum was found to
produce an antibacterial substance Cephalosporin C (Abraham and Newton, 1961).
7-Aminocephalosporanic acid (7-ACA) can be derived from cephalosporin C by
chemical means and it is from this molecule that the various cephalosporins originate
(Morin et a/., 1962).
Unlike the 6-APA core of penicillins the 7-ACA nucleus of cephalosporins can be
modified with two different side chains R-i and R2 (Figure 1.4). As with the
penicillins modification of the basic structure has produced a variety of compounds
with differences in spectrum of activity and pharmacokinetics. The cephamycins
such as cefoxitin, which was initially derived from Streptomyces lactcimdurams, are
also generally considered along with the 'true' cephalosporins (Oniski et al., 1974).
Cephamycins are similar in structure to the cephalosporins except they are
substituted at C-7 with a 7-a-methoxy group, which enhances P-lactamase stability.
Figure 1.6 gives examples of the structural formulas of the R-, and R? cephalosporin
side chains. The substituent at the Ri position generally affects antibacterial activity
and P-lactamase stability whereas, position R2 affects pharmacokinetic behaviour
and metabolic stability.
Cephalosporins are traditionally classified according to generations that are based on
the date they were introduced clinically and on their antibacterial properties. The
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first generation agents have a narrower spectrum and are more active against Gram-
positive bacteria than subsequent cephalosporin generations. The second-generation
cephalosporins demonstrate an improved anti-Gram-negative spectrum of activity,
which in some cases includes activity against anaerobes (for example the
cephamycins cefoxitin, cefotetan and moxalactam). The greatest anti-Gram-negative
activity has, however, been achieved with the third and newly described fourth
generation agents. Representatives of the cephalosporin generations along with
routes of administration are listed in Table 1.2.
The oxyaminothiazolyl group, that can be present at the Ri position, enhances Gram-
negative activity it is incorporated into most third and fourth generation
cephalosporins (see R] side chain of ceftazidime - Figure 1.6). The
oxyaminothiazolyl group blocks the access of (3-lactamases to the (3-lactam ring.
Attaching an acidic moiety on the Ri side chain (as in ceftazidime and moxalactam)
increases cephalosporin activity against P. aeruginosa (O'Callaghan, 1979). The
presence of a bulky side chain at the R: position markedly impairs oral absorption;
orally administered cephalosporins (such as cephalexin) generally have a simple
methyl group at this position (Figure 1.6).
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Table 1.2 Classification of the cephalosporins
First generation Second generation Third generation Fourth generation
Cephalothin (P) Cefamandole (P) Cefopcrazone (P) Cefepimc (P)
Cepluiloridine (P) Cefotctan (P) Cefotaxime (P) Cefpirome (P)
Cefazolin (P) Cefoxitin (P) Ceftazidime (P)
Cephalexin (O) Ceftriaxone (P)
Cefaclor (O) Moxalaclam (P)
O - oral administration, P - parenteral administration.
1.5.3 Monobactams
Monobactams were discovered as naturally occurring compounds in Gram-negative
soil bacteria (Sykes and Bonner, 1985) The weak antibacterial activity of these
natural single-ringed substances led to the development of synthetic monobactams.
Aztreonam was subsequently made available for clinical use in the 1980s (Figure
1.7). Aztreonam has no affinity for the PBPs of Gram-positive bacteria or anaerobic
organisms and is considered a narrow-spectrum antibiotic, with its activity confined
to Gram-negative bacteria including P. aeruginosa (Brewer and Hellinger, 1991).
Aztreonam has the oxyaminothiazolyl side chain (at Ri) which is present in many
third and fourth generation cephalosporins Aztreonam is administered parenterally,
oral absorption being poor (Brewer and Hellinger, 1991).
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The carbapenems have the broadest antibacterial spectrum of any currently available
P-lactam and are active against Gram-positive and Gram-negative pathogens,
aerobes and anaerobes. Thienamycin, produced by Streptomyces cattleya, was the
first natural carbapenem to be discovered in the mid 1970s, however, it was found to
be chemically unstable (Figure 1.8) (Barza, 1985; Moellering et a!., 1989).
Imipenem (N-formimidoyl-thienamycin) is a semi-synthetic derivative of
thienamycin and was introduced into the clinical setting in the 1980s (Figure 1.8).
Finding new carbapenems has been relatively difficult because of their metabolic and
chemical instability, together with poor semi-synthetic yields (Barza, 1985). The
carbapenem choice has been extended by the addition of meropenem (Figure 18),
and panipenem, the latter is available only in Japan (Edwards, 1995). These agents
are all parenterally administered.
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The carbapenems have high affinity for PBPs in the majority of bacteria the
exceptions are methicillin-resistant S. aureus (MRSA) and Enterococcus faecium.
PBP2 is the primary target of both meropenem and imipenem. Binding of the
carbapenems to PBP2 is an advantage because there are relatively fewer molecules
of PBP2 compared with other essential PBPs; therefore, inhibition of PBP2 can be
achieved at lower antibiotic concentration (Williams et a/., 1986). Although both
imipenem and meropenem bind to PBP2, there are some differences between
imipenem and meropenem with regard to the additional PBPs that they can bind to;
for example, meropenem is thought to have greater potency against P. aeruginosa
because unlike imipenem it has affinity for both PBP2 and PBP3 (Edwards and
Turner 1995).
Both imipenem and meropenem have low molecular weights, are zwitterions, and
have a hydrophilic structure; these properties account for their ability to penetrate
bacteria readily (Moellering et at., 1989). At position C-6 the carbapenems have a
side chain in the trans conformation, this conformation is different from all other (3-
lactams, which have a substituent at the C-6 or C-7 that is in the cis position (Figure
1.8). The conformation of this side chain is associated with the stability of the
carbapenems to many of the clinically relevant (3-lactamases (Livermore and
Williams, 1996).
The major differences between imipenem and meropenem are pharmacological
rather than microbiological. Imipenem (and panipenem) unlike meropenem is
destroyed by a renal enzyme dehydropeptidase I (DHP-I) to an inactive but
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nephrotoxic metabolite. Imipenem is administered with cilastatin which inhibits
DHP-1, preserving imipenem and preventing renal toxicity (Moellering et a/., 1989).
The imipenem C-2 side chain is responsible for susceptibility to hydrolysis by DHP-
1, and a methyl group at C-l has been associated with the enhanced resistance of
meropenem to DHP-1 (Moellering et a/., 1989). Imipenem has the potential for CNS
disturbances, meropenem appears not to cause seizures and is suitable for the
treatment ofmeningitis (Wiseman et al1995).
Although, the first carbapenem was clinically introduced at a similar time to the
3GCs and aztreonam, carbapenem resistance has been developing much more slowly
compared with these agents. Carbapenem-resistant bacteria are however beginning
to be described with increasing frequency, especially in geographical areas where
carbapenems have been widely employed. Moreover, an expanding number of
different carbapenem hydrolysing P-lactamases can be identified from these
carbapenem resistant isolates (discussed in Sections 1.11 - 1.12), especially in
geographical areas were carbapenems have been employed widely. Therefore, as
with all other P-iactam classes, the P-lactamases look set to seriously damage the
therapeutic reliability of these agents.
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Two strategies have been adopted in the battle to overcome P-lactamase-mediated
resistance: (i) development of P-lactam antibiotics stable to P-lactamase hydrolysis;
(ii) combining a broad-spectrum P-lactamase labile P-lactam with a protective P-
lactamase inhibitor. Clavulanic acid (produced by Streptomyces clavuligerus) was






clinically (Brown el a/., 1976). The discovery of clavulanic acid stimulated further
work on p-lactamase inhibitors and led to the clinical introduction of sulbactam and
tazobactam which are penicillanic acid sulphones (English et al1978; Arnoff et al.,
1984) (see Figure 1.9 for chemical structures). All three compounds generally have
weak antibacterial activity and their advantage resides in their ability to inhibit
certain (3-lactamases (see Section 1.6).
The three clinically available P-lactamase inhibitors are all classed as irreversible
■"'suicide" inhibitors, that is they are molecules that bind initially at the P-lactamase
active site where they are then, through the catalytic action of the P-lactamase itself,
converted into an activator that renders the p-lactamase inactive (Bush, 1988).
Amoxyciliin/clavulanate, ticarciilin/clavuianate, ampicillin/sulbactam and
piperacillin/ tazobactam are examples of the commercially available P-lactam/p-
lactamase inhibitor preparations.
The main limit to the p-lactam/inhibitor combinations is that they are only effective
against certain P-lactamases, namely molecular class A and some molecular class D
P-lactamases that are described below (Livermore, 1993a).









1.6 Classification of the [^-lactamases
1.6.1 The Ambler classification scheme
There are two commonly cited P-lactamase classification systems. The classification
scheme initiated by Ambler (1980) is based on the amino acid sequence around the
P-lactamase active site and now consists of four classes A, B, C and D (Jaurin and
Grundstrom, 1991; Huovinen el cil„ 1988). Ambler classes A, C, D are the serine p-
lactamases whereas class B enzymes are metallo-p-lactamases. The primary
structure and catalytic mechanisms of metallo-P-lactamases and serine P-lactamases
are completely different and are discussed below (Section 1.7 - 1.8). A fifth
molecular class (E) has been proposed for the metallo-P-lactamases from
Stenotrophomonas maltophilia (Bicknall el a/., 1985), however, these enzymes are
generally referred to as class B P-lactamases.
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1.6.2 The Bush classification scheme
The Bush classification scheme is the most complete system so far to be devised for
(3-lactamases and correlates substrate and inhibitor profiles with molecular class
(Bush et a/., 1995). This classification system does not use the location of the gene
encoding the (3-lactamase as a classification factor, and this reflects the appreciation
of the mobility of P-lactamase genes, with chromosomal genes finding their way to
plasmids and vice-versa. This classification scheme has divided P-lactamases into
four main functional groups (Table 1.3).
Table 1.3. The four main functional groups of Bush's classification
scheme (adapted from Bush et aL, 1995)








1 Cephalosporinase C No No AmpC. MIR-1
2a Penicillinase A Yes No S. aureus PCI. LEN-1
2b Broad-spectrum A Yes No TEM-1. TEM-2. SHV-1
2be Extended-spectrum A Yes No TEM-3. SHV-2
2br Inhibitor resistant A Diminished No TEM-30. TRC-1
2c Carbenicillinase A Yes No PSE-1. CARB-3. BRO-1
2d Cloxacillinase D or A Yes No OXA-1
2e Cephalosporinase A Yes No L2. B. fragilis CepA
2f Carbapenemase A Yes No Sme-1. Nmc-A. IMI-1
3* Metalloenzvmc B No Yes LI. IMP-1. CphA
4 Penicillinase No No B. cepacia LCR-1
* Rasmussen and Bush (1997) have proposed a subgroup of group 3 metallo-P-
lactamases based on functional characteristics (Section 1.11)
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1.6.2.1 Bush group 1
The majority of Gram-negatives produce chromosomally encoded group 1
cephalosporin-hydrolysing p-lactamases, including most enterobacteria, P.
aeruginosa, Acinetobacter spp. and Aeromonas spp. (Bush el ai., 1995). Group 1
enzymes from different species resemble one another and they are often referred to
as AmpC-type P-lactamases, however, the expression of these enzyme is known to
vary between species (Livermore, 1987). Clavulanic acid, tazobactam and sulbactam
do not demonstrate good activity against this group of enzymes and therefore, they
cannot be employed clinically to overcome this class of P-lactamases (Zhou el ai.,
1993). In vitro, a compound known as BRL.42715 has been shown to be a much
more effective inhibitor of the Bush group 1, molecular class C cephalosporinases
when compared to clavulanic acid, tazobactam and sulbactam; it additionally has the
ability to inhibit molecular class A and class D P-lactamases (Coleman et a/., 1989).
1.6.2.2 Bush group 2
Members of the group 2 P-lactamases have a diverse substrate profile and fall into
six subgroups based on their preferential hydrolysis of penicillins, cephalosporins,
oxyamino-cephalosporins, cloxacillin, carbenicillin or carbapenems. With the
exception of the 2br subgroup these enzymes are sensitive to clavulanic acid,
sulbactam and tazobactam. This group contains some of the most common P-
lactamases including the staphylococcal penicillinase, TEM-1 and SHV-1 and as
with many of the group 2 P-lactamases these are found on plasmids. The group 2f
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carbapenemases (Section 1.12.1) and group 2br TEM-derived (3-lactamases with
diminished sensitivity to clavulanate are the most recent subgroups.
1.6.2.3 Bush group 3
This functional group contains the zinc requiring metallo-|3-lactamases; in vitro these
enzymes are inhibited by metal-ion chelating agents such as EDTA and also the
amino acid modifier /;-chloromercuribenzoate (pC'vlB), but not by serine-directed
inhibitors. Payne el at., (1997) have recently reported the inhibition of some
metallo-P-lactamases by mercaptoacetic acid thiol ester derivatives. The metallo-P-
lactamases hydrolyse a broad-spectrum of substrates, most notably the carbapenems.
This group of enzymes will be discussed later in detail (Section 1.11).
1.6.2.4 Bush group 4
This group consists of a small number of penicillinases not well inhibited by
clavulanic acid. (Bush et a! , 1995).
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1.7 Mechanisms of (3-lactam hydrolysis by serine (3-lactamases
Most (3-lactamases are serine-based and belong to a superfamily of serine-proteases,
that includes the PBPs. The reaction catalysed by (3-lactamases and PBPs is
essentially the same:
1 2 3
E + So ES -> E-S -> E+P
E represents the enzyme (either (3-lactamase or PBP), S represents the (3-lactam
substrate, ES is a non-covalent intermediate and E-S represents the formation of a
covalent acyl-enzyme intermediate. The main difference between the reaction
catalysed by (3-lactamases and the reaction catalysed by PBPs is the rate of the
deacylation step (reaction 3). The deacylation step proceeds rapidly with (3-
lactamases but with PBPs this reaction is very slow or does not happen at all. (3-
Lactamases, therefore, can hydrolyse the (3-lactam to form an inactive antibacterial
product whereas the PBPs are inactivated by the (3-lactam as result of the long-lived
acyl-enzyme intermediate (Sanders and Sanders, 1992).
The serine [3-lactamases (Ambler classes- A, C, and D) possess at least three highly
conserved functional and structural elements at their active site, that supply most of
the groups involved in catalysis. These elements are commonly referred to as the
serine-X-X-lysine (SXXK -X is any amino acid), serine-aspartic acid-asparagine
(SDN) and lysine-threonine-glycine (KTG) motifs (Bush, 1997). The serine residue
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of the SXXK element is responsible for the attack on the carbonyl C of the (3-lactam
ring and for class A (and class D) enzymes this residue is designated serine-70, this
is based on a standard numbering scheme proposed by Ambler et a/., (1991). In
class C P-lactamases the active site serine is at position 64 (Medeiros, 1997).
The SXXK, SDN and KTG motifs are also also conserved in PBPs (Table 1.4), thus
the serine p-lactamases and PBPs are thought to share a common evolutionary
ancestor (Frere, 1995). Additionally, x-ray crystallography has shown that the class
A and class C P-lactamases closely resemble the R61 D,D-peptidase from a
Streptomyces species (Frere, 1995).
Table 1.4 Conserved elements of serine P-lactamases involved in
catalysis (adapted from Bush, 1997).
(Tlactam-interactive Element 1 Element 2 Element 3
protein





Class C p-lactamase 64 150 314
S-X-X-K Y-A-N K-T-G
Class D p-lactamase 70 144 214
S-X-X-K Y-G-N K-T-G
R61 D.D-peptidasec 62 159 298
S-X-X-K Y-S-N H-T-G
d Amino acid numbering according to Ambler el al., (1991).
b
X - any amino acid
L PBP ofStreptomyces species R.61 (Kelly and Kuzin, 1995)
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In the class A (3-lactamase mechanism of action lysine (K) 73 (Table 1.4) acts as a
general base and deprotonates the hydroxyl group of serine (S) 70 (Table 1.4). This
proton is then donated to serine 130 (Table 14) which in turn donates the proton to
the nitrogen atom of the (3-lactam amide bond (Stryndka et al., 1992), this results in
the fission of the amide bond (Figure 1.10). Class C P-lactamases have a tyrosine
residue at position 150 which corresponds to serine 130 in class A P-lactamases and
has been shown to be important for the hydrolysis of substrates but is not essential
for the activity of the enzyme (Dubus et al., 1994). The acyl-enzymes complex is
bulky and only a small molecule such as water can gain access to the carbon atom to
release the enzyme (Figure 1.10). In class A P-lactamases a glutamate residue at
position 166 has been proposed as a possible residue to act as a general base and
deprotonate the water molecule and donate the proton to the oxygen atom causing the
bond between the enzyme and inactive P-lactam to break (Figure 1.10).
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1.8 Mechanism of (3-lactam hydrolysis by metallo-P-lactamases
The mechanism of (3-lactam hydrolysis by class B metallo-p-lactamases is
completely different from that of the serine (3-lactamases and is known to involve a
nucleophilic attack on the carbonyl carbon of the (3-lactam ring by a water molecule
polarized by a zinc ion. Conserved catalytic structural motifs are also shared
amongst the small number of metallo-P-lactamases, although there is considerable
sequence divergence among different members (Figure 1.11).
The crystal structures of three metallo-P-lactamases have been resolved these are P-
lactamase II from Bacillus cereus 569/H, CcrA3 from Bacteroides fragilis QMCN3
and LI from S. maltophilia 11D12 75 (Carfi et a/., 1995; Concha el a/., 1996; Carfi et
a!., 1998a, Carfi et a/., 1998/?; Ullah et a/., 1998). These enzymes all exhibit an
ap/p« fold that is unique to the metallo-P-lactamases (Ullah et al, 1998). The
metallo-P-lactamase polypeptide chain is divided into two domains with the central
P-sheets obeying an approximate two-fold symmetry relationship. The metalio-p-
lactamase site is located in a groove between the two P-sheets which is associated
with a number of loops which bear the residues linked with zinc binding (Ullah et a/.,
1998). All protein zinc ligands are strictly conserved in all class B enzymes with the
exceptions of two mutations -a histidine to asparagine change in the Aeromonas
metallo-P-lactamases and a cysteine to aspartate change in the S. maltophilia
metallo-P-lactamase (Ullah et al., 1998)
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Figure 1.11 Sequence alignment for some molecular class B metallo-
P-Iactamases (adapted from Carfi et al., 1998a)
CcrA3 1 AQKSVKISD—DISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQA 48
Bill 1 SQKVEKTVIK-NETGTISISQLNKNVWVHTELGSFNGEA-VPSNGLVLNTSKGL 52
IMP-1 1 AESLPDLKIEKLDEGVYVHTSFEEVNGWGWPKHGLWLVNAEA 44
CphA 1 AAGMSLTQVSGPVYWEDNYY-VQENSMVYFGAKGV 35
LI 1 VDASWLQPMAPLQIADHTWQIGT-EDLTALLVQTPDGA 37
CcrA3 49 ALLDTPINDAQTEMLVNWVTDSLHA-KVTTFIPNHw|GDCIGGLGYLQRK-GVQ 100
Bin 53 vlvdsswddkltkeliemvekkfqk-rvtdviitHAIIaSriggiktlker-gik 104
IMP-1 45 YLIDTPFTAKDTEKLVTWFVERGY—KIKGSISSjFjslsTGGIEWLNSR-SIP 95
CphA 36 TWGATWTPDTARELHKLIKRVSRK-PVLEVINTNYHTDRAGGNAYWKSI-GAK 87
LI 38 VLLDGGMPQMASHLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAK 91
CcrA3 101 SYANQMTIDLAKEK GLPVPEHGFTDSLTVSLDGMPLQC 138
Bill 105 AHSTALTAELAKKN GYEEPLGDLQTVTNLKFGNMKVET 142
IMP-1 96 TYASELTNELLKKD GKVQATNSFS-GVNYWLVKNKIEV 132
CphA 88 WSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNWHDGDFTLQEGKVRA 141
LI 92 VAANAESAVLLARG GSDDLHFGDGITYPPANADRIVMDGEVITVGGIVFT 141
CcrA3 139 YYLGGGffATDNIWWLPTE NILFGGCMLKDNQATSIGNIS D-ADVTAW 185
Bill 143 FYPGKGHTEDNIWWLPQY NILVGGCLVKSTSAKDLGNVAD-AYVNEW 189
IMP-1 133 FYPGPGHTPDNVWWLPER KILFGGGFIKP YGLGNLGD-ANIEAW 176
CphA 142 FYAGPAHTPDGIFVYFPDE QVLYGNCILK EKLGNLSF-ADVKAY 184
LI 142 AHFMAGHTPGSTAWTWTDTRNGKPV-RIAYADSLSAPGYQLQGNPRYPHLIEDY 194
CcrA3 185 PKTLDKVKAKFPSARYWPG1GD-YGGTELIEHTKQIVNQYIESTSKP 232
Bill 190 STSIENVLKRYRNINAWPGlGE-VGDKGLLLHTLDLLK 227
IMP-1 177 PKSAKLLKSKYGKAKLWPSHSE-VGDASLLKLTLEQAVKGLNESKKPSKPSN 228
CphA 185 PQTLERLKAMKLPIKTVIGGHDSPLHGPELIDHYEALIKAAPQS 228





LI 247 dgqlaketagar 257
CcrA3 - B. fragilis metallo-p-lactamase, Bill - P-lactamase II from B. cereus, IMP-1
found in S. marcescens, CphA - Aeromonas hydrophila metallo-P-lactamase, LI - S.
maltophilia metallo-P-lactamase.
Amino acids in red type indicate zinc-binding ligands.
Amino acids in blue type indicate zinc-binding ligand mutations in the A. hydrophila
CphA metallo-P-lactamase and the S. maltophilia LI metallo-P-lactamase.
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Two zinc binding sites are identified in the metallo-(3-lactamases although their
requirement for zinc has been shown to differ from enzyme to enzyme For example
the CphA metallo-P-lactamase from A. hydrophilci AE036 is known to function
optimally in a mono zinc form, when a second zinc site is occupied enzyme activity
was found to be inhibited (Valladares et al., 1997). Conversely, the metallo-P-
lactamases from B. fragilis and S. maltophilia require two Zrf+ ions for optimal
activity. The P-lactamase 11 enzyme from B. cereus was thought to be active in a
mono zinc form (Carfi et a!., 1995), however, more recently it has been found bind a
second zinc (highly pH dependent) which increases its activity (Carfi et a/., 1998/?).
In the B. fragilis CcrA3 model (proposed by Concha et a!., 1996) a zinc ion (Znl) is
coordinated by three histidines (FI82, H84 and H145 - CcrA3 numbering, Figure
1.11 and 1.12) and to a hydroxide that is also shared by the second zinc ion (Zn2).
The second zinc (Zn2) is coordinated in a trigonal bipyramidal geometry to an
aspartate, cysteine, histidine triad (D86, CI64 and H205), the shared hydroxide and
to an apical water molecule. Substrate binding involves the interaction of the (3-
lactam carbonyl oxygen with Znl and the P-iactam carboxyiate group with a lysine
residue (K. 167). The shared hydroxide makes a nucleophilic attack on the carbonyl
carbon to form a tetrahedral intermediate. The apical water is then thought to
transfer a proton to the nitrogen of the cleaved P-lactam (Concha et a/., 1996; 1997).
A mechanism of action has been proposed for the single zinc form of the B. cereus p~
lactamase 11 enzyme (described by Carti et a!., 1995), however, as mentioned above,
this enzyme is now known to function optimally when a second zinc is bound (Carfi
et cil., 1998b). The first zinc (Znl) is bound in a similar fashion to the CcrA3
enzyme by the equivalent three histidines (H86, H88, HI49 - P-lactamase II
numbering, Figure 1.11) and one water molecule, however, the second zinc is
coordinated by one histidine, one cysteine, one aspartate (H210, CI68, D90) and one
unknown molecule (possibly a carbonate ion).
In the S. maltophilia L1 metallo-P-lactamase model there are also some differences
in the residues involved in catalysis compared with the CcrA3 mechanism (Ullah et
a/., 1998). Znl is coordinated by the conserved histidine triad at positions 72, 74 and
148 (LI numbering Figure 1.11) and a shared hydroxide. The pentavalent Zn2 is
ligated to an aspartate, histidine, histidine triad (D76, H77 and H213, LI numbering-
Figure 1.11) instead of the aspartate, cysteine, histidine triad in CcrA3 (the cysteine
residue is absent in the LI sequence), the shared hydroxide and apical water are,
however, equivalent to those found in CcrA3. As in the B. fragilis model the shared
hydroxide functions as a nucleophile. The carboxylate moiety of the P-lactam is
however hydrogen-bonded to a serine residue (S175) as opposed to the lysine (KI67,
CcrA3 numbering) residue of CcrA3, it should be noted that lysine is conserved in
this position in all metallo-P-lactamases except for LI (Ullah et a/., 1998).
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Figure 1.12 Proposed catalytic mechanism of the CcrA3 metallo-P-
lactamase (Concha et al., 1996)
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1.9 The regulation of P-lactamase expression
The expression of a P-lactamase is either inducible or constitutive. Induction can be
defined as the transient switching-on of P-lactamase synthesis and occurs when
bacterial cells are exposed to certain (3-lactams, otherwise known as inducing agents.
Conversely, constitutive P-lactam production is independent of an inducer being
present and is the mode of expression of many of the Gram-negative plasmid-
mediated P-lactamases. Changes in the level of P-lactamase expression can arise
from an increase in the number of gene copies encoding p-lactamase, alteration in
the promoter or attenuator regions affecting gene transcription, or from changes in
the regulation of inducible P-lactamase expression (Sanders and Sanders, 1992).
1.9.1 Model for the regulation of AmpC P-lactamases in Citrobacter freundii and
Enterobacter cloacae
Various models have been proposed to explain how the presence of a P-lactam
antibiotic may lead to increased transcription of genes encoding p-lactamases. One
widely accepted model of P-lactamase induction is based on the regulation of AmpC
P-lactamases in E. cloacae and C. freundii and appears to be interlinked with the
process of bacterial cell wall assembly and disassembly (Jacobs et a/., 1994).
In the proposed model cell wall fragments are released as a result of peptidoglycan
breakdown triggered by P-lactam inhibition of PBP activities A protein known as
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AmpG serves as a permease and transports a large cell wall muropeptide into the
cytoplasm and this contains anhvdro muramic acid (Normark et a/., 1990). An
AmpD protein (a muramyl-peptide amidase) specifically recognises substrates that
contain anhvdro muramic acid and can cleave the large muropeptide for the recycling
of the cell wall (Hdlt je et a/., 1994). The increased breakdown of peptidoglycan that
occurs as a result of P-lactam action leads to the AmpD enzyme becoming
overloaded and thus large muropeptides are able to escape the action of AmpD and
instead activate AmpR. AmpR is a DNA binding regulatory protein that can bind to
ampC and increase its transcription and results in P-lactamase synthesis. Mutation of
AmpD can lead to the modification of the muramyl-peptide amidase or to its
complete inactivation. Complete loss of AmpD results in constant hyperproduction
of P-lactamase and strains that have lost AmpD function are known as stably
derepressed mutants. Derepressed mutants occur naturally in inducible populations
usually at a frequency of 10~7 (Weidmann, 1986).
1.10 Mechanisms of carbapenem resistance
Soon after the introduction of the first carbapenem, imipenem, it became apparent
that resistance could develop to this P-lactam As with all other P-lactam classes
carbapenem resistance can result from one or a combination of mechanisms
including the association of outer membrane impermeability with a slow carbapenem
hydrolysing P-lactamase, a PBP alteration, or the production of an efficient
carbapenem-hydrolysing P-lactamase.
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1.10.1 Association of outer membrane impermeability and the production of a
P-lactamase
1.10.1.1 Association of outer membrane permeability change and a Bush group
1 cephalosporinase in P. aeruginosa
P. aeruginosa strains were amongst the earliest imipenem-resistant bacteria to be
isolated, often from patients suffering from either cystic fibrosis or nosocomial
respiratory tract infections (Acar, 1985; Pedersen et a/., 1985). In the 1970s P.
aeruginosa infections were identified as a serious problem resulting from the
microorganisms high intrinsic resistance to a number of antibiotics and the
production of antibiotic modifying enzymes (Bryan, 1979). It has been assumed that
poor antibiotic permeability across the outer membrane is attributable to a limited
number of small-sized diffusion pores that exclude many antibiotics; imipenem
overcame this difficulty by penetrating through the D2 porin (Yoshihara and Nakae,
1989). However, imipenem resistance was subsequently found to be associated with
the loss of this outer membrane protein (OMP) D2 (Buscher et a/., 1987; Lynch et
a/., 1987) D2 is a trimer that forms a selective channel for low molecular weight
zwitterionic compounds such as imipenem (Yoshihara et a/., 1991; Gotoh and
Nishino, 1990).
Although impermeability has a major role to play in imipenem resistance in P.
aeruginosa it has been recognised that it is the combination of the P. aeruginosa
chromosomal cephalosporinase and a change in permeability that results in a
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resistant phenotype (Livermore, 1992a). Imipenem hydrolysis has been detected
with several Bush group 1 cephalosporinases, however, imipenem hydrolysis occurs
at a very slow rate (Livermore and Yang, 1987). The importance of these enzymes
in mediating resistance to the carbapenems is only apparent in a less permeable
background. The slowed rate of entry of imipenem through the outer membrane,
permits the large amount of slow acting p-lactamase in the periplasmic space to
inactivate imipenem before it reaches its target site on the cytoplasmic membrane
(Lindberg et al., 1987). Laboratory mutants of P. aeruginosa that lack D2 and P-
lactamase expression have been shown to be almost as susceptible to imipenem as
mutants which expressed their full complement of D2 but no p-lactamase and this
indicates the need for both enzyme and permeability to produce resistance
(Livermore, 1992a). High level production of the eephalosporinase is not an
essential requirement and it has been shown that the cephalosporinase of P.
aeruginosa is part of the imipenem resistance mechanism whether it is inducible or
derepressed (Zhou el a/., 1993).
Meropenem resistance appears to be little affected by the type of P-lactamase
expression in P. aeruginosa mutants with or without D2 (Livermore, 1992a) and is
instead associated with a MexA-MexB-OprM mediated efflux system (Masuda and
Ohya, 1992, Chen et a/., 1995). This efflux system confers broad-spectrum cross-
resistance to P-lactams, quinolones, tetracyclines and chloramphenicol in P.
aeruginosa when it is over expressed, conversely inactivation of the efflux pump
results in a hypersensitive phenotype (Li et a/., 1995). Imipenem is not affected by
the MexA-MexB-OprM efflux mechanism and it has been suggested that a possible
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reason for this is that either the efflux pump does not recognise imipenem, or
imipenem enters the cell so rapidly that the pump is overwhelmed (Livermore,
1996).
1.10.1.2 Association of an outer membrane permeability change and a Bush
group 1 cephalosporinase in enterobacteria
To date, carbapenem resistance has been rarely described in members of the family
Enterobacteriaceae. One mechanism of carbapenem resistance that is described in
enterobacteria is the production of a plasmid or chromosomally encoded (5-lactamase
that efficiently hydrolyses the carbapenems (see Section 1.11). Another mechanism
of carbapenem resistance in the Enterobcicteriaceae is a reduction in outer membrane
permeability that is generally coupled with high-level cephalosporinase production.
This has been reported in Enterobacter aerogenes (Chow and Shlaes, 1991, De
Champs el a/., 1993; Erhard et al., 1993, Hopkins and Towner, 1990; Tzouvelekis et
at., 1992), E. cloacae (Bush et al., 1985; Lee et a!., 1991; Raimondi et al., 1991),
Providencia (Proteus) rettgerii (Raimondi et al., 1991), Proteus mirabiUs (Mentar et
ci/., 1991), C. freundii (Marinardi et al., 1991) and Klebsiella pneumoniae (Bradford
et al., 1997) MacKenzie et a! (1997) recently described a carbapenem resistant K.
pneumoniae isolate, identified during an outbreak in Scotland, however, the
resistance mechanism was different from the one described by Bradford et al. (1997)
and involved the loss of an OMP and increased production of an SHV-type extended
spectrum P-lactamase (MacKenzie et al., 1997).
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The emergence of carbapenem resistant species that belong to the
Enterobacteriacecie is disturbing as these organisms are commonly encountered
hospital pathogens, particularly in intensive care units, and the carbapenems are one
of the few antibiotic-options left available for their treatment (Bradford et ci/., 1997;
de Gheldre el a/., 1997). It has been suggested that the selection of cephalosporinase
overproducing strains by broad-spectrum cephalosporins might subsequently
facilitate the selection of carbapenem resistant strains. Fortunately, however, at
present carbapenem resistant Enterobacteriaceae, with decreased permeability and
hyperproduction of the chromosomal cephalosporinase remain rare, and it is
interesting that, in the absence of imipenem porin deficient mutants are rapidly
overgrown by revertants that have normal amounts of porin (Raimondi et a!., 1991).
Therefore, in the absence of imipenem, porin deficient mutants appear to be at a
disadvantage, which may be due to the inability to accumulate certain nutrients
(Livermore, 1991)
i.10.2 Carbapenem-resistance and PBP modification
Alterations in PBPs leading to carbapenem resistance appear to be of little
importance in Gram-negative bacteria. There are, however, examples of where PBP
modification has been associated with resistance, such as in imipenem-resistant
Acinetobacter baumanii and P. aeruginosa (Gehrlein et a/., 1991; Bellido et al.,
1990). PBP modification and carbapenem resistance is much more important in
Gram-positive species. MRSA, E. faecium and Listeria monocytogenes are three
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examples of Gram-positive organisms with PBP alterations leading to imipenem
resistance (Livermore. 1996, Pierre et a/., 1990).
1.10.3 Carbapenem hydrolysing (3-lactamases
Carbapenem hydrolysing enzymes include some of the most recently described (3-
lactamases. The molecular class C, Bush group 1 cephalosporinases could also be
included in this group. However, the carbapenerns do not represent a major substrate
in their hydrolytic profile and their carbapenemase activity is only of significance
when coupled with impermeability. In contrast, several other (3-lactamases
efficiently hydrolyse the carbapenems and can be the primary cause of resistance.
The carbapenem-hydrolysing (3-lactamases are often referred to as 'carbapenemases',
although it should be stressed that they do not exclusively hydrolyse carbapenems
nor do they confer resistance to only imipenem and or meropenem. Carbapenemases
can confer resistance to other (3-lactams and may hydrolyse penicillins or
cephalosporins more efficiently than the carbapenems. Carbapenemases can be
divided into two groups according to whether they are metallo-(3~lactamases or serine
(3-lactamases.
1.11 Carbapenem-hydrolysing metallo-P-Iactamases
The chromosomal Iv encoded B. cereus II enzyme was the first metallo-(3-lactamase
to be described back in 1966. It was shown that the cephalosporinase activity of the
metallo(3-lactamase II enzyme could be inhibited by EDTA, and for many years the
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B. cereus metallo-P-lactamases were considered to be biochemical curiosities
(Sabath and Abraham, 1966). Following the identification of the B. cereus II |3-
lactamase, further metallo-P-lactamases were reported in S. maltophiUci, Myroides
odoratus (formerly Flcivobacterium odoratum) and Legionella gormami. The clinical
significance of these enzymes was debatable because these organisms were
considered to be rare pathogens (Saino et a/., 1982; Sato et al., 1986; Fujii et aI.,
1986). Although the clinical importance of some these enzymes was under question
it was, however, speculated that carbapenemases belonging to the metallo-(3-
lactamase category would become the major threat to the reliability of the
carbapenems (Livermore, 1993b; Payne, 1993). Indeed, in the past five or six years
the clinical importance of metallo-P-lactamases has begun to be realised, as an
increasing number of established pathogens have been reported to produce metallo-
P-lactamases that are encoded by transferable plasmids (specifically the IMP-1 and
CcrA enzymes - see Sections 1.11.1.3 and 1.11.1.5) (Bandoh et al., 1992; Ito el a/..
1995; Minami el a!., 1996).
Rasmussen and Bush (1997) recently proposed a new classification of the Bush
group 3 metallo-P-lactamases and on the basis of functional characteristics placed
these enzymes into three subgroups (Table 1.5).
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Tablel.5 Functional classification of metallo-P-lactamases
Subgroup Enzyme Host organism
3a P-lactamase II Bacillus cereus
3a BlaB Chryseobacterium meningosepticum
3 a CcrA Bacteroidesfragilis
3 a LI Stenotrophomonas maltophilia
3a IMP-1 Serralia marcescens*
3b CphA Aeromonas hydrophila
3b PCM-1 Burkholderia cepacia
3b NN Myroides odoratus
3 c NN Legionella gormanii
NN-not named
* 1MP-1 first reported in S. marcescens
1.11.1 Bacteria that produce subgroup 3a nietallo-P-Iactamases
Subgroup 3a includes the metallo-P-lactamases produced by B. cereus,
Chryseobcicterium meningosepticam, B. fragilis, S. maltophilia and the IMP-1
metallo-P-lactamase identified in a variety of Gram-negative bacteria (Rasmussen
and Bush, 1997). These metallo-p-lactamases recognise a wide range of substrates
and hydrolyse penicillins at a rate comparable to or better than of imipenem,
although they usually hydrolyse cephalosporins more slowly than imipenem. The
broad spectrum activity of the subgroup 3a metallo-P-lactamases is thought to be
related to the direct interaction of P-lactams with the two zinc centres of these
enzymes (Ullah et al., 1998).
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1.11.1.1 Bacillus cereus (3-lactamase II metallo-p-laetamase
The zinc dependent B. cereus II enzyme is chromosomally encoded and inducibly
expressed (Rasmussen and Bush, 1997). The sequences of three P-lactamase II
enzymes have been determined, two from B. cereus isolates and one from an
alkalophilic Bacillus spp. and these sequences are very similar to one another
(Ambler et a!., 1985; Hussain et al., 1985, Kato et a!., 1985, Lime/ a!., 1988).
1.11.1.2 Metallo-P-lactamases produced by former Flavobacterium spp.
Bacterial species that were formerly found in the genus Flavobacterium are known to
produce carbapenemases. Blahova et al. (1994) initially described a carbapenemase
in Chryseobacterium (formerly Flavobacterium) meningosepticum and more recently
a metallo-p-lactamase known as BlaB that is produced by C. meningosepticum has
been characterised in detail BlaB has a broad substrate profile and therefore fits into
Bush subgroup 3a, this enzyme appears to be universally produced by this species
(Rossolini et al., 1998).
Sato et al. (1986) have also detected a carbapenemase in M. odoratus (formerly F.
odoratum) isolates, although this carbapenemase has been placed in subgroup 3b by
Rasmussen and Bush (1997).
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1.11.1.3 Metallo-(3-lactamases produced by Bacteroidesfragilis
Between 1-3% of B. fragilis isolates are known to produce a metallo-(3-lactamase
that has been named CcrA and CfiA (Bandoh el a/., 1993; Rasmussen et a/., 1994b;
Rasmussen el a/., 1997). Sequence analysis has revealed that CcrA and CfiA are
essentially the same enzymes and will be collectively referred to here as CcrA
(Rasmussen et a/., 1990; Thompson and Malamy, 1990). On a single occasion the
CcrA enzyme has been found on a small self-transmissible 13.6 kb plasmid (Bandoh
et a/., 1992), The sequence of this plasmid-encoded (3-lactamase is identical to the
chromosomal CcrA (3-lactamase (Rasmussen and Bush, 1997).
The majority of B. fragilis isolates that harbour Ccr.A express this enzyme at low
levels which does not confer clinical resistance (Rasmussen and Bush, 1997). The
expression ofCcrA is non-inducible, although increased expression ofCcrA, leading
to high level resistance, can occur and this most commonly involves insertion
sequence (IS) element insertions within the promoter region upstream of the Shine
Dalgarno box (Podglajen el ai., 1992; Podglajen et a/., 1994; Rasmussen and
Kovacs, 1991). The ccrA genes are transcribed from transcriptional initiation signals
provided by an IS element integrated within the promoter rather than from their
normal promoters (Podglajen et a/., 1994; Rasmussen and Kovacs, 1991). It is
interesting that IS elements are rare among B. fragilis isolates that do not harbour the
metallo-(3-lactamase gene (Podglajen et a/., 1995). Therefore, metallo-(3-lactamase
positive imipenem susceptible isolates can easily convert to being imipenem resistant
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in a single step by the insertion of an IS element into the promoter (Podglajen et al.,
1992; Podglajen et al., 1994).
Other than B. fragilis the only other Bacteroides spp. known to produce a
carbapenemase is B. distosonis and this enzyme appears to be distinct from CcrA
(Hurlburt et al., 1990).
1.11.1.4 MetaHo-(3-Iactamases produced by Stenotrophomonas maltophilia
High-level carbapenem resistance in S. maltophilia was first shown to be attributed
to a metallo-P-lactamase, named LI, by Saino et al.. (1982). The S. maltophilia
metallo-p-lactamases are inducible, chromosomally encoded enzymes that are found
universally within the species and can hydrolyse a range of clinically important P-
lactams (Akova et al., 1991; Felici and Amicosante, 1995), The broad-spectrum LI
enzyme, initially studied in S. maltophilia strain GN12873, was found to function as
a tetramer composed of four equal subunits and have an isoelectric point (pi) of 6.9
(Saino et al., 1982). Subsequent reports have shown that S. maltophilia isolates
produce metallo-P-lactamases with pi values different from that of the original LI
enzyme (Cullman and Dick, 1990; Payne et al., 1994a; Paton et al., 1994). Thus LI
from S. maltophilia GN 12873 is not solely representative of the metallo-P-
lactamases produced by this species.
An investigation by Payne et a!., (1994a) showed that 16 clinical isolates produced
seven different metallo-P-lactamases (m-P-ls) all differentiated by pi and designated
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m-P-1 types 1-7. Biochemical characterisation of m-P-1 types 1-6 further illustrated
subtle differences within this group of enzymes (Payne et a/., 1994b). The
differences in substrate profiles between this group of enzymes was most evident
with the chromogenic cephalosporin nitrocephin where hydrolysis rates ranged from
12-87% relative to imipenem (Payne et aI., 1994b).
To date, the metallo-P-lactamases from only two S. maltophilia strains (11D1275 and
GN12873) have been investigated and compared at the molecular level (Walsh et al.,
1994; Sanschagrin et al., 1998). These enzymes are known to share 88.6% amino
acid identity with one another, which further suggests that within the LI type
metallo-P-lactamase family there is a degree of heterogeneity (Sanschagrin et al.,
1998). Heterogeneity of these metallo-P-lactamases has important implications
particularly in terms of future drug design.
1.11.1.5 Producers of the IMP-1 meiallo-P-Iactamase
The molecular characterisation of a metallo-P-lactamase designated IMP-1 was first
described by Osano el al. (1994). IMP-1 was identified in a clinical strain of
Serratia marcescens and was isolated in Japan, the metallo-P-lactamase was
chromosomally encoded and it conferred resistance to imipenem and broad-spectrum
P-lactams (Osano et al., 1994). Prior to Osano's report, two other papers from Japan,
one written by Watanabe et al. (1991) and the other by Minami et al. (1993),
described unnamed plasmid mediated metallo-P-lactamase in P. aeruginosa and it is
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now known that Watanabe's metallo-p-lactamase is identical in sequence to IMP-1
(Iyobeetal., 1996).
Since these discoveries it is now recognised that the b/cti\u> gene has been dispersing
widely among Gram-negative bacteria in hospitals throughout Japan. However, as
yet there have been no published reports of the IMP-1 enzyme outside Japan. IMP-1
has been identified in P. aeruginosa, Pseudomonas putida, Pseudomonas
fltiorescens, S. marcescens, Alcaligenes xylosoxidans, K. pneumoniae, Acinetobacter
spp., P. rettgeri (Ito el a/., 1995; Senda el a/., 1996a; Senda et al1996b; Ito et al.,
1997). The />/c?imp cassette is found on a novel integron-like element where blaww is
located between the integrase gene (int/3) and the aminoglycoside acetyltransferase
gene (acc(6')-lb) and it is transposed into plasmids or the chromosomes of Gram-
negative bacteria by this integron element (Arakawa et al., 1995). Dispersion of
IMP-1 amongst Gram-negative bacteria is mediated by large transferable plasmids
with wide host ranges (Ito et a/., 1995) It has speculated that because of the
transferable nature of this P-lactamase, carbapenem resistant Gram-negative
organisms which produce IMP-1 may be prevalent in the near future (Senda et al.,
1996b).
It is interesting that the levels of carbapenem resistance found in IMP-1-positive
strains are diverse, although resistance to other P-lactams such as ceftazidime is
consistent (Senda et a/., 1996b). It is known that the acquisition of the IMP-1 gene
alone does not necessarily confer high-level carbapenem resistance (Senda et al.,
1996a). In P. aeruginosa high levels of carbapenem resistance have been shown to
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be associated with the diminished production of OMP D2 and the production of a
metallo-P-lactamase with similar properties to IMP-1 (Minami et al., 1993; Minami
et al., 1996). The combination of IMP-1 and decreased outer membrane
permeability has also been shown to be major factors in high-level carbapenem
resistance in S. marcescens (Maaimo el aI.. 1996). It has also been suggested that
additional factors such as secondary changes in regulatory systems of metallo-p-
lactamase gene expression, efflux system, and/or multiplication of the structural gene
may be implicated in conveying high level carbapenem resistance (Senda et al.,
1996a). The involvement of these factors, unlike impermeability, is however, less
likely because strains carrying IMP-1 are consistently highly resistant to other P~
lactams.
In Japan the carbapenems are the market leaders among parenteral P-lactams,
whereas in many other areas of the world their use is much more restricted
(Rasmussen and Bush, 1997). The widespread use of the carbapenems, imipenem
and also panipenem, has been suggested as a reason why IMP-1 has emerged in
Japan (Livermore, 1997). The heavy prescription of 1-oxa-cephamycins moxalactam
(latamoxef) and flomoxef has also been implicated in the selection of these IMP-1
producing strains (Livermore, 1997).
In recent reports from Japan great emphasis is often placed on the identification of
IMP-1 producing bacteria However, some of these papers have identified additional
non-IMP-1 carbapenem resistant isolates but these have been somewhat ignored. For
example one report identified twenty carbapenem-resistant S. marcescens strains and
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only four of these isolates tested positive for IMP-1, therefore the mechanism of
resistance in the remaining sixteen isolates remained undetermined (Ito el a/., 1995).
In a further report one hundred and thirty two carbapenem resistant P. aeruginosa
strains were probed for IMP-1 and fifteen strains were found to carry the />/«imp gene
and again the resistance mechanisms in the majority of the strains were not studied
(Senda el a/., 1996a). These points suggest that more thorough investigations are
required to assess the true importance of different carbapenem resistance
mechanisms.
1.11.2 Bacteria that produce subgroup 3b nietalIo-(3-lactamases
Subgroup 3b is composed of enzymes that have a strong preference for the
hydrolysis of carbapenems. The metallo-j3-lactamases from Aeromonas species, B.
cepacia and M. odoratus have been placed in this subgroup.
1.11.2.1 i\letaIlo-(3-lactaniases produced by Aeromonas spp.
Individual Aeromonas isolates have been found to produce up to three different
chromosomally encoded (3-lactamases, including a molecular class C Bush group 1
cephalosporinase, a molecular class A or D Bush group 2d penicillinase, and a
molecular class B Bush group 3b metallo-(3-lactamase (Hayes el a!., 1994; Walsh el
a/., 1995a; Hayes el a!., 1996). The Aeromonas metallo-(3-lactamases have a narrow
substrate profile-they display high catalytic efficiencies for imipenem, but poor
hydrolysis of either benzylpenicillin or cephaloridine (Rasmussen and Bush, 1997).
b
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It has been suggested that the narrow spectrum of activity of the Aeromonas metallo-
P-lactamases may be a consequence of their mono-zinc nature which results in
replacing direct metal substrate contacts with specific protein: substrate interactions
leading to the preservation of catalytic efficiency at the expense of a greatly reduced
spectrum of activity (Ullah et a/., 1998).
The narrow substrate spectrum of the Aeromonas metallo-P-lactamases has also been
a stumbling block in their identification as they poorly hydrolyse nitrocephin, the
standard substrate used for (3-lactamase detection (Segatore et a/., 1993). This is
illustrated by the work of Iaconis and Sanders (1990) who initially reported the
identification of two P-lactamases in a strain of A. jandaei AER14 (formerly A.
sobria), one of which was responsible for imipenem hydrolysis. Later, a Bush group
1, molecular class C cephalosporinase (AsbAl), and a Bush group 2d cloxacillin-
hydrolysing p-lactamase (AsbBl) were characterised genetically and biochemically
by Rasmussen et a/. (1994a). These two P-lactamases corresponded to the P-
lactamases from A. jandaei AER14 that were visualised on an IEF gel, however,
neither of these p-lactamases hydrolysed imipenem. More recently it has been
established that A. jandaei AER14 produces a third metallo-P-lactamase (AsbMl)
not detectable with nitrocephin and this had been co-purified with the AsbBl P-
lactamase in the original report by Iaconis and Sanders (1990). Felici et a/., (1993),
Hayes et at. (1994) and Walsh et al. (1995a) have also demonstrated that Aeromonas
metallo-P-lactamases display a very low activity against nitrocephin. The
Aeromonas metallo-P-lactamases are inhibited by EDTA and the addition of zinc has
been shown to restore activity after EDTA inhibition (Rasmussen and Bush, 1997).
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The sequences of three Aeromonas metallocarbapenemases have been previously
determined; these include two A. hydrophila genes, cphA and cphA2, and the A.
veronii bv. sobrici (formerly A. sobria) imiS gene (Massidda et al., 1991; Rasmussen
and Bush, 1997; Walsh et al., 1998). The amino acid sequences of CphA, CphA2
and ImiS share a high level of identity with one another (>96%). The production of a
metallo-P-lactamase related to CphA from A. hydrophila has been shown to be a
common feature amongst several different Aeromonas species including A. veronii
bv. sobria (Rossolini ei al., 1996). The N-terminus of an A. jandaei AsbM 1 metallo-
P-lactamase has also been sequenced but was shown to be only 26% similar to both
CphA and ImiS over the first 27 amino acids (Yang and Bush, 1996; Walsh ei al.,
1998). It has been speculated that if this low level of identity is maintained
throughout the protein it would indicate a major divergence of the metallo-p-
lactamases found in Aeromonas species (Walsh ei al., 1998).
Production of a metallo-P-lactamase is normally regulated in Aeromonas strains.
The enzyme is produced at negligible levels in the absence of an inducer, while its
production increases several hundred-fold in the presence of an inducer. Induction
leads to the expression of all three P-lactamases that have been shown to be present
in individual Aeromonas strains. Derepressed mutants that constitutively produce all
three P-lactamases can also be obtained and it appears that these enzymes are all
controlled by a common regulatory system (Walsh et al., 1995a). Recent studies
have shown that the expression of inducible chromosomally encoded P-lactamases in
Aeromonas species is controlled by a two component system that differs radically
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from the C. freundii paradigm for inducible P-lactamases (Alksne and Rasmussen,
1997; Niumsup eta/., 1997).
1.11.2.2 Burkholderia cepacia metallo-P-lactamase
A metallo-P-lactamase named PCM-1 that is produced by B. cepacia has also been
assigned to subgroup 3b (Rasmussen and Bush, 1997). PCM-1 has an unusual
inhibition profile in that it is inhibited by both metal-ion chelators and the inhibitors
clavulanate and tazobactam (Baxter and Lambert, 1994). PCM-1 is inducibly
expressed and appears to be ubiquitous amongst B. cepacia (Baxter and Lambert,
1994; Simpson et a/., 1993). No sequence is yet available for PCM-1.
1.11.3 Bacteria that produce subgroup 3c metalio-P-Jactamases
Subgroup 3c consists of the metallo-P-lactamase from Legionella gormanii, which is
distinguishable from the other metallo-P-lactamases because of its strong hydrolysis
of cephalosporins, including expanded-spectrum cephalosporins (Fujii et a/., 1986;
Rasmussen and Bush, 1997). The L. gormanii enzyme has not been studied in detail.
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1.12 Serine-based carbapenemases
1.12.1 Molecular class A Bush group 2f carbapenemases
Three molecular class A Bush group 2f carbapenemases have been characterised in
detail, these related enzymes have been designated IMI-1, NMC-A and Sme-1. IMI-
1 was identified from two E. cloacae strains in California in 1984, NMC-A was
found to be produced by a single E. cloacae strain isolated in Paris in 1990 and Sme-
1 was reported from two S. marcescens strains isolated in London back in 1982
(Nordmann et al., 1993; Rasmussen el al., 1996; Yang eta/., 1990). Recently, there
have been further reports of carbapenem resistant S. marcescens isolates producing a
non-metallo imipenem-hydrolyzing -(3-lactamase and it is presumed that these are
Sme-1 homologues (Quinn et a/., 1997; Carmeli et al., 1997).
The E. cloacae IMI-1 and NMC-A enzymes are highly homologous and share 95%
amino acid identity, whereas Sme-1 shares about 70% amino acid identity with these
two enzymes (Livermore, 1997). Although these enzymes have been found to be
chromosomally encoded, they have been referred to as 'acquired carbapenemases',
because they are supplementary to the normal chromosomal AmpC-type
cephalosporinase of E. cloacae and S. marcescens (Livermore, 1997). IMI-1, NMC-
A and Sme-1 are inducible (3-lactamases that are under the control of a LysR-like
regulator protein analogous to the AmpR regulator of Amp-C (Rasmussen et al.,
1996; Naas and Nordmann, 1994; Naas el al., 1995). Some of the features that
separate these serine carbapenemases from the metallo-p-lactamases include: greater
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resistance to imipenem than meropenem, with meropenem MICs often below the
breakpoints for susceptibility; hydrolysis of aztreonam (none of the metallo-P-
lactamases so far described can hydrolyse this substrate) and inhibition by clavulanic
acid (Livermore, 1997).
1.12.2 Acinetobacter carbapenemases
Carbapenem resistance is increasingly being reported in Acinetobacter spp. from
different geographical locations (Livermore, 1997). AR1-1 was the first reported
Acinetobacter carbapenem-hydrolysing J3-lactamase, and was produced by a strain of
A. baumanii that was originally isolated in Scotland in 1985 (Paton et a/., 1993).
ARI-1 was subsequently found to be encoded by a 45kb plasmid-mediated (Scaife et
a/., 1995).
More recently imipenem-hydrolysing p-lactamases have been identified in
carbapenem resistant strains isolated from South America, Europe, South East Asia
and the Middle East (Brown et a/,, 1998; Hornstein et a/., 1997; Weinbren et al.,
1998; Afzal-Shah and Livermore, 1998). Hornstein et al. (1997) detected an
oxacillin-hydrolysing P-lactamase that appears to be involved in the imipenem
resistance mechanism of a single Acinetobacter isolate and Brown et at. (1998) have
demonstrated the involvement of a plasmid-mediated molecular class A
carbapenemase. AR1-2, in clinical isolates from S. America, Europe and S. E. Asia.
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It should also be noted that a metallo-(3-lactamase has also been identified in an
Acimtobacter spp. although, there has been no molecular characterisation of this
enzyme (Perez et a/., 1996).
1.13 Clinical significance of carbapenemase-producing bacteria
Several different bacterial species have been found to produce carbapenemases.
Many of these organisms have in the past not been considered as classical hospital
pathogens, but have emerged as important causes of nosocomial infections in recent
years.
1.13.1. Acinetobacter spp.
For many years Acinetobacter spp. were not considered as clinically important
pathogens, however, they now account for 10% of nosocomial infections in intensive
care units in Europe alone (Brown et a/., 1998). Moreover, the nosocomial
Acinetobacter isolates are increasingly multi-drug resistant with the carbapenems
often being the treatment of choice (Amyes and Thomson, 1995; Hornstein et a/.,
1997). Therefore, the recent reports of carbapenem resistance in Acinetobacter are
of serious concern to the medical community. The ARI-2 plasmid-encoded
carbapenemase appears to be strongly associated with carbapenem resistance as it
has been demonstrated that a strain cured of an AR.I-2 bearing plasmid is susceptible
to the carbapenems, unlike the parent strain (Brown et al., 1998).
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1.13.2 Aeromonas spp.
Species of the genus Aeromonas are widely dispersed in aquatic environments and
are increasingly found to be causative agents in clinical infections. There are
currently fourteen species in the genus that have been defined using biochemical
typing methods, DNA-DNA hybridisation and 16S rRNA sequence data (Martinez-
Murcia and Esteve, 1992; Jones and Wilcox, 1995). The major pathogenic species
are A. veronii bv. sobria, A. hydrophila and A. caviae (Janda el al., 1995).
Gastroenteritis is one of the frequent Aeromonas associated infections and appears to
be common in countries with warmer climates. In some geographical regions
isolation rates of up to 50% have been recorded for symptomatic patients (usually
children under 5), although antibiotic treatment is usually unnecessary due to the
self-limiting nature (San Joaquin and Pickett, 1988; Thornley el al., 1997).
Aeromonads additionally cause skin and soft tissue infections, although these occur
more frequently in immunocompromised patients (Gold and Salit, 1992).
Aeromonas bacteraemia is most commonly seen in individuals with haematological
malignancies, solid tumours and hepatobiliary diseases, it is rare in
immunocompetent patients (Janda and Duffy, 1988, Golik el al., 1990). Additionally
reported Aeromonas infections include meningitis, endocarditis, ocular infections
and osteomyelitits (Frejj, 1984, Janda and Duffey, 1988).
Although most Aeromonas spp. produce an inducible carbapenemase, paradoxically,
when standard in vitro susceptibility is performed these bacteria remain sensitive to
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the carbapenems. Only a handful of naturally occurring carbapenem resistant
Aeromonas isolates have been recorded when testing with a conventional inoculum
size, these strains were derepressed for (3-lactamase production (Morita el al., 1994).
It is however, known that the carbapenem minimum inhibitory concentrations
(MICs) for Aeromonas strains that produce a carbapenemase are subject to an
inoculum effect. Employing a large inoculum of 10s colony forming units (cfu)
results in the carbapenem MICs becoming higher than the breakpoint for
susceptibility (Rossolini el al., 1996). However, it is highly improbable that the
bacterial population would be this large in vivo. Therefore, in its induced state the
metailo-P-lactamase is probably not of clinical importance.
1.13.3 BurkhoUleria cepacia
B. cepacia is traditionally thought of as a pathogen of onions (Burkholder, 1950),
however, more recently this organism has been recognised as an opportunistic
pathogen in humans, particularly cystic fibrosis (CF) patients where it is associated
with a rapidly fatal pneumonia and septicaemia (Pitt et al., 1996). Acquisition of B.
cepacia by CF patients is a problem because this organism is resistant to most
antibiotics, including carbapenems (Simpson et al., 1993). Carbapenem resistance in




Bacillus spp. are aerobic Gram-positive bacilli that are usually found in soil, water,
air and on vegetation. B. cereus is primarily associated with toxin-mediated food
poisoning, and it is B. anthracis that is principal Bacillus spp. pathogen. Isolates of
Bacillus spp. from clinical specimens are generally dismissed as contaminants,
although non-anthrax Bacillus spp are occasionally reported to cause infections in
immunocompromised patients. These infections in immunocompromised individuals
remain extremely rare (Blue et al., 1995; Strittmatter et al., 1996; Berner et aI.,
1997). The prevalence of metallo-P-lactamase II in Bacillus spp. has not been
studied in any detail, it is thought, however, that this enzyme is universal in B. cereus
(Livermore, 1992).
1.13.5 Bacteroiiles spp.
Bacteroides spp. are among the most clinically important anaerobic bacteria for two
reasons. Firstly, they are the bacteria most often isolated from patients with post
surgery anaerobic infections, and secondly they are resistant to a broad range of
antimicrobials. (3-Lactams are one of the agents most widely used to treat anaerobic
infections (Rasmussen et a/., 1997). Cefoxitin, an agent formerly highly active
against anaerobes now displays decreased potency and imipenem is often the main
hope in terms of P-lactam therapy in conquering anaerobic infections. The
identification of the CcrA carbapenemase in B. fragihs jeopardises the effectiveness
of imipenem (Rasmussen et al., 1997), however it should remembered that ccrA-like
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gene is carried by only 1-3% and only a fraction of these strains are carbapenem
resistant.
1.13.6 Enterobacter cloacae
E. cloacae is the species of the genus Enterobacter that is most commonly isolated
from nosocomial infections (de Gheldre et a/., 1997). E. cloacae is the cause of
bacteraemia, respiratory and urinary tract infections (Pitout et a/., 1997).
Carbapenemase-producing strains appear at present to be extremely rare, whereas,
carbapenem resistance involving the overproduction of a cephalosporinase and the
loss of an OMP have been reported on a few occasions (Sections 1.10.2, 1.10.5.1).
Multidrug resistant E. cloacae (including imipenem resistance) are a particular threat
because there is virtually no therapeutic options left for such strains (de Gheldre et
a/., 1997).
1.1.3.7 Former Flavobacterium spp.
The natural habitats of the ex-flavobacterial spp. are soil and aquatic environments.
Both M. odoratum and (meningosepticum can cause nosocomial infections. C.
meningosepticum, as the name suggests is associated with meningitis in neonates and
is considered to be the ex-flavobacterial spp of greatest clinical significance (von
Graevenitz, 1995). The ex-flavobacterial spp. have wide patterns of resistance to
antibiotics, including the carbapenems.
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1.13.8 Serratia marcescens
S. marcescens in common with E. cloacae is a common cause of hospital acquired
infections in immunocompromised patients. S. marcescens is responsible for urinary
tract, respiratory tract and wound infections, septicaemia and endocarditis.
Carbapenems are considered as one of the normal treatment options for an infection
caused by S. marcescens and therefore, descriptions of carbapenemases leading to
treatment failure is a serious problem
1.13.9 Stenotrophomonas maltophilia
S. maltophilia has risen to prominence over the last decade as an important
nosocomial pathogen because of the increasing frequency of its isolation and its
broad spectrum of antimicrobial resistance, affecting patients with lowered defence
mechanisms. S. maltophilia is associated with a variety of clinical syndromes
including: bacteriaemia, endocarditis and respiratory tract infections (Denton and
Kerr, 1998). S. maltophilia is, however, often isolated from mixed infection in
which its pathogenic role is debatable. The emergence of the organism as a pathogen
has been attributed to selective pressure by the use of broad-spectrum antibiotics. S.
maltophilia is resistant to many currently available broad-spectrum antibiotics and
therefore, infections caused by S. maltophilia are particularly difficult to treat
(Denton and Kerr, 1998). The production of the LI metallo-P-lactamase is known to
confer P-lactam resistance and clinical resistance to imipenem is virtually universal
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in all strains (Payne et al., 1994a). It is thought that poor diffusion of P-lactams
across the cell membrane may contribute to resistance (Cullman, 1991).
1.13.10 Clinical significance of other bacteria that produce IMP-1
A. xylosoxidans, P. fluorescens, P. putida, and P. rettgeri are all responsible for
hospital acquired infections. P. aeruginosa is the Pseudomonas spp. most commonly
associated with human disease and is a common hospital pathogen. It produces
infection of burns and wounds, urinary tract and septicaemia. The lungs of CF
patients are particularly susceptible to infection with P. aeruginosa. Reports of K.
pneumoniae strains producing IMP-1 is of particular concern, as this organism is an
important hospital pathogen and also a notorious vector of resistance. K.
pneumoniae causes bacterial pneumonia, urinary tract infections and bacteraemia and
has been responsible for large hospital epidemics (Hobson et al., 1996).
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1.14 Aims of this thesis
1. To carry out a survey on carbapenem resistant clinical isolates from Japan and
determine the resistance mechanisms involved, concentrating on the role of (3-
lactamases.
2. Develop an imipenem substrate based modification to the standard isoelectric
focusing technique for the rapid identification of carbapenem-hydrolysing (3-
lactamases
3. Investigate the resistance mechanism involved in conferring carbapenem
resistance in two A. veronii bv. sobria strains isolated in Vellore, South India.
4. Assess the heterogeneity of metallo-(3-lactamases produced by S. maltophilia at
the molecular level.
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2: MATERIALS AND METHODS
2.1 Bacterial strains and plasmids
The strains and plasmids employed in this study are listed in Tables 2.1 and 2.2. P.
aeruginosa strains and Aeromonas species were both identified using API 20 NE
strips (Bio Merieux, France).
2.2 Storage of bacterial cultures
Bacteria were grown overnight at 37°C in cryovials (Alpha Laboratories, Eastleigh,
Hampshire) containing 900pl of nutrient broth. After overnight incubation, lOOp! of
50% glycerol was added to the vial and mixed, to give a final concentration of 5%
glycerol. The cultures were then stored at -70°C.
2.3 Reagents
All chemicals were purchased from Sigma Chemicals (Poole, Dorset), unless
otherwise stated. All solutions were prepared with either distilled or pyrogen-free
water (MilliQPF, Millipore,Watford, Herts).
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Table2.1Bacterials rainsusedinthistu y Bacterials rain
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Table 2.2 Plasmids used in this study
Plasmid Characteristics Source or reference
pK.18 Kanamycin-resistant. lacZ'. pl5 origin Pridmore. 1987
p(JB8902 Recombinant plasmid encoding metallo-
P-lactamase blau gene of S. maltophilia
IID 1275
Walsh et ai. 1994
No designated identification Recombinant plasmid encoding metallo-
f-lactamase gene imiS from,!, veronii bv.
sobria 163 a
Walsh et al.. 1998
2.4 Culture media
Media constituents were obtained from either Oxoid (Basingstoke, Hants) or Difco
Laboratories (Detroit, MI, USA). All media was made up according to the
manufacturer's instructions. Sterilisation ofmedia, to destroy all vegetative cells and
bacterial endospores, was achieved by autoclaving at 121°C and 15 pounds of
pressure for 15 minutes.
Mac Conkey Agar (Oxoid), Nutrient Agar (Oxoid) and Nutrient Broth No. 2 (Oxoid)
were employed for the growth of all bacteria included in this study. Iso-Sensitest
Agar (Oxoid), a semi-defined media, was used for antibiotic susceptibility testing.
Luria-Bertani (LB) broth was prepared by adding lOg of Bacto-tryptone (Difco), 5g
Bacto-veast extract and !0g of NaCl to 800mL of distilled water. The pH was then
adjusted to 7.0 with 1M NaOH before finally making up the volume to Uitre. LB
agar was prepared by adding 1.5% Bacteriological Agar No. 1 (Oxoid) to LB broth.
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2.5 Antibacterial compounds
Table 2.3 lists the antibiotics used, information on their solubility and the suppliers
of these compounds. Stock solutions of chloramphenicol, kanamycin, BRL42715
and kanamycin were protected from light and stored at -20°C; all other compounds
were prepared on the day of use.
Fable 2.3 Antibacterial compounds
Antimicrobial Diluent Supplier
Ciprofloxacin water Bayer (Newbury. Berkshire)
Tazobactam water Lcdcrlc Laboratories (Cvanamid of
Great Britain Ltd.. Hants)
Ceftazidime saturated NaHCO.d and water Glaxo-Wellcome (Uxbridge.
Middlesex)
Cefotaxime water Hoechsl-Roussel Pharmaceuticals
(Uxbridge. Middlesex)
Imipenem water Merck Sharp & Dohmc (Hoddesdon.
Herts)
Sulbactam water Pfizer Central Research (Kent)
Ampicillin water Sigma Chemicals (Poole. Dorset)
Cefoxitin water Sigma Chemicals
Cephalondine water Sigma Chemicals
Chloramphenicol 70% ethanol Sigma Chemicals
Kanamycin water Sigma Chemicals
Oxacillin water Sigma Chemicals
BRL427I5 water SmithKline Beecham Pharmaceuticals
(Surrey)
Carbcnicillin water SmithKline Bcecham Pharmaceuticals
Nitrocephin DMSO'1 and 50mM sodium phosphate
buffer. pH 7.0 or w ater
SmithKline Beccham Pharmaceuticals
Meropencm water Zeneca Pharmaceuticals (Macclesfield.
Cheshire)
Cefepime water Eli Lilly
'Enough to dissolve antimicrobial powder
69
2.6 Antibiotic susceptibility testing
The minimum inhibitory concentrations (MICs) of antibiotics were determined by
the agar dilution method (Working Party of the British Society of Antimicrobial
Chemotherapy, 1991). Bacterial strains were grown overnight at 37°C in Nutrient
Broth No.2, with shaking. Following incubation cell cultures were diluted to 10'
colony forming units (cfu)/ml and 1 pi of the diluted cell suspension was inoculated
using a multipoint inoculator (Denley, Surrey) onto agar plates containing two-fold
serially diluted antibiotics. E. coli NCTC 10418, P. aeruginosa NCTC 10662 and S.
aureus NCTC 6571 were used as control strains, with known MIC values for the
antibiotics tested.
2.7 Preparation of ^-lactamases
2.7.1 Small-scale preparation of P-laetamases
Bacterial strains were grown overnight on 10ml nutrient agar slopes at 37°C.
Following overnight incubation, the bacterial cells were washed off the surface of the
slope with 1ml of 50mM sodium phosphate buffer, pH 7.0. The sample was then
transferred to a bijoux bottle and placed in an ice/water bath. The cells were burst by
ultrasonication for 2x15 seconds at an amplitude of 8pm, with a 30 second cooling
period (MSE Soniprep 150, MSE Instruments, Crawley). Cell debris was removed
from the lysate by centrifugation (MSE Microcentaur Centrifuge) at high speed for
10 minutes at 4°C. P-Lactamase extracts were stored at -20°C until required.
70
2.7.2 Large-scale preparation of (3-lactamases
Large-scale ^-lactamase extracts were prepared from 100ml cultures according to the
method described by Payne and Farmer (1998). A flask containing 100ml of nutrient
broth was inoculated with 1ml of an overnight broth culture. The cultures were then
grown at 37°C, with shaking, to an optical density of approximately 0.7 at 500nm
and at this stage, if appropriate, imipenem was added as a P-lactamase inducer, at a
final concentration of 'A the strains imipenem MIC. After a further 2 hours of
continuous shaking at 37°C the cells were harvested by centrifugation (GS3 rotor,
Sorvall® R.C-5B, Du Pont) at 6000 rpm for 15 minutes and at 4°C. The pellet was
resuspended and washed in 10ml of 50mM sodium phosphate buffer, pH 7.0,
followed by centrifugation as previously described. The washed cells were
resuspended in 1ml of 50mM sodium phosphate buffer, pH 7.0 and placed in an
ice/water bath. The cells were burst by ultrasonication for a minimum of 2 x 30
seconds at an amplitude of 8pm with a 1 minute cooling period between each burst.
The lysate was cleared of all cell debris by centrifugation (MSE Microcentaur
Centrifuge) at high speed for 30 minutes and 4°C. P-Lactamase extracts could then
be stored at -20°C.
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2.8 Analytical isoelectric focusing (IEF)
P-lactamase preparations were examined by IEF based on the method first described
by Matthews et a/. (1975).
2.8.1 Casting an 1EF gel
P-Lactamases were focused on a horizontal thin layer polyacryiamide gel containing
carrier ampholines (pH 3.5-10). The composition of the IEF gel is given in Table
2.4, tetramethylethylenediamine (TEMED) and riboflavin were the last components
to be added. The polyacryiamide gel was poured between two clean glass plates,
separated by rubber tubing, and approximately 2mm apart. One glass plate was
coated with a solution containing 0.5% (w/v) gelatine (ca.225 bloom from calf skin)
and 0.05% (w/v) chromium potassium sulphate dodecahydrate, this enabled the gel
to stick to one of the glass plates. The other glass plate was siliconised to allow easy
separation of the two plates once the gel had polymerised. The gel was left to
polymerise for 4-5 hours.
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Fable 2.4 Composition of a polyacrvlamide IEF gel
Material
40% (w/v) ampholines

















2.8.2 Pre-cast IEF gels
(3-Lactamase extracts were also subjected to IEF on pre-cast polyacrylamide gels
(Ampholine4 PAGplate) containing 2% (v/v) ampholines of pEI range 3.5-9.5
(Pharmacia Biotech, St. Albans, Herts). The pre-cast gel was placed on the cooling
plate of a Multiphor II Electrophoresis Unit (Pharmacia Biotech). Paper electrode
contacts moistened with 1M H4PO4 (anode) and 1M NaOH (cathode) were placed on
the surface of the gel according to the manufacturer's instructions.
2.8.3 Agarose IEF gel
(^-Lactamases were focused on a horizontal agarose IEF gel containing carrier
ampholines (pH 3 .5-10). The composition of the agarose IEF gel is listed in Table
2.5. IEF grade agarose was dissolved in distilled water by heating in a microwave
oven, followed by cooling to 60°C in a waterbath. The D-sorbitol and ampholines
were added to the melted agarose and pipetted, to a depth of approximately 2mm,
onto the hydrophobic surface of a Gelbond sheet (250 x 125 x 0.8mm), placed on the
73
surface of a Multiphor II Electrophoresis Unit (Pharmacia Biotech). The gel was
cooled for a minimum of 30 minutes to ensure gel consistency and strength. Excess
moisture was removed from the gel using filter paper. Electrode wicks were soaked
in 1M H3PO4 (anode) and 1M NaOH (cathode) and placed on to the corresponding
poles.
Table 2.5 Composition of an agarose IEF
Material Volume or mass employed Final concentration
40% (w/v) ampholines 1.5ml 2% (w/v)
Agarose IEF VIII (Sigma) 240mg 0.8% (w/v)
Distilled water 15.0ml -
D-sorbitol 20% (w/v) 13.5ml 9% (w/v)
2.8.4 Nitroeephin spot testing and sample loading
The quantity of each p-lactamase preparation to be loaded on the gel was determined
by nitrocephin spot testing. The amount of sample loaded on to the gel (pi) was
equal to the time taken (seconds) for a mixture of 33pl of P-lactamase and lOOpl of
nitrocephin (50pg/ml), in a microtitre plate, to change from yellow to red. Twelve
samples could be loaded on to the self-cast IEF gel and 24 samples could be loaded
on to the pre-cast gel. Isoelectric focusing was performed overnight at 4°C at 1W
(constant), 500V (limiting) and 20mA (limiting).
74
2.8.5 Detection of P-Iactamase activities after 1EF
After IEF the polyacrylamide gel was stained by overlaying the gel with a sheet of
Whatman No.54 paper (Whatman. Maidstone, Kent) soaked in nitrocephin solution
(500|ig/ml). The focused (3-lactamases appeared as red bands on a yellow
background. The P-lactamase isoelectric point (pi) values were determined from a
graph of pi against distance migrated for coloured pi markers (pi Calibration Kit
Electran®, range 4.7-10.6, BDH Laboratory Supplies, Poole, Dorset). The stained
gel was photographed with a Polaroid camera (setting B4, F8), fitted with a Tiffen
green filter.
2.8.6 Inhibitor studies after IEF
For inhibitor studies, Whatman No. 54 filter paper, soaked with the desired inhibitor
was placed on the surface of the focused gel. After 10 minutes the inhibitor soaked
paper was removed and a nitrocephin overlay was applied as described above.
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2.9 (3-Lactamase assays
2.9.1 Substrate profiling of P-lactamases
P-Lactamase activity was determined by monitoring the hydrolysis of a range of p-
lactam agents with a X2 double beam UV/Vis spectrophotometer, fitted with a
temperature controlled cuvette holder (Perkin Elmer). Assays were carried out in
lcm path length quartz cuvettes (working volume -3ml) for 2 minutes at wavelength
optimal for each P-lactam (Table 2.6). Assays were performed in either 50mM
sodium phosphate buffer, pH 7.0 or 25mM piperazine-A,Ap-bis(2-ethanesulphonic
acid) (PIPES) buffer, pH 7.0 at 37°C. For substrate profiling each P-lactam was
assayed at a final concentration of lOOpM, except for ampicillin which was assayed
at 500pM.
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P-Lactamase activity was calculated as the amount of substrate (pmoles/nmoles)
hydrolysed/minute/ml of enzyme sample using the formula described by Payne and
Farmer (1998):
AAbsorbance/minute x Vr/1000 x 1/Ve
AE x 10 6
AAbsorbance/minute - rate of absorbance change.
AE - molar extinction coefficient of hydrolysis (AE was determined by measuring
the absorbance of a P-lactam solution of known concentration at the optimal
wavelength for the compound The AE was then determined by inserting the
absorbance and concentration of the solution into Beer Lambert's equation, A = eel,
A = absorbance, e = molar extinction coefficient, c = concentration of P-lactam
solution and I = cuvette path length).
V'r - volume of reaction (ml).
1/Ve - volume of enzyme (ml) added and factor needed for the conversion of sample
volume to 1ml
2.9.2 P-Lactamase specific activity
The protein concentration of p-lactamase preparations were determined by the
method of Waddell (1956). P-Lactamase specific activity could then be calculated as
pinoles or nanomoles of P-lactam hydrolysed/minute/mg of protein.
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2.9.3 Determination of maximal hydrolysis rates (Vmax) and the Michaelis
constant (Km)
P-Lactamases were assayed with decreasing substrate concentrations and decreasing
rates of hydrolysis. The reciprocal of the substrate concentration was plotted against
the reciprocal of the rate of hydrolysis, according to the method of Lineweaver and
Burk (1934), to determine the Vmax and Km. The efficiency of hydrolysis was
calculated by dividing Vmax by Km values.
2.9.4 Inhibition studies
Determination of the inhibitor concentrations required to inhibit 50% of j3-lactamase
activity (lD?o) were performed spectrophotometrically (Hayes, 1995). A range of (3-
lactamase inhibitor concentrations were incubated with P-lactamase preparations for
10 minutes at 37°C before the addition of the reporter substrate (lOOpM imipenem or
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lOOpM nitrocephin). The ID50 value could be determined from plotting a graph of
percentage inhibition against inhibitor concentration.
2.10 (3-Lactamase purification
Whatman DE52 and QA52 pre-swollen anion exchange celluloses were employed
for (3-iactamase purification. DE52 cellulose is substituted with a diethylaminoethyl
(DEAE) group, QA52 has a quaternary amine group, and these groups define the
matrices as positively charge anion exchangers. DE52 and QA52 are designated
weak and strong anion exchangers, respectively, and this refers to the pH range over
which the exchanger is ionised.
2.10.1 Extraction of periplasmic proteins
An overnight culture was used to inoculate 1 litre of Nutrient Broth. The culture was
incubated at 37°C with shaking for 18 hours. The culture was harvested (GS3 rotor,
Sorvall® RC-5B. Du Pont) at 6000 rpm for 15 minutes and at 4°C. The cells were
resuspended in 25ml of sodium phosphate buffer, pH 7 0. The bacterial suspension
was then mixed with 4.5ml of lOOmM EDTA, pH 8.0 (this permeabilises the outer
membranes) and 0.5ml of lysozyme (10mg/l) (this digests the cell wall). The mixture
was then left to stand at room temperature for 5 minutes. The spheroplasts were
stabilised by CaCl2 (final concentration lOmM) and removed by centrifugation (GS3
rotor) at 6,000rpm for 30 minutes at 4°C. The supernatant containing periplasmic
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proteins was collected ready for dialysis or for ammonium sulphate precipitation
(Section 2. 10.4).
2.10.2 Matrix preparation and column packing
The pre-swollen anion exchangers were pre-equilibrated with a concentrated solution
(0.5M) of buffer (either sodium phosphate buffer or Tris-Cl, adjusted to the required
pH)„ by stirring the matrix with 6ml of buffer/g of wet ion-exchanger. The slurry-
was allowed to settle and the supernatant containing any broken down matrix
("fines") was decanted. Removal of fines is important as they can lead to uneven
column packing. The above process was repeated several times until the buffer/ion-
exchanger slurry was at the desired pH.
When preparing the column care was taken to remove all air bubbles to minimise any
problems with column flow rates, by allowing a small amount of buffer to flow
through the column outlet. At this stage, the flow rate of the column could be
calibrated. The matrix was also degassed, by applying a vacuum to the matrix
solution for 10 minutes Twenty ml of thick slurry (the matrix comprised of 75% of
the slurry volume) was poured down a glass rod into a column (dimensions: 1.6cm
diameter x 15cm) and the matrix was packed to a height of 10cm. The use of a glass
rod prevents the trapping of air bubbles in the matrix as it settles. The column was
then attached to a buffer reservoir and the packed column was equilibrated with
several column volumes of lower ionic strength starter buffer (either 10-20mM
sodium phosphate buffer or Tris-Cl buffer at the desired pH). The pH and
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conductivity of the buffer was checked before application and after column elution to
make sure that they remained the same.
2.10.3 Sample application
P-lactamase preparations were placed in dialysis tubing and dialysed against 2 x
Uitre starter buffer, with a change of buffer after 4 hours before being applied to the
equilibrated column. After the sample was loaded onto the column, the ion exchange
matrix was washed with starter buffer to remove any unbound material (3-10 column
volumes). The optical density of the eluent at A280 was monitored until the flow-
through contained negligible contaminants. P-Lactamase was eluted by a linear
NaCl gradient, with a steady increase in the ionic strength from 0-1M NaCI prepared
in starter buffer. An LKB-BROMMA 2070 fraction collector (Pharmacia Biotech, St
Albans, Herts) collected the gradient-eluted samples in 3ml aliquots. Samples were
assayed by spectrophotometry and 1EF. Following sample elution, the column
matrix was regenerated to remove any remaining contaminants according to the
manufacturer's instructions.
2.10.4 Concentration of protein samples by ammonium sulphate precipitation
Ammonium sulphate precipitation was performed at 4°C with all solutions pre-
cooled to this temperature. Ammonium sulphate was added in increments with
constant stirring to a final concentration of 80%. Each addition of ammonium
sulphate was made only after the previously added amount had completely dissolved.
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When all the salt had been added the mixture was stirred for a further 30 minutes to
allow equilibration of the solvent and protein. The mixture was then centrifuged
(GS3 rotor, Sorvall® RC-5B, Du Pont) at 8000 rpm for 30 minutes at 4°C. The
supernatant was decanted off and discarded. The wet precipitate was then ready in a
minimum volume of appropriate buffer. The P-lactamase activity of the resuspended
pellet and discarded supernatant was assayed by nitrocephin spot testing to check
that the P-lactamase had been precipitated. Concentrated protein samples were
dialysed against the appropriate buffer to remove all ammonium sulphate before
further manipulations.
2.10.5 Gel filtration employing the Fast Protein Liquid Chromatography System
(FPLC)
A Superose 12 HR 10/30 column (Pharmacia Biotech, St Albans, Herts), mounted on
a Pharmacia FPLC system, was used for molecular mass estimations and P-lactamase
purification. All solutions used for gel filtration were degassed and filtered through a
0.22pM filter (Millipore, Watford, Herts). The Superose 12 column was stored in
20% ethanol and was washed with pyrogen free water (MilliQPF, Millipore) to
remove the ethanol. This wash was followed by equilibration of the column with 2 x
25ml column volumes of column buffer (20mM sodium phosphate buffer, pH 7.0,
containing 50mM NaCl).
The sample was centrifuged before application to the column. A maximum of 200pl
in volume, containing no more than 5-10mg of protein (or 30mg of protein/ml) was
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loaded onto the column. The column was run at a flow rate of 0 4ml/minute. After
sample loading the proteins were eluted with the column buffer and collected in
0.5ml fractions. Fractions were assayed by spectrophotometry and IEF.
The column was calibrated by running lmg of four different proteins (bovine serum
albumin, ovalbumin, carbonic anhydrase and cytochrome C), of known molecular
mass, through the column. The separation of these proteins, as they passed through
the column, could be detected by measuring the A28o on a UV wavelength monitor
attached to the column outlet. A plot ofmolecular mass against elution volume could
be generated, forming a standard graph from which the molecular mass of a (3-
lactamase could be determined.
2.11 Preparation of outer membrane proteins (OMPs)
OMPs were prepared from a 250ml nutrient broth culture grown with shaking
■» ®
overnight at 37°C. Cells were harvested by centrifugation (GS3 rotor, Sorvall R.C-
5B, Du Pont) at 8000 rpm for 15 minutes and at 4°C. The cell pellet was washed
twice in phosphate-buffered saline (PBS) and centrifuged as above. The washed
cells were resuspended in 2.5ml of pyrogen-free water (MilliQPF, Millipore,
Watford, Herts) and placed in an ice/water bath before bursting the cells by
ultrasonication (MSE Soniprep 150) at 8um for 8 x 30 seconds with 1 minute cooling
intervals. Sarkosyl was added to a final concentration of 0.7% to solubilise the
cytoplasmic membrane. The lysate was then centrifuged (H1000B rotor, Sorvall®
RT 600D) at 3000 rpm for 15 minutes at 4°C to remove any unbroken cells and
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debris. The sarkosyl insoluble OMPs were harvested by centrifugation (SM-24 rotor,
SorvallA RC-5B) at 20,000 rpm for 1 hour at 4°C. The OMPs were washed with
pyrogen-free water and centrifuged as above. The pellet was finally resuspended in
lml of pyrogen-free water and stored at -20°C.
2.12 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE)
Sodium dodecyl sulphate polyacrylamide gels, with 12% acrylamide in the
separating gel, were prepared according a standard protocol (Maniatis el «/., 1982)
using a minigel apparatus (Proteinll, Bio-Rad). Prior to electrophoresis, samples
were mixed with an equal volume of SDS loading buffer (50mM Tris-Cl buffer
adjusted to pH 6.8, containing 10% (v/'v) glycerol, 2% (w/v) sodium dodecyl
sulphate, 0.1% (w/v) bromophenol blue and lOOmM dithiothreitol). The samples
were boiled for 5 minutes at 100°C and a maximum of 25pl of each sample could be
loaded into each gel well. The gel was run at 25mA for approximately 1 hour until
the dye front had nearly reached the bottom of the gel.
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2.13 Preparation of DNA
2.13.1 Small-scale preparation of chromosomal DNA
Small-scale quantities of chromosomal DNA were prepared according to the method
described in Unit 2.4A of Current Protocols in Molecular Biology (Wilson, 1994),
which includes a hexadecyltrimethvl ammonium bromide (CTAB) extraction for the
removal of polysaccharides and proteins. The DNA pellet was redissolved overnight
at 4°C in lOOpl TE buffer (lOmM Tris, ImM EDTA, pH 8.0) containing
ribonuclease A (50pg/ml).
For convenience, chromosomal DNA was also prepared with the Genie genomic
DNA extraction kit (Helena Biosciences, Sunderland, Tyne and Wear).
2.13.2 Large-scale preparation of chromosomal DNA
Large-scale quantities of chromosomal DNA were prepared according to the method
described in Unit 2.4A of Current Protocols in Molecular Biology (Wilson, 1994).
Additional purification on a caesium chloride gradient was however, omitted from
the protocol, which was essentially a scale up of the genomic DNA miniprep. This
procedure was employed to obtain large amounts of genomic DNA for the
construction of a genomic DNA library from A. veronii bv. sobria strain 13.
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2.13.3 Small-scale piasniid preparation
Small-scale quantities of plasmid DNA were prepared by means of a Hybaid
Recovery™ plasmid miniprep kit (Teddington, Middlesex).
2.13.4 Large scale plasmid preparation
Large-scale quantities of plasmid DNA was prepared by means of either a QIAGEN
midi or QIAGEN maxi plasmid purification kit (QIAGEN Ltd., Crawley, W.
Sussex). Purification of high copy number plasmids using the QIAGEN midi kit
routinely yielded 75-lOOp.g of DNA, whereas, the maxi kit yielded 300-500pg of
DNA
2.14 Agarose gel electrophoresis
Standard agarose gel electrophoresis was applied for both analytical and preparative
separation of DNA fragments Agarose gels were prepared with 1 x Tris/acetate
(TAE) buffer diluted from a 10 x TAE stock solution (1 litre volume containing
400mM Tris-acetic acid, 20mM disodium EDTA, pH 8.0). The appropriate
concentration (typically 1-2%) of electrophoresis grade agarose (Gibco BRL, Life
Technologies, Paisley, Glasgow) was added to the electrophoresis buffer and melted
in a microwave oven, with intermittent swirling to ensure even mixing. The melted
agarose was cooled to 55°C before pouring into a sealed gel casting platform, fitted
with a gel comb. After approximately 30 minutes, the gel was placed in an
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electrophoresis tank and 1 x TAE buffer was placed in the tank to cover the gel to the
depth of about 1mm. DNA samples containing 1 x tracking buffer were loaded onto
the gel (10 x tracking buffer: 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene
cyanol, 30% (w/v) sucrose). A standard molecular weight marker was among the
samples loaded onto the gel (X DNA cut with HitidUl or lOObp ladder) and these
were obtained from Gibco BRL, Life Technologies. Electrophoresis was carried out
between 50-100V and the progress of the separation was monitored by the migration
of the dyes in the tracking buffer (bromophenol blue migrates with DNA molecules
around 0.5 kb and xylene cyanol with DNA fragments of around 5kb).
Ethidium bromide (0.5 pg/ml) was incorporated into the gel and electrophoresis tank
buffer for direct visualisation of DNA with a UV transilluminator (UV Products,
Cambridge), following electrophoresis. Alternatively, gels that were run in the
absence of ethidium bromide were stained by covering the gel in a solution of
ethidium bromide (0.5 pg/ml in water) for 30 minutes. The gels were photographed
with a Polaroid camera fitted with a Tiffen orange filter (setting B, F8).
2.15 Enzymic manipulation of DNA
2.15.1 Digestion of DNA with restriction endonucleases
Complete restriction endonuclease cleavage of DNA was commonly carried out in
20(.il reaction volumes containing 0. l-4pg of DNA, 1 x appropriate restriction buffer
(Helena Biosciences, Sunderland, Tyne and Wear) and 1-5 units of restriction
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enzyme/pg of DNA. The amount of DNA to be cleaved and/or the reaction volume
was increased or decreased if necessary, keeping the proportions of the reaction
components constant The reaction mixture was incubated at the recommended
temperature (in general 37°C) for 2 hours. If the products were to be analysed by
agarose gel electrophoresis the reaction was stopped by adding 5pl (20% of reaction
volume) of 10 x tracking buffer. Otherwise the reaction was terminated by either
extracting the DNA with phenol and precipitation in ethanol according to the method
described in Current Protocols in Molecular Biology Unit 2.1 (Moore, 1994), or, if
appropriate, the restriction enzyme was heat inactivated.
2.15.2 Preventing self-Iigation of vector termini
Self-annealing of linearised vector during ligation reactions was prevented by pre-
treatment with calf intestine alkaline phosphatase (CIP) (Boehringer Mannheim,
Lewes, E. Sussex). CIP catalyses the hydrolysis of 5'-phosphate residues from DNA,
leaving dephosphorylated products that possess 5'hydroxyl termini. One pg of
vector DNA was first restricted with the appropriate restriction enzyme in a total
reaction volume of 50f.il. One pi ofCIP was added to the reaction and incubation was
continued for 1 hour at 37°C. The reaction was terminated by extracting the DNA
with phenol and precipitation in ethanol according to the method described in
Current Protocols in Molecular Biology Unit 2,1 (Moore, 1994).
88
2.15.3 DNA Ligation
Ligation of DNA was performed using T4 DNA ligase (Boehringer Mannheim,
Lewes, E. Sussex) with lx ligation buffer. The total reaction volume was lOpl
containing a 3:1 molar ratio of insert DNA to vector. Ligation reactions were
incubated overnight at 16°C.
2.16 Electrotransformation
2.16.1 Preparation of competent cells
I ml of an overnight culture was added to a 200ml prewarmed broth and the culture
was incubated with shaking 4 hours until the mid-logarithmic phase had been
reached. Cells were harvested by centrifugation (GS3 rotor, Sorvall® R.C-5B) at
6000 rpm for 15 minutes and at 4°C and resuspended in 10ml of ice cold sterile
distilled water The suspension was then diluted to 200ml with ice cold water and
the cells pelleted as described previously. Cells were washed twice more as
described above. The thoroughly washed pellet was resuspended in an ice-cold
solution of 30% (v/v) glycerol, where it was further washed before finally being
suspended in 500p.l of ice-cold 10% (v/v) glycerol. Cells were distributed into 50pl
aliquots and stored at -70°C.
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2.16.2 Transformation
Before transformation, ligated DNA samples were dialysed with a "drop dialysis
technique" (Marusyk and Sergeant, 1980). A 0.025pm pore size diameter, Millipore
"V" series membrane was floated (shiny side uppermost) in a petri-dish that was
filled with 15ml of distilled water. The DNA sample was carefully placed onto the
membrane and dialysed for at least 30 minutes at room temperature. The desalted
sample was then recovered with a micropipet.
Competent cells and l-2pl of dialysed DNA were added to a chilled, disposable
electroporation cuvette and mixed thoroughly. The outside of the cuvette was wiped
dry and the cuvette lightly tapped to remove all air bubbles and ensure that the
sample was distributed evenly in the bottom of the cuvette. One pulse was applied
(Bio-Rad, 2.5kV, 25pFD, 2000hm) and immediately 1 ml of pre-warmed nutrient
broth medium was added. Electroporated cells were then transferred to a 1.5ml
microcentrifuge tube and incubated for 2 hours at 37°C. Alter incubation 50-200pl
aliquots were spread on to selective agar.
2.17 Polymerase Chain Reaction (PCR)
2.17.1 Design of oligonucleotide primers
Primers were designed with Primer 3 Software (http://www.genome.wi.mit.edu/cgi-
bin/primer/primer3.cgi) and by reference to previously published data. The primers
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were synthesised by Oswell (Southampton University, Southampton), the details of
primers are referred to in the relevant chapters
2.17.2 PGR procedure
PGR amplification was performed in a 1 OOpil volume with the Techne PHC-2 Dri-
Block Cycler (Cambridge Bioscience, Cambridge). Reaction mixtures contained 1 x
MgCf-free PCR buffer (Promega, Southampton), 0.5p.M of each primer,
approximately 25ng of template DNA, 2.5 units of Taq DNA polymerase (Promega),
200pM (each) deoxynucleoside triphosphate (Boehringer Mannheim, Lewes, E.
Sussex), l-3mM MgCh (Promega). A negative control consisting of the reaction
mixture minus template DNA was included for each experiment an assay for overt
contamination. The contents of each PCR tube were mixed and overlaid with 50p!
of mineral oil to prevent evaporation of the PCR reaction mixture. PCR cycling
parameters are listed with primers in the relevant chapters. PCR products were run
on a 1% agarose gel (Gibco BRL, Life Technologies, Paisley), stained with ethidium
bromide and visualised under UV light.
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2.18 DNA hybridisation techniques
2.18.1 Labelling of DNA probes
DNA fragments to be used as probes were labelled with fluorescein-11-dUTP (Fl-
dUTP) by means of the ECL™ random prime labelling and detection system
(Amersham, Life Science, Buckinghamshire) according to the manufacturer's
instructions.
2.18.2 Dot blotting
A positively charged nylon membrane (Hybond™-N+, Amersham Life Science,
Buckinghamshire) was lightly marked with a grid to guide the application of target
DNA samples, allowing 1 cm2/2p.l sample. DNA samples were diluted with an equal
volume of 2x SSC containing carrier DNA (GeneBloc, Flelena Biosciences,
Sunderland, Tyne and Wear) at a final concentration of 2ng/pl DNA samples were
then denatured by boiling for 5 minutes followed by immediate chilling on ice. Two
p.1 samples of denatured DNA were applied to the membrane, the filter was left to




DNA fragments were separated by agarose gel electrophoresis and Southern blotted
on to a positively-charged nylon membrane (Hybond™-N+, Amersham Life Science,
Buckinghamshire), according to the method described in Unit 2.9A of Current
Protocols in Molecular Biology (Brown, 1993)
2.18.4 Hybridisation
Hybridisations with heat-denatured fluorescein-labelled DNA probes were carried
out in either heat sealable bags or plastic boxes. Positive hybridisation results were
detected by the ECL™ Random prime system (Amersham Life Science,
Buckinghamshire). The blots were hybridised overnight at 60°C according to the
manufacturer's instructions and sheared denatured heterologous DNA (GeneBloc,
Helena BioScienc.es, Sunderland, Tyne and Wear) was added to the hybridisation
buffer to decrease non-specific hybridisation. The following stringency washes were
carried out: 2x15 minute washes with 1 x SSC and 0.1% (w/v) SDS, followed by 2
x 15 minute washes with 0.05 x SSC and 0.1% (w/v) SDS at 60°C. The hybridisation
signals were recorded by placing a blot with a sheet of blue light sensitive
autoradiography film (Hyperfilm™-ECL, Amersham Life Science) in a film cassette
and exposing the film for 30 minutes.
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2.19 Elimination of plasmids by ethidium bromide curing
Ethidium bromide has been shown to be efficient in eliminating plasmids that carry
drug resistance determinants (Bouanchaud et al1969) and was employed to test
whether an imipenem-hydrolysing (3-lactamase was encoded by an
extrachromosomal element.
Curing was performed with a series of tubes containing Nutrient Broth No.2 and
ethidium bromide at concentrations ranging from 0.06-64mg/l. The tubes were
inoculated with approximately 10" organisms/ml and incubated overnight at 37°C,
with shaking. The culture tube that contained the highest concentration of ethidium
bromide and still allowed visible growth was plated on to Nutrient Agar and
incubated overnight at 37°C. Between 40 and 50 individual colonies were inoculated
from the Nutrient Agar plate into individual tubes containing 4.5ml of sterile saline
(0.85% (w/v) NaCl). Cured strains were then identified by inoculating lOpl of each
inoculated saline onto plates containing sub-inhibitory concentrations of imipenem
(1/2 imipenern MIC). Ten pi of each inoculated saline was also inoculated on to
plates with no imipenem. Following overnight incubation at 37°C plates were
examined for colonies that did not grow on the antibiotic plate. (3-Lactamase extracts
were prepared from subcultures of the colonies that failed to grow at sub-inhibitory
concentrations of imipenem. (3-Lactamases were detected as described in Section 2.7
to see if there was a loss of a particular (3-lactamase band.
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3: RESULTS
A study of the mechanisms involved in carbapenem resistance in
Pseudomonas aeruginosa isolates from Japan
3.1 Introduction
Recently, there have been increasing reports from Japan of carbapenem-resistant
clinical isolates, belonging to both the Enterobocteriaceae and Pseudomonciceae
families, some of which produce a metallo-j3-lactamase designated IMP-1 (Section
1.! 1 1.5). Therefore, the following study was undertaken to evaluate the role of P-
lactamases in conferring carbapenem resistance in clinical isolates from Japan. The
contribution of the IMP-1 P-lactamase, chromosomal cephalosporinases and novel
carbapenemases were all examined
3.2 Background to bacterial strains
Sixty-one P. aeruginosa clinical isolates were received from Japan. These strains
were isolated from patients with respiratory and urinary tract infections from 21
different hospital centres (designated A-U in Table 3.1) in Japan, in 1994.
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3.3 Susceptibility testing
Fiftv-two of the 61 Japanese P. aeruginosa strains were originally reported as being
imipenem-resistant, having an MIC of >4mg/l (Dr K. Sato - personal
communication). On receipt of the strains, their susceptibility to imipenem was re¬
determined and in addition, the MICs of three other (3-lactams, meropenem,
carbenicillin and ceftazidime, and the quinolone ciprofloxacin, were also tested.
The susceptibility testing results are shown in Table 3.1; 47 of the isolates were
resistant to imipenem (MIC >4mg/l), 25 of these strains were also resistant to
meropenem (MIC >4mg/l). Four strains were resistant to meropenem (MIC >4mg/l),
but not imipenem. Twenty-two strains were resistant to carbenicillin (MIC
>128mg/l), 25 were resistant to ceftazidime (MIC >2mg/l) and 23 isolates were
resistant to ciprofloxacin (MIC >4mg/l).
3.4 Isoelectric focusing of (3-lactamases from P. aeruginosa isolates
Isoelectric focusing was performed on small-scale crude cell extracts prepared from
the 61 P. aeruginosa strains. After staining the IEF gel with nitrocephin, 74% of the
P. aeruginosa strains were found to possess one or more (3-lactamase (Table 3.1).
The most prevalent (J-lactamase had a pi value of 9.2 was found in 41% of isolates
(Table 3.1). Metallo-(3-lactamases in P. aeruginosa have been reported to have pis
of 9.0 and 9.5 (Watanabe et al1991; Minami et a/., 1996). The chromosomal
cephalosporinases of P. aeruginosa also have high pi values (Bush et al., 1995).
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Table 3.1 Antibiotic susceptibility of 61 clinical P. aeruginosa isolates
and their ^-lactamase profiles
Hospital MIC (mg/L)a
Strain Unit (A-U) IMP MPM CARB CTAZ CIPRO pl(s)
10662* - 1 0.25 32 1 0.12 8.7
2 A 8 8 256 16 4 9.2
3 A 16 8 64 2 0.12 9.3
8 A 8 8 128 2 2 ND
4 B 8 32 >256 4 >8 5.4, 8.7
5 B 2 8 256 2 0.25 8.2
6 B 8 2 32 1 0.5 ND
13 B 8 32 >256 4 >8 5.3
14 B 8 32 >256 16 >8 5.4
16 B 2 2 128 2 0.25 ND
24 B 8 1 32 1 0.5 ND
22 C 8 2 64 2 0.12 ND
41 C 8 1 16 0.25 0.064 9.2
23 D 8 4 128 32 0.064 9.2
25 E 16 8 256 32 >8 9.2
26 E 8 4 32 1 0.25 9.2
79 E 16 8 128 2 0.25 5.3, 9.2
101 E 4 1 >256 32 >8 9.2
30 F 16 8 128 32 >8 9.2
38 F 8 2 32 1 >8 9.2
39 F 8 16 256 4 8 9.2
34 G 4 8 256 32 >8 8.95
35 G 8 8 256 4 0.25 9.2
36 G 8 0.25 64 2 8 ND
37 G 16 32 256 16 >8 9.2
a
- Blue numbers represent a resistant MIC, black numbers equal sensitive MIC.
10662* - P. aeruginosa NCTC 10662 = sensitive laboratory control strain.
IMP, imipenem; MPM, meropenem; CARB, carbenicillin; CTAZ, ceftazidime;
CIPRO, ciprofloxacin; ND, not detected.
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Table 3.1 Antibiotic susceptibility of 61 clinical P. aeruginosa isolates
and their (3-lactamase profiles (continued)
Hospital MIC (mg/l)a
Strain Unit (A-U) IMP MPM CARB CTAZ CIPRO pl(s)
43 H 8 8 256 4 >8 9.2
44 H 16 8 64 4 0.25 9.2
50 H 16 8 128 2 >8 9.3
52 H 16 4 128 2 0.064 9.2
45 I 8 8 256 4 >8 8.7
46 I 8 2 32 1 1 9.2
93 I 4 8 128 4 >8 8.5, 9.2
48 J 8 8 64 4 0.12 8.95
60 J 64 32 >256 32 >8 8.95
54 K 8 4 128 2 0.12 ND
55 K 16 16 256 16 8 9.2
64 K 2 4 128 4 >8 ND
86 K 1 0.25 128 2 0.25 8.3, 8.6
65 K 1 0.032 32 1 0.25 ND
56 L 8 2 64 2 0.25 8.4, 8.95
83 L 8 2 64 1 0.064 8.9
67 M 8 8 64 2 0.12 9.2
68 M 16 4 32 2 0.25 9.2
69 M 16 8 64 2 0.25 ND
84 M 2 0.25 32 1 0.5 ND
71 N 8 2 32 1 0.12 8.5, 9.2
73 N 4 8 128 2 0.25 ND
74 N 8 1 16 0.5 0.064 ND
80 O 8 16 >256 2 >8 9.3
98 O 2 1 >256 2 >8 8.4, 9.2
100 o 8 2 32 1 0.25 8.95
a
- Blue numbers represent a resistant MIC, black numbers equal sensitive MIC.
IMP, imipenem; MPM, meropenem; CARB, carbenicillin;
CTAZ, ceftazidime; CIPRO, ciprofloxacin; ND, not detected.
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Table 3.1 Antibiotic susceptibility of 61 clinical P. aeruginosa isolates
and their P-lactamase profiles (continued)
Hospital MIC (mg/l)a
Strain Unit (A-U) IPM MPM CARB CTAZ CIPRO pl(s)
87 P 2 2 256 4 0.5 9.2
94 P 8 8 >256 2 >8 5.4
102 P 4 2 32 1 0.12 8.8
90 Q 16 4 64 2 0.12 ND
96 R 8 2 64 2 0.12 ND
97 R 8 4 64 1 0.12 ND
103 R 16 2 32 1 0.12 8.8
62 S 16 64 >256 16 >8 8.3, 9.2
63 T 4 2 256 8 >8 9.3
66 U 16 8 256 4 0.5 ND
75 U 8 4 32 4 0.25 5.3, 9.2
a
- Blue numbers represent a resistant MIC, black numbers equal sensitive MIC.
IMP, imipenem; MPM, meropenem; CARB, carbenicillin;
CTAZ, ceftazidime; CIPRO, ciprofloxacin; ND, not detected.
3.5 PCR detection of the metallo-P-lactamase gene blamp
It has been shown by Senda etal., (1996b) that PCR can be successfully applied to
rapidly detect an intragenic 587 bp fragment of the gene in clinically isolated
Gram-negative rods. Therefore, PCR with bla\up specific primers was used to
determine whether any of the 61 Japanese Paeruginosa isolates possessed this gene.
Five IMP-1 producing strains (S. marcescensTN9106, S. marcescens AK9374, S.
marcescens FHSM4055, P. aeruginosa M18 and P. aeruginosa 101/1477) were
employed as positive PCR controls and three standard laboratory strains (E. coli
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NCTC 10418, P. aeruginosa NCTC 10662 and S. marcescens NCTC 1377) were
employed as negative controls.
The PCR primer sequences are shown in Figure 3.1 (Senda et al., 1996b). The PCR
procedure was performed, as described in Section 2.17.2, with 1.5mM MgCh. The
PCR cycling parameters are shown in Table 3.2, however, the annealing temperature
was increased from the published 55°C (Senda et al., 1996b) to 60°C because non¬
specific DNA fragments were amplified for P. aeruginosa NCTC 10662 and S.
marcescens NCTC 1377 when annealing was performed at 55°C.
Figure 3.1 PCR primers for bla\mm
Sequence Position"
5' CTA CCG CAG CAG AGT CTT TG 3' 1241
5' AAC CAG TTT TGC CTT ACC AT 3' 1808
"
Numbering is according to Arakawa et al., (1995).
Table 3.2 PCR cycling parameters for the amplification of blamp
Segment Temperature (°C) Time (minutes) Function No. of cycles
1 94 2 Denaturation 1
9 94 1 Denaturation
60 1 Annealing >" x30
72 1.5 Extension -
->
J 72 10 Final extension 1
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3.6 PCR detection ofM«imp in the 61 P. aeruginosa strains from
Japan
All of the 61 P. aeruginosa strains were subjected to PCR analyses to detect the
blam? gene, however, all these strains were found to be blamp negative. A 587 bp
DNA fragment could be amplified from the five IMP-1 positive control strains
(Figure 3.2). Template DNA was prepared from the bacteria strains by using the
Genie genomic DNA extraction kit, although boiling a single colony suspended in
25pi of pyrogen-free water for 10 minutes was an equably suitable method and
furthermore, it was more convenient.
Figure 3.2 Amplification of a 587bp intragenic />/«imp PCR product
from an IMP-1 producing strain
1 2
Lanes: 1, lOObp DNA ladder; 2, 587bp PCR product from blamp positive control
strain.
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3.7 DNA hybridisation with an intragenic bla\Mp gene probe
Total genomic DNA samples from the 61 P. aeruginosa strains were dot blotted and
hybridised with an intragenic blamp gene probe. The probe consisted of the 587bp
DNA fragment generated by PCR from S. marcescens TN9106. Gene probing was
performed because it is less specific than PCR; however, this method also confirmed
these 61 Japanese P. aeruginosa strains to be negative for an IMP-1-like gene. Figure
3.3 shows a dot blot of the five IMP-1 positive strains hybridised with the blamp
probe.
Figure 3.3 Dot blot of DNA from five IMP-1 positive strains
hybridised with bla\Mp
S. marcescens TN9106
Of S. marcescens AIC9374
P. aeruginosa M18
m P. aeruginosa 101/1477
as s. marcescens FHSM4055
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3.8 Imipenem hydrolysis assays using small-scale ^-lactamase
extracts
Hydrolysis of imipenem was assayed for spectrophotometrically, using small-scale
(3-lactamase preparations. Efficient hydrolysis of imipenem could be easily detected
using small scale (3-lactamase extracts (prepared in 50mM sodium phosphate buffer,
pH 7.0) from IMP-1 positive control strains. However, no imipenem hydrolysis was
detected in any of the 61 Japanese P. aeruginosa strains by this method.
3.9 The role of chromosomal cephalosporinases in imipenem
resistance
It is well documented that imipenem resistance in P. aeruginosa is often caused by
decreased expression of the outer membrane protein D2 (Section 1.10.1.1). In
addition to the loss of D2, imipenem resistance in P. aeruginosa is also known to
require the activity of the derepressed AmpC chromosomal molecular class C
cephalosporinase (Section 1.10.1.1). A simple method described by Zhou et al.,
(1993) was applied to determine whether the chromosomal cephalosporinase was
involved in the imipenem/meropenem resistance mechanism in any of the 61
Japanese P. aeruginosa isolates and also IMP-1 positive controls. MICs of
imipenem and meropenem were determined either alone or in the presence of a fixed
concentration (4mg/l) of the serine (3-lactamase inhibitor BRL42715. The MIC of
BRL42715 alone was also determined to demonstrate that it is the P-lactamase
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inhibitor role of BRL42715 that results in any decrease in the carbapenem MICs and
not its antibiotic effect.
Two P. aeruginosa mutant strains, M1405p-con D2" and M2297(3-con D2", that have
derepressed AmpC p-lactamase expression and lack D2 were employed as positive
controls. Negative controls included M1405p-def D2", M2297p-def D2", that are
non-inducible P-lactamase basal mutants that lack the D2 porin and, therefore,
should show no decrease in imipenem MIC in the presence of BRL42715. The
effects of BRL42715 on the imipenem and meropenem MICs of the control strains
are shown in Table 3.3.
The MIC for BRL42715 alone was >128mg/L for both control strains and test strains
and, therefore, any decrease in MIC was the result of P-lactamase inhibition by
BRL42715 and not its antibiotic effect.
In the presence of BRL42715 a four- to 16-fold decrease in the imipenem MIC is
indicative of the involvement of a cephalosporinase in the mechanism of imipenem
resistance (Zhou et al., 1993) and can be seen in Table 3.3 for the two positive
control strains (M1405P-con D2" and M2297P-con D2"). The meropenem MICs of
these control strains are little affected by BRL42715, regardless of the levels of p-
lactamase expressed. When this method was carried out on the 61 P. aeruginosa
strains from Japan, between a four- to 16-fold decrease in imipenem MIC was shown
for 57 of the 61 strains examined and only two strains showed a four-fold decrease in
their meropenem MIC, the rest beihg unaffected. By adding BRL42715 in
104
combination with imipenem the imipenem MICs for the Japanese P. aeruginosa
strains were all less than the breakpoint for resistance (4mg/L).
The imipenem and meropenem MICs of five IMP-1 positive strains were also tested
in the presence and absence ofBRL42715 but neither the imipenem nor, meropenem
MICs were affected by BRL42715.
Table 3.3 The effect of the serine (3-lactamase inhibitor BRL42715










8 1 4 2
8 1 2 1
0.5 0.5 2 2
0.5 0.5 1 1
J MP, imipenem; MPM, meropenem.
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3.10 Determining whether imipenem-resistant P. aeruginosa strains
are (3-lactamase derepressed
Eight of the imipenem-resistant Japanese P. aeruginosa strains were chosen for
nitrocephin hydrolysis assays. These assays were performed to determine whether (3-
lactamase derepression is a requirement for imipenem resistance. The eight selected
strains included: four strains that showed a four- to 16-fold decrease in their
imipenem MICs in the presence of BRL42715 (strains 3, 30, 60, 66), and four strains
(2, 4, 39, 43) that showed no decrease in their imipenem MIC in the presence of
BRL42715 Nitrocephin hydrolysis assays were performed with imipenem induced
and non-induced large-scale (3-lactamase extracts prepared in 25mM PIPES buffer,
pH 7.0.
Strains 3, 30, 60 and 66 decreased their imipenem MICs in the presence of
BRL42715 (Table 3.4); however this was not necessarily associated with derepressed
(3-lactamase activity, as three out of the four strains (3, 60, 66) showed a >25-fold
increase in (3-lactamase activity following induction with imipenem. The four strains
(2, 4, 39, 43) that are resistant to imipenem but unaffected by BRL42715 also had
variable levels of (3-lactamase activity.
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Table 3.4 The specific activities of crude [3-lactamase extracts from
four P. aeruginosa strains that show between a four- to 16-fold
decrease in their imipenem MIC in the presence of BRL42715 and
from four strains that show no decrease in their imipenem MIC in
the presence of BRL42715 (measured against nitrocephin)
Specific activity (sp act)* Induction ratio
Strain Noninduced Induced (induced/non-induced sp act)
10662" 1 479 479
M18b 460 2433 5
->c
J 2 72 36
30 3649 3706 1
60 32 844 26
66 -vJ 844 281
2d 17 2021 118
4 462 594 I
39 115 5160 45
43 63 2220 35
* Nanomoles of nitrocephin hydrolysed/minute/mg of protein.
aP. aeruginosa NCTC 10662 sensitive laboratory control.
b P. aeruginosa M18 = IMP-1 positive strain.
4
Four P. aeruginosa strains that show a four- to 16-fold decrease in their imipenem
MIC in the presence of BRL42715.
''
Four P. aeruginosa strains that show no decrease in their imipenem MIC in the
presence of BRL42715.
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3.11 Imipenem hydrolysis assays using large-scale ^-lactamase
extracts
P. aeruginosa strains 3, 30, 60, 66, 2, 4, 39 and 43 were chosen for further
biochemical study. P-Lactamase extracts were prepared on a large scale in the
presence and absence of imipenem as an inducer. 50mM sodium phosphate buffer,
pH7.0 was replaced with 25mM PIPES buffer, pH 7.0 because some metallo-P-
lactamases have been reported to be unstable in 50mM sodium phosphate buffer, pH
7.0 (Watanabe el a/., 1991) and 25mM PIPES, pH 7.0 has been recommended for
metallo-P-lactamase assays (Payne and Farmer, 1998). Both induced and non-
induced crude P-!actamase extracts were also prepared in the presence and absence
of both 1 pM and lOOpM ZnSCE to ensure that any potential metallo-P-lactamases
were clearly identified.
Hydrolysis of imipenem could not, however, be detected with any of the P-lactamase
extracts prepared from these eight P. aeruginosa strains, under each condition used.
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3.12 IEF and P-lactamase typing
Isoelectric focusing was repeated using the large-scale induced p-lactamase
preparations from the eight P. aeruginosa representative strains (3, 30, 60, 66, 2, 4,
39, 43). Focusing of the P-lactamases was followed by overlaying the gels with
BRL42715 (lOOpM), cloxacillin (lOOpM) and clavulanic acid (ImM) before staining
with nitrocephin. The purpose of these inhibitor overlays was to provide further
evidence that it is a molecular class C, Bush group 1 cephalosporinase that is
involved in the imipenem resistance mechanism in the Japanese P. aeruginosa
strains BRL42715 inhibits serine P-lactamases, although it cannot be used to
distinguish between the different classes of serine P-lactamases. Cloxacillin,
however, is recognised as a good inhibitor of the molecular class C, Bush group 1
cephalosporinases, and clavulanic acid is a good inhibitor of molecular class A P-
lactamases, but not class C cephalosporinases (Bush el a/., 1995). The TEM-1 P-
lactamase was employed as a positive molecular class A p-lactamase control. The P-
lactamase extract from P. aeruginosa NCTC 10662 was employed as a positive class
C cephalosporinase control. The effect of these inhibitors on the P-lactamases from
the eight P. aeruginosa strains are summarised in Table 3.5, where it can be seen that
the high pi P-lactamases from the P. aeruginosa strains are inhibited by BRL42715
and cloxacillin, but not clavulanic acid. This suggests that all the P-lactamases are of
molecular class C.
109
Table 3.5 Effects of BRL42715, cloxacillin and clavulanic acid on (3-




Bands seen after treatment with:
BRL42715 Cloxaeillin Clasodanic acid
(100pm) (100pm) (lrnM)
TEM-1 5.4 ND 5.4 ND
10662 8.7 ND ND 8.7
*)
J 9.3 ND ND 9.3
30 9.2 ND ND 9.2
60 8.95 ND ND 8.95
66 8.95 ND ND 8.95
2 5.4. 8.7 ND 5.4 8.7
4 9.2 ND ND 9.2
39 9.2 ND ND 9.2
43 9.2 ND ND 9.2
ND. not detected.
3.13 Analysis of outer membrane proteins
Outer membrane proteins were prepared from the eight selected P. aeruginosa
strains (3, 30, 60, 66, 2, 4, 39, 43). The outer membrane proteins from these strains
were examined to determine whether these isolates lacked the D2 outer membrane
protein. Unfortunately, a comparison between the outer membrane proteins from the
imipenem-resistant Japanese P. aeruginosa strains and their isogenic impenem-
susceptible parents could not be made because the parent strains were not available
Instead the outer membrane profiles from these strains were compared with P.
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aeruginosa M2297(3-con and P. aeruginosa M2297(3-con D2\ these are control
strains that produce and are deficient in the D2 porin respectively.
Figure 3.4 shows the outer membrane proteins profiles from four randomly selected
P. aeruginosa strains (3, 30, 60, 66) that show a four- to 16-fold decrease in their
imipenem MICs in the presence of BRL42715. These strains appear to have
diminished production of the D2 porin when the SDS polyacrylamide gel was stained
with Coomassie blue. Figure 3.5 shows that the four P. aeruginosa strains (2, 4, 39,
43), showing no decrease in imipenem MIC in the presence of BRL42715 are also
deficient in the D2 porin.
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Figure 3.4 Outer membrane protein profiles of four P. aeruginosa
strains that show a four- to -16-fold decrease in their imipenem





24.5 kD mk* ^ —
Red arrowhead indicates D2 porin
Lanes: 1, molecular weight markers (molecular weights listed to the left); 2,
M2297(3-con; 3, M2297J3-con D2"; 4, strain 3; 5, strain 30; 6, strain 60; 7, strain 66.
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Figure 3.5 Outer membrane protein profiles of four P. aeruginosa







- "■ '• - ■ ■—
Red arrowhead indicates D2 porin
Lanes: 1, molecular weight markers (molecular weights listed to the left); 2,
M2297P-con; 3, M2297P-con D2"; 4, strain 2; 5, strain 4; 6, strain 39; 7, strain 43.
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3.14 Discussion
When the 61 clinical P. aeruginosa isolates, included in this study were subjected to
PCR with bkiiwp primers they were all found to be negative for this apparently highly
conserved gene. Furthermore, DNA hybridisation with an intragenic 6/«imp gene
probe also confirmed these strains to be negative for an IMP-1-like enzyme. These
results are in agreement with previous studies (Senda et al., 1996b) where all strains
that have so far been found to harbour the bhi\\\? gene are highly resistant to almost
every cephem, in particular ceftazidime (MIC >128mg/l). From Table 3.1 it can be
seen that for the P. aeruginosa strains in this study, the highest recorded ceftazidime
resistance was 64mg/l and therefore, none of these isolates fit the profile of
previously reported 1MP-1 producing strains.
Chromosomal cephalosporinases are ubiquitous amongst P. aeruginosa. By
determining the MIC of imipenem alone and in the presence of a fixed concentration
of the serine (3-lactamase BRL42715, it was possible to show that the chromosomal
cephalosporinase contributed significantly to imipenem resistance in the majority of
the 61 strains included in this survey. A greater than two-fold decrease in the
imipenem MIC was demonstrated in al! but four of the 61 strains, which showed only
a two-fold decrease. In contrast, inhibition of the chromosomal cephalosporinase by
BRL42715 has little effect on the meropenem MICs and, therefore, the .P. aeruginosa
cephalosporinase is not a major contributor to meropenem resistance. This
phenomenon is thought to be related to the greater stability of meropenem to the P.
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aeruginosa chromosomal cephalosporinase when compared with imipenem
(Livermore, 1992a).
The imipenem MIC of the five IMP-1 producing strains were not affected by
BRL42715 and therefore the chromosomal cephalosporinase does not appear to be a
contributing factor to imipenem resistance in these isolates.
Isoelectric focusing of (3-lactamases from selected strains, followed by overlays with
the inhibitors BRL42715, cloxacillin and clavulanic acid provided further evidence
that the Japanese P. aeruginosa strains possess a class C cephalosporinase that is
involved in the imipenem resistance mechanism. The results of Table 3.4
additionally show that derepression and thus high level production of the
cephalosporinase is not necessarily a requirement for imipenem resistance because
the strains in this study were either constitutive or inducible producers of (3-
lactamase. These results are in agreement with the findings of Zhou et a!., (1993).
Analysis of the outer membranes of selected P. aeruginosa strains, however, did
confirm that these strains are deficient in the carbapenem specific porin channel D2
(Figures 3.4 and 3.5)
Efficient hydrolysis of imipenem could not be detected from small-scale (3-lactamase
extracts prepared from the P. aeruginosa strains. Additionally, no efficient
hydrolysis of imipenem could be detected from large-scale extracts, prepared under
different conditions, from four strains that were unaffected by BRL42715, or from
four randomly selected strains that displayed a significant decrease in their imipenem
1 15
MIC in the presence of BRL42715. Therefore, these results ruled out the
involvement of a novel carbapenemase in the imipenem resistance mechanism.
Active efflux systems (Nikaido, 1994) or other porin species (Livingstone et a!.,
1995) may be contributing factors in imipenem resistance in the four strains that are
unaffected by BRL42715.
Determining the mechanism of bacterial resistance to carbapenenis in P. aeruginosa
is a complex process. Synergism between a cephalosporinase and lowered outer
membrane permeability is by far the most prevalent mechanism of imipenem
resistance in the strains studied in this survey, which also highlights that the IMP-1-
mediated mechanism of resistance is currently a much rarer event in P. aeruginosa. It
remains to be seen whether the IMP-1 resistance mechanism becomes as widespread




A rapid substrate-based technique for the detection of
carbapenemases after isoelectric focusing
4.1 Introduction
Matthews first described the application of analytical IEF for the characterisation of
3-lactamases in 1975. IEF is a very useful technique to employ initially when
comparing the 3-lactamases produced by different bacteria. In the past IEF has been
described as 'one of the most critical assays used to verify the identity of 3"
lactamases' (Bush et a!., 1988). The vast array of 3-lactamases identified over the
last 20 years (see Section 1.4.4) has meant that pi values are no longer sufficient to
classify a 3-lactarnase and that additional biochemical and molecular data are now an
essential requirement. Furthermore, it is now known that the carbapenem-
hydrolysing metallo-3-lactamases of the genus Aeromonas poorly hydrolyse
nitrocephin, the substrate conventionally used for the detection of 3-lactamases after
1EF and, therefore, go undetected in IEF gels (Hayes et ci/., 1994; Walsh et cil
1995a).
117
For the above reasons several modifications to IEF have been described to enhance
the utility of this procedure including the identification of Aeromonas metallo-P-
lactamases (Massida et a/., 1991, Payne el a/., \994a; Walsh et a/., 1995a).
This section now describes the development of a modified substrate-based technique
for the identification of carbapenemases after IEF. The principle behind the
technique is that P-lactamases are allowed to focus on an IEF gel and this is then
overlaid with agar containing imipenem (0.5mg/l) and an indicator organism (E. coli
NCTC 10418) that is susceptible to imipenem (imipenem MIC - 0.12mg/l). After
overnight incubation at 37°C, no growth of the indicator organism should be seen,
except above the position where P-lactamases have focused and hydrolysed the
imipenem.
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4.2 Assessing the ability of a carbapenemase to hydrolyse imipenem
in an agar overlay
A microbiological screening method was designed to assess whether the
carbapenem-hydrolysing P-lactamase (NMC-A) from Enterobacter cloacae strain
NOR-1 (Nordmann et a/., 1993) was able to hydrolyse imipenem in an agar overlay,
allowing the E. coli NCTC 10418 indicator organism to grow. This involved pouring
a layer of electrophoresis grade agarose into a petri dish and spotting different
volumes (pi) of a large scale imipenem-induced (1/4 MIC) P-lactamase extract
prepared from E. cloacae NOR-1 on top of the set agarose. The layer of agarose was
covered with lso-Sensitest (1ST) agar containing 0 5mg/l imipenem and IOOpl of a
1/100 dilution of an overnight E. coli NCTC 10418 broth culture. The volume of
1ST agar poured over the agarose surface was varied to determine the depth of agar
that would give optimum results.
Figure 4.1 shows the results of this microbiological screening assay. The zone of A.
coli NCTC 10418 growth was dependent on the amount of P-lactamase extract
spotted onto the agarose and on the depth of agar poured over the surface of the
agarose. This experiment demonstrated that it was important to apply only a thin
layer of agar and a depth of approximately 2.5mm was considered to give optimum
results. This method was also successfully repeated with imipenem-induced (1/4
MIC) P-lactamase extracts from carbapenemase-producing Aeromonas hydrophila
strain T429125 (Walsh et a/., 1997) and Serratia marcescens S6 that produces the
carbapenemase Sme-1 (Yang et a!., 1990).
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Zones of E. coli NCTC 10418 growth
a
P-Lactamase extract from E. cloacae strain NOR-1
b Volume (pi) of p-lactamase extract spotted onto the layer of agarose
4.3 Imipenem/agar overlay modification with a polyacrylamide IFF
gel
Once it had been established that carbapenemases could hydrolyse imipenem in an
agar overlay, allowing E. coli NCTC 10418 to grow, this method could be applied
after IEF. p-Lactamase extracts prepared from E. cloacae NOR-1, S. marcescens S6
and A. hydrophila T429125 were focused on a self-cast polyacrylamide gel.
Repeated attempts were made to detect the carbapenemases by the imipenem/agar
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overlay and an ampicillin/agar overlay. None of the carbapenenrases could be
detected with either of these [3-lactams.
4.4 Imipenem/agar overlay modification with an agarose IEF gel
Two possible reasons why the carbapenemases could not be detected with the
imipenem/agar overlay modification to a self-cast polyacrylamide 1EF gel were (i)
the pH gradient of the IEF gel was interfering with the growth of the E.coli NCTC
10418; or (ii) the polyacrylamide in the IEF gel, particularly unpolymerised
acrylamide monomers, may have an adverse effect on the growth of E.coli NCTC
10418.
E. coll has a growth optimum between pH 6.0 and 7.0, although it will grow in pH
conditions as low as 4.4 and as high as 9.0. Therefore, although the pH gradient may
affect the growth of E.coli NCTC 10418 it would be expected that a {3-lactamase
with a pi value between 6.0 and 7.0 such as NMC-A (pi 6.9) would be detectable.
The effect of polyacrylamide was investigated by substituting a self-cast
poiyacrylamide IEF gel with an agarose IEF gel (Section 2.8.3). Replacing
polyacrylamide gels with agarose gels confirmed that polyacrylamide gels were not
suitable for the modified IEF technique, because carbapenemases that had previously
gone undetected could now be identified. Figure 4.2 shows an agarose IEF gel that
has been stained with (a) nitrocephin, compared with an agarose IEF gel that has
been (b) overlaid with 1ST agar containing imipenem and E. coli NCTC 10418. In
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Figure 4.2 two areas of growth can be seen in lanes 1 and 4. Lane 1 corresponds to
A. hydrophila T429125 -the area of growth does not line up with either of the two 3-
lactamase bands that are visualised by nitrocephin overlay. This observation is in
agreement with what is known about the metallo-P-lactamases ofAeromonas, that is
they are not detectable with nitrocephin (Hayes et al., 1994; Walsh et a/., 1995a).
Lane 4 corresponds to E. cloacae NOR.-1 and growth can be seen where NMC-A has
focused (pi 6.9). Lane 3 contains the P-lactamase extract from S. marcescens S6,
however the carbapenemase Sme -1 (pi 9.7) could not be detected. The P-lactamase
OXA-7 (Medeiros et a/., 1985) was included on the gel as negative control (Lane 2).
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Figure4.2AnagaroseIEFelove laidwith( )nitrocephinb1STagarc ntainingim p n m(0.5mg/l)d E.coliNCTC10418 Lanes:1,A.hydrophilaT419125(pibetween6.9-8 0);2OXA-77.653Smarce cens6(pi8. ,7 ;,E.cloacaeNOR-1 6.9,9.3).
4.5 Employing a pH tolerant indicator for the detection of high pi
carbapenemases
A pH tolerant E. coli NCTC 10418M mutant was selected by growing the organism
on nutrient agar plates made up with Tris-Cl buffer, pH 10.0. E. coli NCTC 10418M
was then employed as the indicator organism in the imipenem/agar overlay to
determine whether the pH gradient of the IEF gel was affecting the growth of the E.
coli NCTC 10418 parent strain above the Sme-1 carbapenemase, which has a much
more basic pi value (pi 9.7) compared with the carbapenemases from A. hydrophila
T429125 and E. cloacae NOR.-1 Figure 4.3 shows that when the IEF gel was
overlaid with agar containing imipenem and the pH tolerant mutant the Sme-1
carbapenemase from S. marcescens could be detected and, therefore, the pH of the
IEF gel does affect the growth of the indicator organism.
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Figure4.3AnagaroseIEFeloverlaidwith( )nitrocephinanb1STgarc ntainingm penem(0.5mg/l)a d E.coliNCTC10418M (a)Nitrocephin(b)Imipenem/agaroverlay ■'
Pi 9.7 7.65 6.9
Lanes:1,A.hydrophilaT419125(pibetween6.9-8.0));2OXA-77.653Smcirce cens6( i8. ,;,E.cloacaeNOR-1( i 6.9,9.3).
4.6 Imipenem agar modification with a pre-cast IEF gel
During the development of this substrate-based technique for the detection of
carbapenemases after IEF a paper was published by Yang and Bush (1996) on the
biochemical characterisation of a carbapenem-hydrolysing AsbM 1 P-lactamase from
A. jandaei AER14M (formerly identified as A. sobria AER14M). The study by
Yang and Bush (1996) included the application of an imipenem/agar overlay
following IEF to show the presence of AsbMl (pi 9.1). The method described by
Yang and Bush (1996) involved using commercially prepared pre-cast
polyacrylamide gels and the spreading of the indicator organism (E.coli ACTC
25922) over the surface of the agar overlay, as opposed to mixing the diluted
indicator organism w ith molten agar and pouring this over the surface of the IEF gel.
Only polyacrylamide gels prepared in the laboratory had been tested in this current
study, therefore the IEF/overlay technique was repeated this time employing pre-cast
IEF gels and swabbing the diluted E. coli NCTC 0418 over the solidified agar
surface and it became apparent that this technique could be successfully performed
with commercially prepared polyacrylamide gels. Figure 4.4 shows the detection of
a carbapenemase (pi 6.4) produced by Stenotrophomoncis maltophilia strain 511
(Felici et a/., 1993; Payne et a/., 1994a) and the ImiS metallo-P-lactamase (pi 9.3)
produced by A. veronii bv. sobria 163a (Walsh et a!., 1995a), following the
procedure of Yang and Bush (1996).
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Carbapenemases could additionally be detected when the procedure described by
Yang and Bush (1996) was repeated using a self-cast polyacrylamide, the only
difference between this method and the one employed in Section 4.3 being the
streaking of the indicator organism over the agar surface.
Figure 4.4 A polyacrylamide IEF gel overlaid with (a) 1ST agar
containing imipenem (0.5mg/l), with E. coli NCTC 10418 streaked
over the agar surface and (b) nitrocephin
(a) (b)
12 12
Lanes: 1, A. veronii bv. sobria 163a (pis 7.4, 7.9); 2, S. maltophilia 511 (pi 6.4, 9.7).
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4.7 Discussion
Substrate-based overlay studies after IEF provide a simple approach for the
characterisation of (3-lactamases. This methodology offers the advantage that
enzyme activities can be detected without firstly having to perform P-lactamase
purification and is particularly beneficial when bacteria produce more than one |3-
lactamase.
This section has described the development of a technique that specifically enables
carbapenemases to be detected, including the metallo-(3-lactamases of two
Aeromoncis species (Figures 4.2 - 4.4). Both an iodometric method (Massida el al.,
1991) and a bromothymol blue/imipenem IEF overlay method (Walsh et a!., 1995a)
have previously been employed to detect the Aeromonas carbapenemases. Elowever,
Ftayes (1995) could not detect the Aeromonas carbapenemases by either of these
methods which implies that they are both problematic. In contrast the imipenem/agar
overlay has been successful in detecting the metalio-P-lactamases from two
Aeromonas species in this study, and Yang and Bush (1996) have also reported the
identification of carbapenemases from another Aeromonas species by an
imipenem/agar overlay method published recently.
From this study, it has been revealed, however, that an important factor in
determining the success of this technique is whether the indicator organism is
inoculated over the surface of the imipenem/agar layer. When a broth culture of E.
co/i NCTC 10418 was mixed with molten agar carbapenemases could only be
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detected when focused on agarose IEF gels and Sme-1 with a pi of 9.7 could only be
identified with a pH tolerant mutant. However, when the E. co/i NCTC 10418 was
streaked over the surface of the agar carbapenemases could be detected when
focused on self-cast and pre-cast polyacrylamide gels in addition to agarose IEF gels.
Aeromoncis carbapenemases with reported pis of > 9.0 could also be revealed (Figure
4.4). The reason for the importance of this step may possibly be that by swabbing E.
co/i NCTC 10418 on the agar surface the organism is not in direct contact with the
polyacrylamide or subject to the influence of the IEF gel pH gradient.
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5: RESULTS
The isolation of imipenem-resistant,4m>m0/i0s veronii biovar (bv.)
sobria, that possess a novel carbapenemase from a water source in
India
5.1 Introduction
Aeromonas veronii bv. sobria (formerly A. sobria) is a major pathogenic species of
the genus Aeromonas. In common with most Aeromonas species, it has the ability to
express up to three different chromosomally encoded, inducible (J-lactamases a
molecular class C cephalosporinase, a molecular class A or class D penicillinase and
a molecular class B metallo-carbapenemase (Section 1.11.2.1).
This section reports the identification of two imipenem-resistant A. veronii bv. sobria
strains isolated from a water source in Vellore, South India; and the preliminary
evidence for the production of a novel Aeromonas carbapenemase in these two
isolates.
5.2 Background to bacterial strains
During July 1996, a study was undertaken by Amyes to examine antibiotic resistance
in environmental bacteria from water sources in the town of Vellore, South India.
130
Aeromonas species were found to be particularly abundant in the water sources
sampled and more significantly seven Aeromonas strains were recorded as being
resistant to imipenem (MIC >4mg/l), with six of these strains additionally resistant to
meropenem (MIC >4mg/l) (Amyes, 1996). Therefore, ten Aeromonas isolates from
the survey by Amyes (1996), including the strains identified as being carbapenem-
resistant, were obtained for further investigations outlined in this chapter.
5.3 Species identification and ^-lactam sensitivities of ten Aeromonas
isolates
The speciation of the ten Aeromonas isolates was determined with API 20NE strips
(Table 5.1). The sensitivities of these ten strains to various (3-lactams (including the
carbapenems) were determined by the agar dilution method (Table 5.1). In Table 5.1
it can be seen that only two A. veronii bv. sobria isolates, strains 13 and 99, were
found to be resistant to imipenem (MIC >4mg/l) by the agar dilution method, the
meropenem MIC of these two strains was at the breakpoint for resistance (4 mg/1).
Previously it had been shown by the Etest method that seven of the ten strains were
resistant to imipenem and five of these strains also resistant to meropenem (Amyes,
1996). These conflicting results can however be explained by an inoculum effect
(see Section 5.4). When preparing a bacterial culture for the Etest method it is
recommended that the density of culture should be adjusted to equal that of a 0.5
McFarland turbidity standard, this contains approximately 10x cfu/ml, whereas an
inoculum of 104 cfu is recommended for the agar dilution method (see below -
Section 5.4).
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All of the A. veronii bv. sobria strains were highly resistant to both ampicillin and
oxacillin (MIC >512 mg/1), whereas A. hydrophila strain 98 was more susceptible to
ampicillin (Table 5.1). A. veronii bv. sobria strains 13 and 99 were additionally
highly resistant to cephaloridine and showed reduced susceptibility to cefoxitin,
although these two strains remain sensitive to both the third and fourth generation
cephalosporins (Table 5.1).
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5.4 Inoculum size
An experiment was carried out to analyse the inoculum effect on the imipenem MIC
of the ten Aeromonas strains. The imipenem MIC was determined by the agar
dilution method and inoculum sizes of 104, 105, 106, 107 and 108 cfu were tested. A.
veronii bv. sobria strains 13 and 99 were the only isolates resistant to imipenem
when inocula of 104or 105 cfu were tested (Table 5.2). With an inoculum of 106 cfu,
six of the nine A. veronii bv. sobria strains were resistant to imipenem (MIC
>8mg/l). All of the A. veronii bv. sobria strains were resistant to imipenem with an
inoculum of 107 cfu. A. hydrophila strain 98 remains sensitive to imipenem even
with an inoculum of 108 cfu.
Table 5.2 The effect of bacterial inoculum size on imipenem
sensitivity
Strain 104
Imipenem MIC (mg/1) with 10" cfu
10s 106 107 108
13 8 8 64 >256 >256
27 2 4 32 >256 >256
36 1 2 16 >256 >256
47 0.5 2 8 128 128
51 0.25 1 2 32 32
52 1 2 4 256 >256
98 0.12 0.25 0.25 0.25 0.25
99 8 16 16 32 >256
110 2 2 16 32 >256
115 0.5 0.5 0.5 256 >256
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5.5 P-Lactamase assays
Small-scale P-lactamase extracts were prepared in 50mM sodium phosphate buffer,
pH 7.0 from the ten Aeromonas strains and assayed spectrophotometrically against
100pM imipenem. Efficient hydrolysis of imipenem could only be detected with P-
lactamase extracts from imipenem-resistant strains 13 and 99.
Hydrolysis assays were also performed with induced (imipenem !4 MIC) and non-
induced large-scale P-lactamase extracts prepared from A. veronii bv. sobria strains
13, 27, 99, and 110 to analyse further the P-lactamase activities in carbapenem-
sensitive and -resistant strains. Enzyme activity was assayed against ampicillin
(500pM), cephaloridine (100pM) and imipenem (lOOpM). Imipenem was
additionally recorded after pre-incubation at 37°C for 10 minutes with lOmM EDTA
(Table 5.3).
Table 5.3 shows that P-lactamase extracts from the two carbapenem-resistant strains
13 and 99 can hydrolyse all three P-lactams tested in the absence of a P-lactamase
inducer, and in the presence of the imipenem inducer there is a less two-fold increase
in enzyme activity. In contrast, with the two sensitive A. veronii bv. sobria strains,
27 and 110, P-lactam-hydrolysis is only evident in extracts prepared from induced
cultures, where a dramatic increase in P-lactamase activity against imipenem and
ampicillin can be noted. No hydrolysis of cephaloridine was detectable in induced P-
lactamase preparations from strain 27 and 110. A marked difference is also seen in
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the effects of imipenem hydrolysis in the presence of the metallo-(3-lactamase
inhibitor EDTA. Pre-incubation of the metallo-(3-lactamase extracts from strains 27
and 110 results in >95% inhibition of imipenem hydrolysis, whereas, only partial (<
33%) inhibition of imipenem hydrolysis is achieved when P-lactamase extracts from
imipenem-resistant strains 13 and 99 were pre-incubated with EDTA.
5.6 IEF of induced and non-induced P-Iactamase preparations from
ten Aeromonas isolates
IEF was performed on induced (imipenem lA MIC) and non-induced large-scale P-
lactamase extracts prepared from the ten Aeromonas strains. Induced and non-
induced P-lactamase preparations from A. veronii bv. sobria 163a, a strain which
expresses three different p-lactamases characterised in detail by Walsh et al., (1995a)
was also included on the IEF gel. Figure 5.1 shows that the P-lactamase banding
patterns were essentially the same for both non-induced and imipenem induced cells,
although the P-lactamase bands were more intense when the strains are induced.
Exceptions to this were the extracts from induced strain 163a and induced strain 36
where additional bands can be seen, compared with the non-induced extracts. In the
induced extract from 163a two P-lactamases bands are detectable with nitrocephin as
reported previously (Walsh et al., 1995a), these correspond to the penicillinase
AmpS (pi 7.9) and the cephalosporinase CepS (pi 7.4); however, only one band is
detectable in the non-induced 163a strain. The most notable feature of Figure 5.1 is,
however, the distinctive P-lactamase banding patterns of the two imipenem-resistant
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strains 13 and 99, which in addition to a basic (3-lactamase of pi 8.3 also includes an
intense band with an acidic pi value (5.84). Less intense bands are also seen above
and below the pi 5.84 band of strain 13 and 99 and are possibly 'satellite bands', that
is different forms of the main pi 5.84 3-lactamase band (Payne and Farmer, 1998).
The pi values written in parenthesis in Figure 5.1 were all determined with the aid of
commercial pi markers as described in Section 2.8.4.
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5.7 Identification of imipenem-hydrolysing (3-lactamases after IEF
The imipenem/agar overlay of Yang and Bush (1996), and modified as previously
described in Section 4.6 was applied to determine the pi of the imipenem-
hydrolysing enzyme produced by the two imipenem-resistant A. veronii bv. sobrici
strains 13 and 99. This method was performed on non-induced and imipenem-
induced 3-lactamase preparations from strains 13 and 99. A cell extract from S.
maltophilia that produces two P-lactamases (LI-type carbapenem-hydrolysing
metallo-P-lactamase - pi 6.4 and an L2 cephalosporinase - pi 9.7) was employed as
both a positive and negative control. Figure 5.2 shows the IEF gel overlaid with (a)
nitrocephin and (b) agar containing 0.5mg/l imipenem with a diluted overnight E.coli
NCTC 10418 broth culture streaked over the surface of the agar. A single zone of E.
coli NCTC 10418 growth can be seen in the lanes (3-6) corresponding to induced
and non-induced P-lactamase extracts from A. veronii bv. sobria strains 13 and 99
(Figure 5.2b). This zone of E. coli NCTC 10418 growth indicates the presence of a
carbapenemase that focuses at pi 5.84, which is also detectable with nitrocephin. A
zone of growth is also seen in lane 2 of Figure 5.2b and this corresponds to the S.
maltophilia LI carbapenem-hydrolysing metallo-P-lactamase (pi 6.4).
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5.8 IEF with EDTA and BRL42715 inhibitor overlays
IEF followed by overlays with metallo-P-lactamase inhibitor EDTA (lOOmM) and
the serine P-lactamase inhibitor BRL42715 (lOOpM) prior to nitrocephin staining has
previously been shown to rapidly distinguish metallo-P-lactamases from serine P-
lactamases (Payne et a/., 1994a). Therefore, this method was applied to further
characterise the pi 5 .84 and pi 8.3 P-lactamase bands ofA veronii bv. sobria strains
13 and 99. P-Lactamases from three additional A. veronii bv. sobria strains (27, 110
and 163a) were also focused on the gel. A TEM-1 (serine-based) P-lactamase and a
cell extract from S. maltophilia 511 (described in Section 5.7) were included as
controls.
It can be seen from Figure 5.3a that the S. maltophilia LI metallo-P-lactamase (lane
6, pi 6.4) was the only P-lactamase band to be affected by the metallo-P-lactamase
inhibitor EDTA. When the gel was overlaid with the serine P-lactamase inhibitor
BRL42715 (Figure 5.3c) the only bands that are not inhibited were the two pi 5.84 P-
lactamase bands belonging to A. veronii bv. sobria strains 13 and 99 and the LI
metallo-P-lactamase of S. maltophilia 511. The results from Figure 5.3, therefore,
show that the pi 8.3 P-lactamase of strains 13 and 99 were serine-based P-
lactamases, as were the nitrocephin detectable p-lactamases of the three other A.
veronii bv. sobria strains (27, 110 and 163a) included on the gel. However, the pi
5.84 P-lactamase band of strains 13 and 99 was not inhibited by either EDTA or
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BRL42715. It should be noted, however, that the satellite bands above and below the
pi 5.84 band do appear to be inhibited by BRL42715.
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5.9 IEF with aztreonam, cloxacillin and clavulanic acid inhibitor
overlays
Additional aztreonam, cloxacillin and clavulanic acid inhibitor overlays were
performed on the focused (3-lactamases of A. veronii bv. sobria strains 13 and 99.
Figure 5.4 shows that two different concentrations (0.1 and ImM) of the molecular
class C cephalosporinase inhibitors aztreonam and cloxacillin have no significant
effect on either the pi 5.84 or the pi 8.3 P-lactamase bands of strains 13 and 99, or on
the molecular class A P-lactamase TEM-1. In contrast the AmpC-type class C
cephalosporinase of P. aeruginosa strain 2297 (included on the gel as a positive
control) is completely inhibited by 0.1 and ImM concentrations of both aztreonam
and cloxacillin.
Figure 5.5 shows that the molecular class A P-lactamase inhibitor clavulanic acid
(ImM) completely inhibited the pi 8.3 P-lactamase band of strains 13 and 99 and the
TEM-1 p-lactamase. There also appeared to be some partial inhibition by clavulanic
acid of the pi 5.84 P-lactamase band from strains 13 and 99. The class C
cephalosporinase ofP. aeruginosa strain 2297 was not affected by clavulanic acid.
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Figure5.4Effectofaztreonam(0 1ndImM)acl xacillin( ndl )oth(3-lactam seb ndfrA veroniib .sobriastrains13and99 ImMaztreonamO.lmaztreonamI cloxacillinO.lc oxacilliNinhibitor 123412341234123 Lanes:1,TEM-1(pi5.4);2P.aeruginosa297i8.3 ;3,stra(p5.8 ,3);4strain995.8 ,8.3).
Figure 5.5 Effect of clavulanic acid (ImM) on the (3-lactamase bands
from A. veronii bv. sobria strains 13 and 99
No clavulanic acid ImM clavulanic acid
1 2 3 4 1 2 3 4
Lanes: 1, P. aeruginosa 2297 (pi 8.3); 2, TEM-1 (pi 5.4); 3, strain 13 (pis 5.84, 8.3);
4, strain 99 (pis 5.84, 8.3).
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5.10 IEF followed by a zinc sulphate gel overlay
It has previously been demonstrated that the application of a zinc sulphate overlay to
an IEF gel before nitrocephin staining can enhance the identification of zinc-
dependent metallo-P-lactamases (Payne el al., 1994a). Therefore, an experiment was
performed to establish whether the pi 5.84 P-lactamase band common to both A.
veronii bv. sobria strains 13 and 99 was affected by increasing concentrations of
ZnSO.4. The P-lactamases from A. veronii bv. sobria strain 13, S. maltophilia 511
and the TEM-1 P-lactamase were focused on an IEF gel and overlaid with 0.01, 0.1,
1.0 and lOmM zinc sulphate concentrations. In Figure 5.6 the LI metallo-P-
lactamase band (pi 6.4) was visibly enhanced by overlaying with increasing
concentrations of ZnSO/j. None of the other P-lactamase bands were affected by
ZnSC>4, including the pi 5.84 band ofA. veronii bv. sobria strain 13.
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5.11 Discussion
This section has reported the identification of two imipenem-resistant A. veronii bv.
sobria (strains 13 and 99), isolated from a water source in South India. Strains 13
and 99 were found to have an imipenem MIC of 8mg/l by the agar dilution method,
employing a conventional inoculum of 104 cfu (Table 5.1). To date, only a handful
of naturally occurring carbapenem-resistant Aeromonas isolates have been recorded
when testing with a conventional inoculum size, these being usually derepressed
mutants for carbapenemase production (Rossolini et ah, 1996).
It is well known that the carbapenem MICs of Aeromonas strains are subject to an
inoculum effect (Rossolini el a/., 1996). Carbapenem-resistance is normally only
detectable when a large inoculum of a carbapenemase-producing strain (108 cfu) is
used in susceptibility testing (Rossolini et al., 1996). Carbapenemase-negative
Aeromonas strains remain always below the breakpoint for susceptibility irrespective
of the inoculum size (Rossolini et a/., 1996). The results of Table 5.2 illustrate the
effect of the inoculum size on imipenem MICs. Nine of the ten Aeromonas strains
tested were found to be imipenem-resistant with an inoculum of 107 cfu. It is
interesting that A. hydrophila strain 98 remains sensitive to imipenem even with an
inoculum of 108 cfu and, therefore, this strain may not possess carbapenemase
activity.
P-Lactamase extracts from A. veronii bv. sobria strains 13 and 99 were found to
possess penicillinase, cephalosporinase and carbapenemase activity (Table 5.3).
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Following P-lactam induction, there was a less than two-fold increase in p-lactamase
activity was detected (Table 5.3) and, therefore, these two strains appear to be
constitutive P-lactamase producers.
The carbapenemase activity of strains 13 and 99 could only be partially inhibited
(<33%) by lOmM EDTA (Table 5.3). The carbapenemase activity of Aeromonas
strains of several different species is usually found to be completely inhibited by
lOmM EDTA and thus demonstrates their metallo-enzyme nature (Rossolini et al.,
1995, Walsh et a/., 1997). Partial inhibition with lOmM EDTA has only previously
been reported for a single isolate, A. hydrophila T429125, where activity against
imipenem decreased by only 55% in the presence of the EDTA chelating agent
(Walsh et a/., 1997). More recent data, however, suggest that A. hydrophila
T429125 produces a metallo-P-lactamase that requires a greater concentration of
EDTA (55mM) to achieve complete inhibition of the carbapenemase activity (T.
Walsh - personal communication). Therefore, the carbapenemase produced by A.
veronii bv. sobria strain 13 and 99 may also be less sensitive to EDTA compared
with the metallo-p-lactamases produced by other Aeromonas isolates.
IEF has shown that both strains 13 and 99 produce two p-lactamases with pi values
of 5.84 and 8.3 (Figure 5.1). The application of an imipenem overlay modification to
IEF demonstrated the presence of a single imipenem-hydrolysing enzyme of pi 5.84
in both strains 13 and 99 (Figure 5.2). These results suggest, therefore, that either the
carbapenemase in these two strains is unlike all other previously described
Aeromonas carbapenemases and can be identified with nitrocephin, or alternatively,
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the carbapenemase is co-focusing with a separate nitrocephin hydrolysing enzyme
(see below). Nevertheless, the pi value (5.84) is considerably different from the
Aeromonas carbapenemases that have been reported previously, which are typically
pi 8.0 or greater (Rossolini et a/., 1996).
IEF/inhibitor overlays facilitated further characterisation of the pi 5.84 and 8.3 P-
lactamases of strains 13 and 99 (Figure 5.3). The pi 8.3 P-lactamase of both strains
13 and 99 were found to be serine-based because they were inhibited by BRL42715,
but not EDTA. The pi 8.3 P-lactamase band was also sensitive to ImM clavulanic
acid and this suggests that it is either a molecular class A or D P-lactamase (Figure
5.5). Insensitivity of the pi 8.3 P-lactamase band to cloxacillin (Figure 5.4) would
imply that, in addition to being not of class C origin, this P-lactamase is also not a
class D enzyme; however, the cloned class D AmpS penicillinase of A. veronii bv.
sobria 163a also does not hydrolyse cloxacillin, although it can readily hydrolyse
oxacillin (Walsh et al., 1995b).
IEF followed by inhibitor overlays further highlighted the unusual nature of the pi
5.84 carbapenem-hydrolysing P-lactamase from strains 13 and 99 (Figure 5.3). The
pi 5.84 p-lactamase band could not be inhibited by either EDTA (lOOmM) or
BRL42715 (lOOpM) and therefore cannot be classified as either a metallo- or serine
p-lactamase. Aeromonas strains are known to produce a penicillinase and
cephalosporinase readily identifiable by nitrocephin staining after IEF, in addition to
a carbapenemase that is not detectable with nitrocephin. Both the penicillinase and
cephalosporinase P-lactamase bands have previously been shown to be inhibited by
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lOOpM BRL42715 (Walsh et a/., 1995a). It was suggested above that strains 13 and
99 could produce two P-lactamases that co-focus at pi 5.84 - one P-lactamase a
carbapenemase, not detectable with nitrocephin and the other a P-lactamase
detectable with nitrocephin. In the knowledge that the pi 8.3 P-lactamase from these
two strains is most likely the clavulanic acid sensitive penicillinase it could be
speculated that the nitrocephin detectable enzyme of pi 5.84 is a cephalosporinase.
However, if this were true BRL42715 would be expected to inhibit the
cephalosporinase. Furthermore, the class C inhibitors aztreonam and cloxacillin also
failed to inhibit the pi 5.84 P-lactamase band, providing further evidence that
cephalosporinase is not co-focusing at pi 5.84.
The observation of inhibition with BRL42715 of the 'satellite bands' above and
below the pi 5.84 P-lactamase band (Figure 5.3c) could imply that either these are
additional P-lactamases or that they are different forms of the pi 5.84 enzyme display
variation in their inhibitor binding affinities. Cloxacillin and aztreonam have no
affect on these 'satellite bands', although there is some partial inhibition with
clavulanic acid (Figures 5.4, 5.5).
Zinc has been shown to serve as a metallo-P-lactamase activator (Sabath and
Abraham, 1966; Bicknell et a/., 1985; Payne et a/., 1994a) and metallo-P-lactamase
inhibitor in the case of the AsbMl carbapenemase from A. veronii bv. sobria
AER14M (Yang and Bush, 1996). In this study, zinc sulphate overlays prior to
nitrocephin staining of an IEF gel failed to have any effect on the pi 5.84
carbapenem-hydrolysing P-lactamase band (Figure 5.6) from strains 13 and 99 and,
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therefore, this enzyme appears to be insensitive to zinc, in addition to a lack of
sensitivity to EDTA.
The above results all indicate the presence of a completely novel carbapenemase in
A. veronii bv. sobria strains 13 and 99. The hyper-production of this carbapenemase
can also be clearly correlated with an increase in carbapenem resistance. The pi 5.84
P-lactamase is designated AVS-1 and the pi 8.3 P-lactamase AVS-2.
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6: RESULTS
Purification of a novel carbapenemase (AVS-1)
from A. veronii bv. sobria strain 13
6.1 Introduction
Section 5 has described the identification of two A. veronii bv. sobria strains 13 and
99 that possess both a novel carbapenemase named AVS-1 with a pi value of 5.84
and a [3-lactamase with a pi of 8.3. This section describes the partial purification of
AVS-1 from strain 13, followed by kinetic analysis of this enzyme.
6.2 Separation of AVS-1 by DE52 anion exchange chromatography
Periplasmic proteins were extracted from A. veronii bv. sobria strain 13 (Section
2.10.1), dialysed against 20mM sodium phosphate buffer, pH 7.0 and loaded onto a
DE52 anion exchange column also equilibrated with 20mM sodium phosphate
buffer, pH 7.0. At pH 7.0 the AVS-1 (3-lactamase should be negatively charged and,
therefore, have affinity for the DE52 anion exchanger; however, under the conditions
described above the enzyme failed to bind to the column.
It has been recommended that the pH of the anion exchange column should be at
least one pH unit above the pi of the protein of interest to allow it to reversibly bind
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to the anion exchange column. Therefore, the DE52 column was re-equilibrated with
20mM sodium phosphate buffer at pH 7.5. This pH was chosen to ensure that it was
far enough away from the AVS-1 pi to achieve binding. Sample dialysed in 20mM
sodium phosphate buffer pH 7.5 was applied to the column, but again the pi 5.84 (3-
lactamase failed to bind.
Another reason as to why the protein elutes in the wash step, before the application
of a salt gradient, can be that the ionic strength of the buffer is too high. The sample
application step was thus repeated with 10mM sodium phosphate buffer, pH 7.0
instead of 20mM; however, once again the pi 5.84 protein failed to bind.
Finally, the sample was applied to a column equilibrated with lOmM Tris-Cl buffer
pH 8.5 and under these conditions the pi 5.84 P-lactamase did bind to the column
and could be subsequently eluted with 30mM NaCl. Despite this, the DE52 may not
be the most suitable anion exchange matrix for purifying this protein, because it
shows weak affinity for the column under conditions that should be extremely
favourable for its binding, that is very low ionic strength and a pH >2.5 units away
from its pi.
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6.3 Separation of AVS-1 by a QA52 anion exchange matrix
An experiment was carried out to determine whether AVS-1 demonstrated greater
binding affinity for QA52 anion exchange matrix compared with DE52. A series of
five test tubes each containing 1,5ml ofQA52 matrix were set up, and each tube was
then equilibrated to a different pH (pH 6.5, 7.0, 7.5, 8.0, 8.5) with either 20mM
sodium phosphate or 20mM Tris-Cl buffer. A known, constant amount of sample
was added to each tube and mixed with the gel matrix. After the matrix had settled,
the supernatant was assayed for carbapenemase activity; if no activity was found in
the supernatant this indicated binding of the AVS-1 P-lactamase to the matrix. No
carbapenemase activity was detected in the supernatant from the tube equilibrated
with Tris-Cl buffer, pH 7.5 and, therefore, AVS-1 appears to show greater affinity
for the QA52 matrix compared with DE52.
A QA52 chromatography column was then prepared and equilibrated with 20mM
Tris-Cl, pH 8 .0, to ensure adequate binding of the AVS-1 enzyme to the column. The
AVS-1 P-lactamase (pi 5.84) was subsequently eluted with 90mM NaCl. Figure 6.1
shows the P-lactamase activity of fractions eluted after the application of the salt
gradient. Figure 6.2 shows that a single P-lactamase band (pi 5.84) was present in the
fractions that demonstrated carbapenemase activity. The pi 8.3 P-lactamase from
strain 13 could bind to the column under the conditions employed; therefore, this
step separated these two P-lactamases from each another.
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Figure 6.2 IEF gel of fractions eluted from the QA52 anion exchange
column
6.4 SDS-PAGE analysis of fractions eluted from the QA52 column
The purity of the pi 5.84 AVS-1 P-lactamase after the anion exchange step was
assessed by SDS-PAGE analysis. Figure 6.3 shows that fractions 55-60 which
demonstrate good P-lactamase activity contain several proteins other than just P-
lactamase. Peak P-lactamase activity was recorded with fractions 56-58, although it
was not possible to determine the molecular weight of the P-lactamase from the
SDS-PAGE gel because no one protein band was significantly prominent in these
fractions.
Pi
54 55 56 57 58 59 60 61 62 63 64
Fraction number
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Lanes: M, molecular weight markers; S, crude sample applied to the QA52 column;
55-56, column fractions.
MS 55 56 57 58 59 60
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6.5 Gel filtration chromatography
Gel filtration chromatography was employed as a further purification step after ion
exchange chromatography, this time separating proteins by size exclusion rather than
charge. Carbapenemase active QA52 fractions were pooled, concentrated by 80%
ammonium sulphate precipitation and dialysed in sodium phosphate buffer before
loading on to a Superose 12 HR 10/30 column. The proteins emerging from the
column were collected in fractions and tested for P-lactamase activity as before. The
P-lactamase active fractions were analysed by SDS-PAGE; however 5 or 6 other
proteins of similar size and charge were always found in those fractions that
displayed carbapenemase activity. Therefore, purification of the AVS-1 protein to
homogeneity was a difficult process and furthermore, it was still not possible to
determine the size of the P-lactamase by SDS-PAGE with coomassie blue staining.
6.6 Determining the size of AVS-1 P-lactamase by gel filtration
Although the molecular mass of the AVS-1 could not be established by SDS-PAGE,
the molecular mass could be estimated from a standard graph obtained after
calibration of the gel filtration column with standard proteins of known size. The
size ofAVS-1 was estimated to be 26kDa.
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6.7 Enzyme kinetics ofAVS-1 P-lactamase
Fractions demonstrating carbapenemase activity and a single (3-lactamase band (pi
5.84) were pooled after QA52 anion exchange chromatography for further
biochemical examination. The Michaelis constant (Km) and the maximum rate of
hydrolysis (Vmax) of AVS-1 are shown in Table 6.1. Partially purified AVS-1
demonstrated hydrolysis of imipenem, nitrocephin, cephaloridine and ampicillin,
although nitrocephin and imipenem were hydrolysed with the greatest efficiency.
Table 6.1 Hydrolysis of (3-lactam antibiotics by AVS-1
Substrate Cmax (pM/min/ml) Km (pM) V IKr max'nm
Imipenem 0.869 172 0.005
Nitrocephin 0.625 69 0.009
Cephaloridine 1.0 800 0.00125
Ampicillin 1.1 1100 0.001
6.8 Inhibitor studies
Purified AVS-1 was pre-incubated for 10 minutes at 37°C with the (3-lactamase
inhibitors listed in Table 6.2. Enzyme inhibition (ID50) was recorded with both
imipenem and nitrocephin as the reporter substrates. EDTA (lOOmM) had no effect
on AVS-1 activity against imipenem or nitrocephin; instead, the hydrolytic activity
of AVS-1 was sensitive to the presence of the serine (3-lactamase inhibitors
clavulanic acid, tazobactam, sulbactam and BRL42715. These results are in marked
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contrast to those obtained by Yang and Bush (1996) for the A. jandaei AER 14M
(formerly/!, sobria) metallo-carbapenemase AsbMl (Figure 6.2).
Table 6.2 A comparison of the inhibitor profile of AVS-1 with that of
another Aeromonas carbapenemase AsbMlb









nitrocephin and imipenem were both used as the reporter substrate and the ID50
values listed here were the same for both of these substrates.
b AsbMl metallo-(3-lactamase purified from an A. jandaei isolate, with imipenem as
the reporter substrate only - data taken from Yang and Bush, 1996.
6.9 Discussion
Ion exchange chromatography has been applied to purify the unusual A. veronii bv.
sobria carbapenemase (AVS-1) that has been identified in two strains, 13 and 99.
The carbapenemase was partially purified from strain 13 on a QA52 cellulose matrix.
Attempts were made to purify AVS-1 to homogeneity by employing gel filtration
chromotography; however, this proved to be difficult because the periplasmic protein
solution extracted from strain 13 appears to contain several proteins of similar pi and
size.
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Enzyme kinetics were determined with partially purified AVS-1 P-lactamase. AVS-
1 was found to efficiently hydrolyse nitrocephin in addition to imipenem, a property
not normally associated with the Aeromonas carbapenemases. Ampicillin and
cephaloridine hydrolysis was also detected, although the Kms for these substrates are
much higher compared with imipenem and nitrocephin and, therefore, AVS-1 has a
lower affinity for these P-lactams. The Km of AVS-1 for imipenem is similar to that
of the metallo-P-lactamase ImiS from A. veronii bv. sobria (formerly A. sobria) 163a
(Walsh et a/., 1996).
Inhibition assays were determined with both imipenem and nitrocephin as the
reporter substrates and ID50 values were found to be the same, regardless of the
reporter substrate used, these results are consistent with the pooled fractions
containing a single P-lactamase. The AVS-1 inhibitor profile was found to differ
radically from previously purified Aeromonas metallo-carbapenemases. The AVS-1
EDTA IDso value measured >100mM, whereas other Aeromonas carbapenemases are
generally highly sensitive to EDTA. One exception to this statement is an EDTA-
resistant strain ofA. hydrophila, alluded to in section 5.11.
In addition to EDTA resistance, AVS-1 was found to be sensitive to the serine P-
lactamase inhibitors clavulanic acid, tazobactam, sulbactam and BRL42715, with
tazobactam showing the greatest inhibitory effect. These results suggest that either
AVS-1 is a serine-based carbapenemase or alternatively these serine P-lactamase
inhibitors are actually behaving as competitive substrates; that is they are competing
with either imipenem or nitrocephin for the AVS-1 active site and this manifests
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itself as inhibition spectrophotometrically. It is already known that molecular class B
metallo-P-lactamases (including Aeromonas metallocarbapenemases) can hydrolyse
BRL42715 (Matagne et al., 1995) and tazobactam is a substrate for the
Stenotrophomonas maltophilia and B. cereus metallo-P-lactamases (Felici and
Amicosante, 1995). It is however puzzling as to why these inhibitors should appear
so effective when assayed spectrophotometrically, yet when BRL42715 and
clavulanic acid are used as IEF inhibitor overlays they have little effect on the AVS-
1 P-lactamase band (Section 5.8 and 5.9). Again, the explanation for these
inconsistencies may arise from the fact that these inhibitors could be substrates for
this enzyme. Once the AVS-1 P-lactamase has hydrolysed the serine P-lactamase
inhibitor in the IEF overlay, it is then able to hydrolyse nitrocephin, as normal and
therefore, the inhibitors show no effect on an IEF gel.
Finally, the size of AVS-1 could only be determined by gel fdtration chromatography
and was found to be 26kDa, however, it should be noted that gel filtration can
underestimate the molecular weights of P-lactamases (Bush, 1989). The cloned and
sequenced Aeromonas metallo-carbapenemases genes encoding CphA and ImiS have




PCR amplification of a metallo-P-lactamase gene from A. veronii bv.
sobria strains 13 and 99
7.1 Introduction
The sequences of three Aeromonas metallo-carbapenemases (cphA, cphA2 and imiS)
have been previously determined and share greater than 95% sequence identity to
one another (Section 1.11.2.1). The following section describes the identification of
a metallo-P-lactamase gene sequence highly homologous to cphA, cphA2 and imiS in
A. veronii bv. sobria strains 13 and 99.
7.2 Initial primer design
An experiment was devised to determine whether A. veronii bv. sobria 13 and 99
harboured an imiS-hke metallo-P-lactamase gene, previously identified in A. veronii
bv. sobria 163a (Walsh el a/., 1998). The strategy was to generate an intragenic imiS
gene probe by PCR, using a recombinant plasmid that carries imiS, as the template
DNA. Intragenic primers (1 and 2) were designed from the nucleotide sequence of
imiS (Walsh el al., 1998). with the aid of Primer 3 software (Section 2.17.1). The
imiS primers shown in Figure 7.1 are also completely conserved within the cphA
metallo-P-lactamase sequence from A. hydrophila AE036 (Massidda et al., 1991).
A single nucleotide in each primer (highlighted in red in Figure 7.1) was not
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conserved in the metallo-(]-lactamase gene cphA2 from A. hydrophila AER19
(Genbank, accession number U60294). The PCR reaction was performed as
described in Section 2.17.2, with 3mM MgCl?, using the amplification parameters
listed in Table 7.1. Under these conditions a 516bp DNA fragment was amplified
from the recombinant plasmid harbouring imiS. The identity of this fragment DNA
fragment could be confirmed by digesting the 516bp PCR product with the
restriction enzyme Sail, which cuts once within the PCR product to yield two
fragments that are 384 and 132bp in length.
Before labelling the intragenic imiS PCR product ready for DNA hybridisation, the
PCR reaction was repeated but this time with the extracted DNA from A. veronii bv.
sobria strains 13 and 99. A PCR product of the correct size (516bp) was also
amplified from strains 13 and 99 and this PCR product could also be cut with Sail
These results strongly suggested that A. veronii bv. sobria 13 and 99 possess an imiS-
like metallo-P-lactamase. Therefore, rather than performing DNA hybridisation it
was decided that the PCR reaction should be repeated with new primers that would
amplify up the entire metallo-p-lactamase gene from strains 13 and 99. which could
then be sequenced.
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Figure 7.1 Intragenic PCR primers homologous to the imiS metallo-
(3-Iactamase gene that yield a 516bp product
Sequence Position"
(1) 5' ACA AGC TGA TCA AAC GGG TC 3' 358
(2) 5' TGA TCA GCG CTT CGT AGT GA 3' 873
"
Numbering is according to Walsh et al., 1998. Guanine (G) is replaced by adenine
(A) and thymine (T) is replaced by cytosine (C) in the cphA2 metallo-p-lactamase
gene (Genbank, accession number U60294).
Table 7.1 PCR cycling parameters for the amplification of imiS
Segment Temperature (°C) Time (minutes) Function No. of cycles
1 94 5 Denaturation 1






J) 72 10 Final extension 1
7.3 The selection of new primers
A second set of primers was designed by looking for regions of homology that exist
between the DNA that is upstream and downstream of the start and stop codons of
imiS and cphA. Only nucleotide sequence data on the open reading frame (ORF) of
cphA2 were available (Genbank, accession number U60294), therefore, nucleotides
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upstream and downstream of cphA2 could not be compared with those from imiS and
cphA. The nucleotides upstream of the imiS ORF show a high sequence identity with
the nucleotides that precede the start codon of cphA. Unfortunately the same cannot
be said of the sequences immediately downstream of imiS and cphA where there is
no sequence homology (Massidda et a/., 1991; Walsh et ai, 1998). Figure 7.2 shows
the primers (3 and 4) chosen to amplify the entire imiS open reading frame as
featured in the imiS sequence (Walsh et a/., 1998). A single nucleotide in the left
hand primer (3) is not conserved in the sequence of cphA. In the sequence of the
right hand primer (4), there are several mismatches between the sequence of imiS and
cphA, which are unavoidable because of the lack of homology that occurs between
these genes downstream. A section of the right hand primer sequence also falls
within the imiS ORF (highlighted in bold type). The primers illustrated in Figure 7.2
produced a DNA fragment, that was 870bp in length, with the positive control
recombinant plasmid encoding imiS, using 1.5mM MgC12 and the cycling
parameters in Table 7.1. No PGR product was obtained with DNA from A. veronii
bv. sohria strains 13 and 99, even when the cycling conditions were varied.
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Figure 7.2 PCR primers that yield an 870bp DNA fragment
Sequence Position
(3) 5' TTC CCC TCA CAA ATC CC ATT 3' 28
(4) 5' CGG CAG CTT ATG ATT GTG AA 3' 900
a
a
Numbering is according to Walsh et al., 1998. In the left hand primer (3) cytosine
(C) is replaced by thymine (T) in the cphA metallo-P-lactamase gene (Massidda et
al., 1991). In the right hand primer (4) cytosine (C) is replaced by guanine (G),
guanine (G) is replaced by adenine (A), adenine (A) is replaced by guanine (G),
thymine (T) is replaced by cytosine (C), thymine (T) replaced by guanine (G),
adenine (A) is replaced by guanine (G) and adenine (A) is replaced by thymine (T) in
the cphA metallo-P-lactamase gene sequence (Massidda et al., 1991).
Bold type in right hand primer (4) indicates sequence that falls within the imiS ORF.
7.4 PCR reaction with primers 2 and 3
It was decided that the PCR reaction should be repeated this time employing primers
2 and 3, which have a similar melting temperature and therefore, form a suitable
primer pair. A combination of primers 2 and 3 amplifies an 843bp DNA fragment
from the positive control recombinant plasmid DNA harbouring imiS. This 843bp
fragment includes 745 nucleotides of the imiS ORF, which is only 20 bases short of
the entire imiS gene (from start to stop codon). The PCR protocol was followed
according to Section 2.17.2 using 3mM MgCh. The PCR cycles described in Table
7.1 were employed except that an annealing temperature of 52°C was required to
prevent amplification of non-specific DNA fragments. A positive PCR reaction was
then achieved with extracted DNA from strains 13 and 99.
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7.5 Sequence analysis of the 843bp PCR products amplified from
strains 13 and 99
The nucleotide sequences of the PCR products amplified from A. veronii bv. sobria
strains 13 and 99 were sequenced automatically on an ABI PRISM™ 377 DNA
Sequencer (SmithKline Beecham Pharmaceuticals). The 786bp determined from the
PCR products were identical for both strains 13 and 99 and are shown in Figure 7.3
along with the deduced amino acid sequences of the truncated metalio-P-lactamase
gene.
The metallo-|3-lactamase amino acid sequence encoded by this 843bp PCR product
from strain 13 and 99 was compared with the amino acid sequences of CphA, CphA2
and ImiS. The differences in the amino acid sequences of these enzymes are shown
in Figure 7.4 Figure 7.4 and Table 7.2 show that the amino acid sequence encoded
by metallo-p-lactamase gene detected by PCR in strains 13 and 99 is very closely
related to the protein sequences of the metallo-P-lactamases CphA, CphA2 and ImiS
(>95% homology).
Five residues were identified that were conserved in the amino acid sequences of
CphA, CphA2 and ImiS, but not in the amino acid sequence deduced from the PCR
products of strains 13 and 99 (highlighted in bold green type in Figure 7.3). The
significance of these five amino acid changes were assessed by aligning the metallo-
P-lactamase amino acid sequence from strains 13 and 99 with the sequences of the
metallo-P-lactamases CcrA3 (from Bacteroides fragilis) and P-lactamase II (from
171
Bacillus cereus). The position of the five amino acids that are different with respect
to the other three Aeromonas metallo-P-lactamases were then identified on the
crystal structures of CcrA3 and P-lactamase II. The position of these five amino
acids could not be identified on a crystal structure of an Aeromonas metallo-P-
lactamase because there are no resolved structures available at present. Only two
residues were found anywhere near the substrate binding site, these were lysine (K)
at position 49 and asparagine (N) at 206. Lysine 49 is in the CcrA3/p-lactamase II
flexible loop region and was identified as possibly an important residue, asparagine
206 on the other hand does not appear to affect anything in the CcrA3/p-lactamase II
model (Brian Clarke, SmithKline Beecham Pharmaceuticals - personal
communication) There are also no significant differences in the locations of lysine
49 and asparagine 206 in the CcrA3 and P-lactamase II crystal structures. Figure 7.5
shows a three dimensional side by side stereo image of the CcrA3 metallo-P-
lactamase with the locations of lysine 49 and asparagine 206 highlighted. The
location of threonine 175 is also indicated in Figure 7.5, however, this should be
ignored as this is not a residue conserved throughout the sequences from CphA,
CphA2 and ImiS - Figure 7.4.
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Figure 7.3 DNA and deduced amino acid sequence of the PCR
products from A.veroniibv. sobria strains 13 and 99
CCGGCTTGCCACAGGGGTGGCGAGGGGGTGGTTGGTTCGAGGGAGCAAG ATG ATG AAA 58
M M K
GGT TGG ATG AAG TGC GGG TTG GCC GGA GCC GTG GTG CTG ATG GCG AGT 106
GWMKCGLAGAVVLMAS
TTC TGG GGG GGC AGC GTG CGG GCG GCG GGG ATC TCC CTT AAG CAG GTG 154
FWGGSVRAAGI SLKQV
AGC GGC CCT GTC TAT GTG GTA GAG GAC AAC TAC TAC GTC AAA GAG AAC 202
SGPVYVVEDNYYVKEN
TCC ATG GTC TAT TTC GGG GCC AAG GGG GTG ACG GTG GTG GGG GCG ACC 250
SMVYFGAKGVTVVGAT
TGG ACG CCG GAT ACC GCC CGC GAG CTG CAC AAG CTC ATT AAA CGG GTC 298
WTPDTARELHKLIKRV
AGC AGC AAG CCG GTG CTG GAG GTG ATC AAC ACC AAC TAC CAC ACC GAT 346
SSKPVLEVINTNYHTD
CGG GCG GGC GGT AAC GCC TAC TGG AAG TCC ATC GGG GCC AAG GTG GTC 394
RAGGNAYWKS I GAKVV
TCG ACC CGC CAG ACC CGG GAT CTG ATG AAG AGC GAC TGG GCC GAG ATT 442
STRQTRDLMKSDWAEI
GTC GCC TTT ACC CGC AAG GGG CTG CCA GAG TAT CCG GAT CTG CCG CTG 490
VAFTRKGLPEYPDLPL
GTG CTG CCC AAC GTG GTG CAC GAT GGC GAC TTC ACC CTG CAA GAG GGC 538
VLPNVVHDGDFTLQEG
AAG GTG CGT GCC TTC TAT GCG GGC CCG GCC CAC ACG CCG GAC GGC ATC 586
KVRAFYAGPAHTPDGI
TTT GTC TAC TTC CCC GAT GAG CAG GTG CTC TAT GGC AAC TGC ATC CTC 634
FVYFPDEQVL YGNCIL
AAG GAG AAG CTG GGC AAC CTG AGC TTT GCC AAT GTG AAG GCC TAT CCG 682
KEKLGNLS FANVKAYP
CAG ACC ATC GAG CGG CTG AAA GCG ATG AAG CTG CCG ATC AAG ACG GGT 730
QT I ERLKAMKLP I KTV
ATT GGC GGT CAC GAC TCG CCG CTG CAC GGC CCC GAG CTG ATT GAT CAC 778
IGGHDSPLHGPELIDH
TAC GAA GC * 786
Y E
* 28 nucleotides short of entire gene.
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Figure 7.4 A comparison between the amino acid sequence encoded
by the metallo-P-Iactamase gene amplified by PCR from A. veronii
bv. sobria strains 13 and 99 with the amino acid sequences of three























* The sequence is nine amino acids short of the entire unmodified protein.
Shaded amino acids indicate ligands involved in zinc binding in the B. and B.
cereus metallo-P-lactamase crystal structures (Concha 1997; Carfi
\99U).
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Table 7.2 Amino acid identity between the 246 amino acid residues
of a metallo-P-lactamase from A. veronii bv. sobria strains 13 and 99
and the Aeromonas metallo-P-lactamases CphA, CphA2 and ImiS
Identity values are expressed as a percentage calculated from an amino acid sequence
that is 246 residues in length.
















Ribbond splayofCcrA3colourc dedinedtindicateesi uediffere c sbetweenthmet llo- P-lactamaseaminocidsequencefroA.veroniibv.sobriast ains13d99aCphA/CphA2 andImiS(sourcefFigur7.5-BrianCla kSmithKlineBeecham).
7.6 Discussion
PCR with /m/A-specific primers has identified a metallo-|3-lactamase gene in A.
veronii bv. sobria strains 13 and 99. Although a metallo-P-lactamase gene has been
detected in strains 13 and 99, it cannot be conclusively stated that this sequence
encodes the pi 5.84 AVS-1 carbapenemase, only cloning or N-terminal sequencing
can provide this answer. However, if the metallo-P-lactamase gene possessed by
strains 13 and 99 does not code for the AVS-1 carbapenemase, this implies that not
only must there be another carbapenemase gene encoded by these two strains but
also the metallo-P-lactamase or other genes involved in its regulation must have
undergone silencing mutational events.
The amino acid sequence encoded by the metallo-P-lactamase gene in strains 13 and
99 was found to be very similar to ImiS, CphA and CphA2 and possess the putative
active site sequence, asparagine-Xi-histidine-X2-aspartate (residues 95-99 of Figure
7.4), that is unique to the Aeromonas metallo-P-lactamases (Rasmussen and Bush,
1997). Additional zinc binding ligands (histidine -position 174, cysteine -position
193 and histidine -position 243) identified from the crystal structures of the B.
fragilis and B. cereus enzymes were found to be conserved in the metallo-P-
lactamase sequence from strains 13 and 99, as they are in the other sequenced
Aeromonas metallo-P-lactamases.
Only five amino acid residues were found to be among the amino acids conserved in
the sequences of CphA, CphA2 and ImiS but not in the 246 amino acids deduced
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from the metallo-(3-lactamase from strains 13 and 99. There may, however, be
further amino acid substitutions amongst the nine amino acid residues at the C-
terminus of the metallo-(3-lactamase from 13 and 99 not determined in this study. If
however, AVS-1 is a metallo-(3-lactamase then one or more of these five amino acid
differences (or any further substitutions at the metallo-3-lactamase C-terminus) must
be responsible for the differences in AVS-1 substrate and inhibitor profiles compared
with other Aeromonas metallo-|3-lactamases. Two possible candidates for the
differences in hydrolytic activity are lysine at position 49 and asparagine at 206
because they are located near the P-lactam binding site. The importance of these




The cloning of two (3-Iactamase genes blaA\s-2 and blaA\s-3 from
A. veronii bv. sobria 13
8.1 Introduction
Chapter 6 has described the purification the AVS-1 carbapenemase, which exhibits
an extended substrate profile, including the hydrolysis of ampicillin and
cephaloridine. Additionally, a metallocarbapenemase sequence has been identified in
both A. veronii bv. sobria 13 and 99 that is closely related in sequence to previously
identified Aeromonas carbapenemases, although it could not be concluded whether
the metallocarbapenemase sequence encodes the AVS-1 carbapenemase. The
following chapter describes the application of different cloning strategies aimed at
cloning b/aAyS-i, to determine its sequence. However, the protocols employed result
in the isolation of two chromosomal genes encoding the pi 8.3 P-lactamase -AVS-2
and an additional P-lactamase designated AVS-3.
8.2 Determining the genetic location of AVS-1
Ethidium bromide has been shown to be efficient in eliminating plasmids that carry
drug resistance determinants (Bouanchaud el a/., 1969). Ethidium bromide curing
was employed to determine whether the AVS-1 carbapenemase was encoded on a
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plasmid (Section 2.19). The curing experiment, however, could not demonstrate loss
of resistance to imipenem. Furthermore, no plasmid could be isolated from strain 13.
Therefore, these results suggest that blaAvs-i is located on the bacterial chromosome.
8.3 Creation of a gene bank from A. veronii bv. sobria 13
A. veronii bv. sobria 13 chromosomal DNA was isolated (Section 2.13.2) and
digested to completion with BamHl. Size fractionated DNA fragments of between 3
and 8kb, obtained following separation in a 0.7% agarose gel and extraction from the
agarose with Geneclean II, were ligated into a cloning vector (Section 2.15.3). The
chosen cloning vector was pK18 which is a 2.7kb pUC-derived plasmid that has a
high copy number, a versatile multiple cloning site and carries a kanamycin
resistance marker. The pK18 cloning vector was also digested with BamYll and
treated with calf intestine alkaline phosphatase to prevent re-annealing (Section
2.15.2). Recombinant DNA was introduced into competent E. coli DH5a cells by
electrotransformation (Section 2.16.1 -2.16.2).
Transformants resistant to (3-lactams were selected on two types of media, the first
containing kanamycin (30mg/l) and ampicillin (20mg/l) and the other containing
kanamycin (30mg/l) and cephaloridine (20mg/l). Ampicillin and cephaloridine were
chosen for the selection of the carbapenemase because purified AVS-1 had
demonstrated hydrolysis of these substrates. Imipenem was not employed for the
selection of the AVS-1 carbapenemase because it is probable that the enzyme will
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not confer imipenem resistance in the E. coli cloning vector host, as this organism is
likely to be more permeable to imipenem than A. veronii bv. sobria.
Four resistant transformants, numbered clones 1-4, were recovered on agar
containing kanamycin and ampicillin but not kanamycin and cephaloridine.
Recombinant plasmids were extracted with the Hybaid Recovery™ plasmid miniprep
kit, three of the ampicillin resistant transformants possessed a recombinant plasmid
with an insert of 5.3kb (clones 2-4) and one recombinant plasmid (clone 1) had an
insert of 3.8kb (Figure 8.1).
(3-Lactamase extracts were prepared from clones 1-4 by inoculating single colonies
into 10ml nutrient broths containing kanamycin (30mg/l) and ampicillin (20mg/l).
after six hours of growth at 37°C the cultures were centrifuged, washed in 50mM
sodium phosphate buffer and subjected to ultra-sonication. The crude cell extracts
were assayed against imipenem; however, no imipenem hydrolysis was detected.
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Figure 8.1 Extracted recombinant plasmids from clones 1-4,
digested with BamHl
1 2 3 4 5
Lanes: 1, Xcut with Clal;2, clone 1 (insert - 3.8kb); 3, clone 2 (insert 5.3kb); 4,
clone 3 (insert 5.3kb); 5, clone 4 (insert 5.3kb).
8.4 Directional cloning in pK18
Cloning of blaAws-i was attempted again, this time digesting the A. veronii bv. sobria
13 chromosomal DNA with two restriction enzymes. This process is known as
directional cloning because foreign DNA is inserted in only one orientation within
the recombinant plasmid. Three different combinations of restriction enzymes were
used to cut the pK18 vector and the chromosomal DNA of strain 13. These
combinations were EcoRl and Sail, £coRl and BamHl and BamHl plus Sail.
Transformants resistant to P-lactams were again selected for on media containing
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kanamycin (30mg/l) plus ampicillin (20mg/l) and kanamycin (30mg/l) plus
cephaloridine (20mg/l).
One ampicillin resistant clone (clone 5) was recovered from the gene bank created by
digesting the chromosomal and vector DNA with ZfcoRI and SalI. Two cephaloridine
resistant clones (clones 6 and7) and five ampicillin resistant clones (clones 8-12)
were recovered from the gene bank created by digesting chromosomal and vector
DNA with AcoRI and BamYH. No (3-lactam resistant clones were obtained from the
gene bank that involved the BamYQJSah digest. The insert of the recombinant
plasmid extracted from clone 5 measured 1.2kb in length (Figure 8.2). The
recombinant plasmids extracted from clones 8-12 had an insert of 4.3kb (Figure 8.3).
An additional DNA fragment was also observed next to the pK18 vector of clones 9-
12. This might, however, be a DNA artefact (Figure 8.3). The plasmids extracted
from the cephaloridine resistant clones 6 and 7 were found to contain no insert
(Figure 8.3).
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Lanes: 1, X cut with Hindll!; 2, clone 5 (insert 1.2kb).
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Lanes: 1, Xcut with Clal,2 clone 6 (no insert); 3, clone 7 (no insert); 4, clone 8
(4.3kb); 5, clone 9 (insert 4.3kb); 6, clone 10 (insert 4.3kb); 7, clone 11 (insert
4.3kb); 8, clone 12 (insert 4.3kb).
8.5 IEF of p-lactamase active clones
Crude cell extracts prepared from E. coli clones 1-12 were tested by nitrocephin spot
testing for P-lactamase activity. p-Lactamase activity was detected in clones 1, 2, 3,
4, 5, 8, 9, 10, 11 and 12; however, the cephaloridine-resistant clones 6 and 7 that did
not contain a DNA insert failed to produce a colour change with the spot testing
reaction. P-Lactamase preparations from clones 1, 2, 3, 4, 5, 8, 9, 10, 11 and 12 were
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focused on an IEF gel. IEF assays showed that clones 2, 3, 4, 8, 9, 10, 11 and 12
encoded the AVS-2 enzyme that focused at pi 8.3 (Figure 8.4). Clones 1 and 5 were
found to encode a different P-lactamase, named AVS-3, that had a pi value of 4.75
(Figure 8.4), this P-lactamase band was previously thought to be a satellite band of
the pi 5.84 AVS-1 P-lactamase.
Figure 8.4 IEF of P-lactamase extracts from clones 1, 2, 3, 4, 5, 8, 9,
10, II and 12
Lanes: I, A. veronii bv. sobria 13; 2, clone 1 (pi 4.75); 3, clone 2 (pi 8.3); 4, clone 3
(pi 8.3); 5, clone 4 (pi 8.3); 6, clone 5 (pi 4.75); 7, clone 8 (pi 8.3); 8, clone 9 (pi
8.3); 9, clone 10 (pi 8.3); 10, clone 11 (pi 8.3); 11, clone 12 (pi 8.3).
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8.6 p-Lactam MICs and P-lactam hydrolysis by E. coli DH5a clones
P-Lactam susceptibility testing was performed on clones numbered 1-5 and 8-12.
All ten clones were found to be resistant to ampicillin, clones 1 and 5 additionally
demonstrated a reduced susceptibility to cephaloridine, none of the clones however,
showed resistance to imipenem (Table 8.1).
Cell extracts prepared from six representative E.coli DH5a clones (1, 2, 5, 8, 9 and
11) were assayed against ampicillin, cephaloridine and imipenem. Extracts from
clones 1 and 5 that carry a recombinant plasmid encoding a pi 4.75 P-lactamase from
A. veronii bv. sobria 13 showed strong hydrolytic activity against ampicillin, but
much weaker cephaloridine hydrolysis. P-Lactamase preparations from clones 2 ,8, 9
and 11 showed good hydrolytic activity against ampicillin, but only poor
cephaloridine activity. None of these clones demonstrated any hydrolysis of
imipenem.
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Table 8.1 (3-Lactam susceptibility of ten E. coli DH5a clones
Clone AMP CEPH IMP
E.coli DH5a* 4 <8 0.25
1 >256 64 0.25
2 >256 <8 0.25
3 >256 <8 0.25
4 >256 <8 0.25
5 >256 32 0.25
8 >256 <8 0.25
9 >256 <8 0.25
10 >256 <8 0.25
11 >256 <8 0.25
12 >256 <8 0.25
AMP, ampicillin; CEPH, cephaloridine; IMP, imipenem.
* E. coli DH5a host containing no recombinant vector.
Table 8.2 P-Lactam hydrolysis of cell extracts of E. coli DH5a





1 149 7 ND
2 19.6 0.08 ND
5 49.64 2.6 ND
8 6.1 0.035 ND
9 12.74 0.023 ND
11 22.83 0.046 ND
* pinoles of substrate hydrolysed per minute per ml of enzyme preparation.
AMP, ampicillin; CEPH, cephaloridine, IMP, imipenem.
ND - not detected.
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8.7 Back probing recombinant plasmid inserts to the chromosomal
DNA from A. veronii bv. sobria strain 13
It was decided that the recombinant plasmids from clones 5, and 8 should be
extracted and the DNA of the inserts, encoding the AVS-3 and AVS-2 P-lactamase
genes, should be automatically sequenced. Before sending the plasmids away for
automatic DNA sequencing (SmithKline Beecham Pharmaceuticals, Collegeville,
P.A.), back probing of these plasmid inserts to the chromosomal DNA from A.
veronii bv. sobria 13 was performed to confirm their origin.
The purified recombinant plasmids from clones 5, and 8 were digested with the
appropriate restriction enzymes (EcoRHSaE and EcoRA/BamHl, respectively) to
release the inserts. The two different inserts could then be purified from the vector
DNA by running the digested plasmids on an agarose gel, slicing the insert from the
gel and extracting the DNA fragment from the agarose. The inserts were then
labelled with Fl-dUTP (Section 2.18.1), ready for hybridisation. Chromosomal
DNA from A. veronii bv. sobria 13 was cut with Bam\A\ and blotted onto a nylon
membrane along with the digested recombinant plasmids from clones 1, 5 and 8,
after agarose gel electrophoresis (Section 2.18.3).
Figure 8.5 shows the labelled 4.3kb insert of clone 8 back probing to the
chromosomal DNA from A. veronii bv. sobria 13, confirming its origin. The 4.3kb
insert from clone 8 does not hybridise with the insert from either clone 1 or clone 5.
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Figure 8.6 shows the hybridisation of the labelled 1 2kb insert from clone 5 to the A.
veronii bv. sobrla 13 chromosomal DNA and to the insert from clone 1 (3.8kb).
Unfortunately the labelled insert from clone 5 was contaminated with vector DNA,
even though repeated attempts were made to completely purify the insert away from
the pK18 vector DNA. Vector DNA in clones 1, 5 and 8 was also detected. Figure
8.6 does, however, show that the labelled insert from clone 5 does not hybridise to
the insert from clone 8.
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Figure 8.5 Hybridisation of the insert from clone 8 to A. veronii bv.
sobria 13 chromosomal DNA
12345 12345
(A) Separated fragments in a 0.7% agarose gel.
(B) Hybridisation of the 4.3kb insert of clone 8 to the DNA fragments on the blotted
gel.
Lanes: 1, X cut with Hindlll, 2, A. veronii bv. sobria 13 chromosomal DNA cut with
ftawHI; 3, recombinant plasmid from clone 1 cut with BamHl, 4, recombinant
plasmid from clone 5 cut with EcoRHSall; 5, recombinant plasmid from clone 8 cut
with EcoBUBamHl
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Figure 8.6 Hybridisation of the insert from clone 5 to A. veronii bv.
sobria 13 chromosomal DNA
(A) (B)
12345 12345
(A) Separated fragments in a 0.7% agarose gel.
(B) Hybridisation of the 1.2kb insert of clone 5 to the DNA fragments on the blotted
gel.
Lanes: 1, X cut with Hindlll; 2, A. veronii bv. sobria 13 chromosomal DNA cut with
BamWL, 3, recombinant plasmid from clone 1 cut with Bam\A\\ 4, recombinant
plasmid from clone 5 cut with EcoRI/Sall; 5, recombinant plasmid from clone 8 cut
with EcoRl/BamHl.
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8.8 Sequence analysis of clones 1, 5 and 8
DNA sequencing of the inserts from clones 5 and 8 was performed on an ABI
PRISM™ 377 DNA Sequencer with the universal primers M13F (forward) and
M13R (reverse), using a primer walking strategy. Unfortunately, it was only
possible to sequence the pi 8.3 P-lactamase gene blaA\s-2 harboured on the clone 8
recombinant plasmid. The pi 4.75 P-lactamase gene blaA\s-3, encoded on the
recombinant plasmid of clone 5 and clone 1, could not be sequenced. Clone 5 was
sequenced using M13F and M13R, however, the sequencing reaction was only
successful in one direction (L. Katz, SmithKline Beecham - personal
communication). When the sequencing information from clone 5 was entered into
NCBI BLAST the sequence was found to be part of the pK18 vector. The primers
were checked for correct labelling, however, it appears that clone 5 had lost its insert
and this explains why only one of the universal primers was successful data (L. Katz
- SmithKline Beecham, personal communication). Clone 1 was reported to give high
background peaks, which is indicative of two clones being present and therefore, also
could not be sequenced (L. Katz - personal communication).
Sequencing the insert of clone 8 was carried out until an open reading frame of
potential interest was located. Figure 8.7 shows the DNA sequence and deduced
amino acid sequence of the blaA\s-2 gene. The AVS-2 p-lactamase was found to be
closely related to the molecular class D penicillinases AsbBl from A. jandaei AER
14M (formerly A. sobria) and AmpS from A. veronii bv. sobria 163a (formerly A.
sobria) (Rasmussen, et a/., 1994a; Walsh et a/., 1995b). The blaAws-2 gene has an
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open reading frame of 795 nucleotides which encodes a protein of 264 amino acids.
A comparison between the amino acid sequences of AVS-2, AsbBl and AmpS is
shown in Figure 8.8. The amino acid identity between these three enzymes was
found to be >95.5% (Table 8.3).
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Figure 8.7 DNA and deduced amino acid sequence of the A. veronii
bv. sobria 13 bla^s-iP-Iactamase gene
ATG TCC CGC CTG CTT CTC TCC AGC CTG CTG GCT GCC GGT CTG CTC GCA 48
MSRLLLSSLLAAGLLA
GCC CTG CCT GCC TCC GCC GCC AGC GGC TGC TTT CTC TAT GCT GAC GGC 96
ALPASAASGCFLYADG
AAC GGC CAG ACC CTC TCC AGC GAA GGG GAC TGC TCC AGC CAG CTG CCA 144
NGQTLSSEGDCSSQLP
CCC GCG TCC ACC TTC AAG ATC CCG CTC GCG CTG ATG GGT TAC GAC AGC 192
PASTFKI PLALMGYDS
GGC TAT CTG GTG GAT GAA GAG CAT CCG GCA CTG CCT TAC AAA CCG AGC 240
GYLVDEEHPALPYKPS
TAT GAC GGC TGG CTG CCC GCC TGG CGT GAA ACC ACC ACC CCG CGC CGC 288
YDGWLPAWRETTTPRR
TGG GAA ACC TAC TCG GTG GTC TGG TTC TCC CAG CAG ATC ACC GAA TGG 336
WETYSVVWFSQQITEW
CTG GGG ATG GAG CGC TTC CAG CAA TAC GTC GAC CGC TTC GAC TAC GGC 384
LGMERFQQYVDRFDYG
AAC CGG GAT CTC TCC GGC AAT CCG GGC AAA CAT GAC GGC CTG ACC CAG 432
NRDLSGNPGKHDGLTQ
GCC TGG CTC AGC TCC AGC CTC GCC ATC AGT CCG GAG GAG CAG GCT CGC 480
AWLSSSLAISPEEQAR
TTC CTC GGC AAG ATG CTG AGC GGC AAG CTG CCG GTC TCG GCG CAG ACC 528
FLGKMLSGKLPVSAQT
CTG CAG TAC ACC GCC AAT ATC CTC AAG GTG AGC GAG ATC GAC GGC TGG 576
LQYTANILKVSEIDGW
CAG ATC CAC GGC AAA ACC GGC ATG GGC TAC CCG AAG AAG CTG GAT GGC 624
QIHGKTGMGYPKKLDG
AGC CTC AAC CGC GCT CAG CAG ATT GGC TGG TTC GTC GGC TGG GCC AGC 672
SLNRAQQI GWFVGWAS
AAA CCG GGC AAA CAG CTG ATC TTC GTC CAT ACC GTG GTG CAA AAG CCC 720
KPGKQLI FVHTVVQKP
GGC AAG CAG TTC GCC TCC CTC AAG GCG AAA GAA GAG GTG CTG GCT GCC 768
GKQFASLKAKEEVLAA
CTG CCT GCA CAA CTT AAA AAG CAG TGA 795
LPAQLKKQ*
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Figure 8.8 Comparison of the amino acid sequences of AVS-2 with
the molecular class D enzymes AsbBl and AmpS from A. jandaei



















a Amino acid residues conserved in all three proteins are represented in black,
whereas, red lettering indicates residues which differ amongst the three proteins
Table 8.3 Amino acid identity between AVS-2, AsbBl and AmpS
Identity values are expressed as a percentage of the 264 amino acid sequence
Enzyme AVS-2 AsbBl AmpS
AVS-2 - - -
AsbBl 95.8 - -
AmpS 97.3 95.5 -
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8.9 Discussion
This chapter has described the protocols employed in an attempt to clone the
carbapenemase AVS-1. The cloning of Aeromonas carbapenemases is known to be
problematic and stems from the fact that these enzymes normally display a very
narrow substrate profile which limits the choice of (3-lactams that can used in the
cloning selection procedure. Furthermore, the Aeromonas carbapenemases do not
confer carbapenem resistance in an E. coli background (Hayes, 1995, Rossolini et a/.,
1995; Walsh - personal communication). Purification of the AVS-1 carbapenemase
from A. veronii bv. sobria revealed that this enzyme hydrolysed not only imipenem
but also nitrocephin, ampicillin and cephaloridine, thus, cloning strategies were
employed that involved the selection of clones with ampicillin and cephaloridine
containing media.
Although several clones were selected on media containing ampicillin, none of these
clones could hydrolyse imipenem. Further analysis of these ampicillin resistant
clones did, however, reveal important information concerning the P-lactamase
complement ofA. veronii bv. sobria strain 13. It was initially thought that this strain
(along with strain 99) possessed two (3-lactamases, an unusual Aeromonas
carbapenemase designated AVS-1 with a pi of 5.84 and a second clavulanic acid
sensitive high pi (8.3) P-lactamase, however, this was found not to be the case.
Isoelectric focusing of ten ampicillin resistant clones identified two different P-
lactamases, neither of them AVS-1. Eight of these clones (2, 3, 4, 8, 9, 10, 11, 12)
harboured the pi 8.3 P-lactamase which could efficiently hydrolyse ampicillin. The
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other two clones (1 and 5) produced a p-lactamase with a pi of 4.75, previously
thought to be a satellite band of the AVS-1 carbapenemase. This enzyme was named
AVS-3 and could hydrolyse both ampicillin and cephaloridine.
Clones containing both AVS-2 and AVS-3 were sent away for DNA sequencing,
although only the sequence of AVS-2 could be determined. Sequence analysis of the
AVS-2 P-lactamase revealed that this enzyme was closely related to the molecular
class D penicillinases AsbBl and AmpS, identified previously in a strain of A.
jandaei and A. veronii bv. sobria, respectively (Rasmussen et al., 1994a; Walsh et
al., 1995b).
Previously, up to three different inducible P-lactamases have been described in
individual Aeromonas isolates including a metallocarbapenemase, a class D
penicillinase and a class C cephalosporinase (Walsh et al., 1995a; Rasmussen et al.,
1994a; Yang and Bush 1996). Three different P-lactamases have now been identified
in A. veronii bv. sobria 13 that include a pi 5.84 carbapenemase (AVS-1), a pi 8.3
class D penicillinase (AVS-2) and a third unidentified P-lactamase AVS-3. It is
possible that this AVS-3 is related to the cephalosporinases such as AsbAl and CepS
previously identified in other Aeromonas isolates (Rasmussen et al., 1994a; Walsh et
al., 1995b). However, the ability of AVS-3 to hydrolyse ampicillin with greater
effiiency than cephaloridine is not a property normally associated with Aeromonas
cephalosporinases (Rasmussen et al., 1994a; Walsh et al., 1995b). Only future
sequencing data on AVS-2 can resolve the classification of this enzyme. Although
the cloning strategies described in this chapter have been successful in recovering
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two P-lactamases from strain 13 the gene encoding the AVS-1 carbapenemase has




An assessment of the heterogeneity of the metallo-P-Iactamases from
clinical Stenotrophomonas maltophilia isolates
9.1 Introduction
The following section describes the application of PCR in the detection of S.
maltophilia metallo-j3-lactamases, followed by DNA sequencing of the PCR
products to ascertain the relationship between S. maltophilia m-(3-l types 1-7
described by Payne et al., (1994a; 1994b). This study also includes the metallo-|3-
lactamase of S. maltophilia 511 characterised biochemically by Felici el a/., (1993)
that has the same pi (6.8) as the m-(3-l type 5 (Payne et al., 1994a). An additional
comparison is also made between the m-(3-l types 1-7 and the amino acid sequences
of the metallo-j3~lactamases from strains GN12873 and IID1275 to determine their
relatedness.
9.2 Bacterial strains
The initial aim was to analyse the m-|3-l types 1-7 from seven S. maltophilia strains
originally isolated from hospitalised patients in the United Kingdom (Payne et al.,
1994a). Unfortunately, strain 136 that harbours m-|3-l type 6 could not be recovered
200
and therefore this study concentrates on m-(3-l types 1-5 and 7 (Table 9.1).
Table 9.1 S. maltopliilia strains that produce
m-(3-l types 1, 2, 3, 4, 5 and 7






A3 7454 7 6.8
9.3 Intragenic PCR primer design and cycling parameters
The nucleotide sequences of the metallo-P-lactamase genes blaL] and blaS from S.
maltophilia IID1275 (Walsh et al., 1994) and S. maltophilia GN12873 (Sanschagrin
et al., 1998) respectively, were aligned using the Genbank Basic Local Alignment
Search Tool (BLAST) program (http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST/nph-
newblast). Intragenic stretches of homology between these sequences were
identified and primers were designed within these regions of homology with the aid
of Primer 3 software (Section 2.17.1). The chosen primer sequences as featured in
blciu from strain 1ID1275 (Walsh et al., 1994) are shown in Figure 9.1. A single
nucleotide in each primer (highlighted in red) was not conserved in the sequence of
blaS from strain GN12873 (Sanschagrin et al., 1998). These primers yield a 671 bp
PCR product.
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The PCR procedure was performed as described in Section 2.17.2, with ImM MgC^.
A recombinant plasmid (pUB8902), encoding the the metallo-(3-lactamase b/au from
S. maltophilia IID1275 (Walsh et al., 1994), was extracted and employed as a
positive PCR control. Template DNA from test S. maltophilia strains was prepared
using the Genie genomic DNA extraction. Standard laboratory strains E. coli NCTC
10418 and P. aeruginosa NCTC 10662 were used as negative PCR controls. PCR
amplification conditions are shown in Table 9.2.
Figure 9.1 Intragenic PCR primers homologous to the known blau
sequence of S. maltophilia IID1275
Sequence Position"'
5' GTT CTA CCC TGC TCG CCT TC 3' 5
5' CTC GAT CAG CTG CGG ATA AC 3' 687
a
Numbering is according to Walsh et al., (1994).
Cytosine (C) is replaced by thymine, and thymine (T) is replaced by adenine
in the sequence ofGN12873 (Sanschagrin et al., 1998).
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Table 9.2 PCR cycling parameters for the amplification of
S. maltophilia metallo-(3-lactamases
Segment Temperature (°C) Time (minutes) Function No. of cycles
1 94 5 Denaturation 1




3 72 10 Final extension 1
9.4 Detection of S. maltophilia metallo-fClactamases by PCR
A single PCR product of 671 bp in size was amplified from the seven S. maltophilia
test strains and from the positive control pUB8902 plasmid DNA. No PCR product
was obtained from the negative control strains.
9.5 Restriction of the PCR products
The 671 bp nucleotide sequence of hla\\ (Walsh et a/., 1994), that could be amplified
by PCR, was entered into the WebCutter 2.0 restriction site analysis program
(http:www.firstmarket.com/cutter/cut2.html) to identify a suitable restriction enzyme
that would cleave once within this fragment of DNA. The restriction endonuclease
Hit7fl cuts once within this sequence to give two fragments that were 381 and 290 bp
in size. Restriction digests with Hinfl were set up with the PCR products amplified
from the seven S. maltophilia strains. The results of the restriction enzyme analysis
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are shown in Figure 9.2. The restriction site is conserved in five of the seven strains,
PCR products from strains 511 and 37 were not digested by Hinfl.
Figure 9.2 S. maltophilia PCR products restricted with Hinfl
600bp——_
M 1A iB 2A 2B 3A 3B 4A 4B 5A 5B 6A 6B 7A 7B 8A 8B
A- uncut PCR product, B- restricted PCR product, M-lOObp ladder, 1- GEL
type 1), 2- 0062 (m-(3-l type 2), 3- U152 (m-p-1 type 3), 4-511, 5- 37 (m-P-1 type5),
6- J2323 (m-p-1 type 4), 7- A37454 (m-P-1 type 7), 8- pUB8902 (LI clone).
9.6 Intergenic PCR primers
PCR primers were designed from upstream and downstream of the blaL\ gene open
reading frame of S. maltophilia IID1275 (Walsh et al1994) in an attempt to extend
the PCR product size to produce a DNA fragment that would contain the entire blau
gene (Figure 9.3). Amplification conditions were applied as in Section 9.3, but with
varying annealing temperatures and MgCb concentrations. A single fragment of
DNA of the appropriate size (944 bp) could be amplified from the positive control
plasmid DNA (pUB8902) employing an annealing temperature of 58°C and ImM
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MgCh. However, when the reaction was repeated with DNA from the seven test S.
maltophilia strains (GEL, 0062, U152, J2323, 37, 511 and A37454), no product was
obtained. Therefore, under these optimised conditions, this primer set appears to
specific for only the metallo-(3-lactamase from S. maltophilia strain II1275D and the
PGR product lengths from the seven test strains could not be extended.
Figure 9.3 Intragenic PCR primers homologous to the known bla^i
sequence of S. maltophilia IID1275
Sequence Position"
5' AAG GAG GCC CAT GCT AGT TT 3' 464
5' CTG CTC TGC TGG ACT CAA CA 3' 1407
a
Numbering is according EMBL Data Bank, accession number X7504.
Guanine (G) is replaced by cytosine, thymine (T) by guanine and adenine (A)
by thymine in the sequence ofGN12873 (Sanschagrin etal., 1998).
9.7 Sequence analysis of intragenic PCR products
DNA sequencing of the 671 bp intragenic PCR products from the seven S.
maltophilia strains (GEL, 0062, U152, J2323, 511,37 and AK37454) was performed
on an Applied Biosystems automated sequencer (Haematology Dept., Edinburgh
University). Sequences were determined on both DNA strands, to check sequence
accuracy. A sequence of 561 bp in length could be determined from each of the PCR
products. The resulting DNA sequences were entered into the BLAST database and
205
aligned against the blctli and blaS nucleotide sequences from S. maltophiUa strain
1ID1275 and strain GN12873, respectively.
The nucleotide and deduced amino acid sequences of the PGR products from the
seven S. mciltophilia strains are shown in Figures 9.4 - 9.9. The Hinfl target site
(GxlANTC) is highlighted by a grey box in the sequences from strains GEL, 0062,
U152, J2323 and AK37454 (Figures 9.4, 9.5, 9.6, 9.7, 9.9). In the sequences from
strains 37 and 511 (Figure 9.7), thymine at position 391 (numbering according to
Walsh et a/., 1994) was replaced by adenine, Hinfl does not recognise this sequence
(GANAC) and therefore, the DNA was not cleaved at this point (Figure 9.2). The
DNA fragments from strains 37 and 513 differ by only four nucleotide substitutions
(Figure 9.8). These nucleotide differences all occured in the third position of a codon
and represent the same amino acid in each sequence. Thus the deduced amino acid
sequences from 511 and 37 are identical.
A comparison between the amino acid sequences derived from the 561 bp DNA
fragment sequenced from the seven S. maltophilia strains and the known amino acid
sequences of the metallo-p-lactamases from 11D1275 and GN12873 (Walsh et a/.,
1994; Sanschagrin et a/., 1998) are shown in Figure 9.10. Amino acid residues
identified from the crystal structure of the metallo-P-lactamase from S. maltophila
IID1275 (Ullah et a!., 1998) as being involved in zinc ion ligation or P-lactam
substrate binding are also highlighted in Figure 9.10. Table 9.3 lists the percentage
amino acid identity between the 187 amino acid section of the LI-type metallo-P-
lactamases sequenced from nine S. maltophilia strains.
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Figure 9.4 Nucleotide and deduced amino acid sequence of a 561 bp
intragenic DNA fragment amplified by PCR from S. maltophilia
GEL (m-|3-l type 1) with bla^i specific primers
68*
GAA GTA CCA CTG CCG CAG CTG CGG GCC TAC ACC GTG GAC GCC TCG TGG CTG
EVPLPQLRAYTVDASWL
120
CAG CCG ATG GCA CCG GTG CAG ATC GCC GAC CAC ACC TGG CAG ATC GGC ACC
QPMAPLQIADHTWQI GT
171
GAG GAC CTG ACC GCG CTG CTT GTG CAG ACC CCC GAC GGC GCG GTG CTG CTC
EDLTALLVQT PDGAVLL
222
GAC GGC GGC ATG CCG CAG ATG GCC AGC CAC CTG CTG GAC AAC ATG AAG GCG
DGGMPQMASHLLDNMKL
273
CGT GGC GTG ACA CCT CGG GAT CTG CGG CTG ATC CTG CTC AGC CAC GCA CAC
RGVT PRDLRLI LLSHAH
324
GCC GAC CAT GCC GGA CCG GTG GCG GAG CTG AAG CGC CGT ACG GGC GCC AAA
ADHAGPVAELKRRTGAK
375
GTG GCG GCC AAC GCC GAA TCG GCG GTG CTG CTG GCG CGT GGC GGC AGC GAT
V A A N A 'E"'^S AVLLARGGSD
426
GAC CTG CAC TTT GGC GAT GGC ATC ACC TAC CCG CCT CCG AAT GCA GAC CGC
DLHFGDGITYPPPNADR
477
ATC ATC ATG GAT GGT GAA GTG ATC ACG GTG GGC GGC ATC GTG TTC ACC GCG
I IMDGEVITVGGIVFTA
528
CAC TTC ATG GCG GGG CAC ACA CAG GGC AGC ACC GCG TGG ACC TGG ACC GAT
HFMAGHTQGSTAWTWTD
579
ACC CGC ATT GGC AAG CCG GTG CGC ATC GCC TAC GCC GGC AGC CTG AGT GCA
TRI GKPVRIAYAGSLSA
* Numbering of nucleotides is in accordance with Walsh et aL, (1994).
Grey boxed nucleotides indicate Hinfl restriction site.
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Figure 9.5 Nucleotide and deduced amino acid sequence of a 561 bp
intragenic DNA fragment amplified by PCR from S. maltophilia
0062 (m-J3-l type 2) with bla\A specific primers
68*
GAA GTA CCA CTG CCG CAG CTG CGG GCC TAC ACC GTG GAC GCC TCG TGG CTG
EVPLPQLRAYTVDASWW
120
CAG CCG ATG GCA CCG CTG CAG ATC GCC GAC CAC ACC TGG CAG ATC GGC ACC
QPMAPLQIADHTWQIGT
171
GAG GAC CTG ACC GCG CTG CTT GTG CAG ACC CCC GAC GGC GCG GTG CTG CTC
EDLTALLVQT PDGAVLL
222
GAC GGC GGC ATG CCG CAG ATG GCC AGC CAC CTG CTG GAC AAC ATG AAG GCG
D G G M P QMASHLLDNMKA
273
CGT GGC GTG ACG CCT CGG GAT CTG CGG CTG ATC CTG CTC AGC CAC GCA CAC
RGVTPRDLRLI LLSHAH
324
GCC GAC CAT GCC GGA CCG GTG GCG GAG CTG AAG CGC CGT ACG GGC GCC AAA
ADHAGPVAELKRRTGAK
375
GTG GCG GCC AAC GCC GAA TCG GCG GTG CTG CTG GCG CGT GGC GGC AGC GAT
V A A N A ~E SAVLLARGGS D
426
GAC CTG CAC TTC GGC GAT GGC ATC ACC TAC CCG CCT GCC AAT GCA GAC CGC
DLHFGDGITFPPANADR
477
ATC GTC ATG GAT GGT GAA GTG ATC ACG GTG GGC GGT ATC GTG TTC ACC GTG
IVMDGEVI TVGGIVFTV
528
CAC TTC ATG GCG GGG CAC ACC CCG GGC AGC ACC GTC TGG ACC TGG ACC GAT
HFMAGHT PGSTVWTWTD
579
ACC CGC AAT GGC AAG CCC GTT CGC ATC GCC TAC GCC GAC AGC CTG AGT GCA
TRNGKPVRIAYADSLSA
* Numbering of nucleotides is in accordance with Walsh et al.7 (1994).
Grey boxed nucleotides indicate HinSL restriction site.
208
Figure 9.6 Nucleotide and deduced amino acid sequence of a 561 bp
intragenic DNA fragment amplified by PCR from S. maltophilia
U152 (m-J3-l type 3) with bla^i specific primers
68*
GAA GTA CCA CTG CCG CAG CTG CGG GCC TAC ACC GTG GAC GCC TCG TGG CTG
EVPLPQLRAYTVDASWL
120
CAG CCG ATG GCA CCG CTG CAG ATC GCC GAC CAC ACC TGG CAG ATC GGC ACC
QPMAPLQIADHTWQIGT
171
GAG GAC CTG ACC GCG CTG CTT GTG CAG ACC CCC GAC GGC GCG GTG CTG CTC
EDLTALLVQT PDGAVLL
222
GAC GGC GGC ATG CCG CAG ATG GCC AGC CAC CTG CTG GAC AAC ATG AAG GCG
DGGMPQMASHLLDNMKA
273
CGT GGC GTG ACG CCT CGG GAT CTG CGG CTG ATC CTG CTC AGC CAC GCA CAC
RGVTPRDLRLI LLSHAH
324
GCC GAC CAT GCC GGA CCG GTG GCG GAG CTG AAG CGC CGT ACG GGC GCC AAA
ADHAGPVAELKRRTGAK
375
GTG GCG GCC AAC GCC GAA TCG GCG GTG CTG CTG GCG CGT GGC GGC AGC GAT
V A A N A EI S AVVLARGGS D
426
GAC CTG CAC TTC GGC GAT GGC ATC ACC TAC CCG CCT GCC AAT GCA GAC CGC
DLHFGDGITYPPANADR
477
ATC GTC ATG GAT GGT GAA GTG ATC ACG GTG GGC GGC ATC GTG TTC ACC GTT
IVMDGEVITVGGIVFTV
528
CAC TTC ATG GCG GGG CAC ACC CCG GGC AGC ACC GCG TGG ACC TGG ACC GAT
HFMAGHTPGST IWTWTD
579
ACC CGC AAT GGC AAG CCG GTG CGC ATC GCC TAC GCC GAC AGC CTG AGT GCA
TRNGKPVRIAYADSLSA
* Numbering of nucleotides is in accordance with Walsh et al., (1994).
Grey boxed nucleotides indicate HinR restriction site.
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Figure 9.7 Nucleotide and deduced amino acid sequence of a 561 bp
intragenic DNA fragment amplified by PCR from S. maltophilia
J2323 (m-J3-l type 4) with bla^i specific primers
68*
GAA GTA CCA CTG CCG CAG CTG CGG GCC TAC ACC GTG GAC GCC TCG TGG CTG
EVPLPQLRAYTVDASWL
120
CAG CCG ATG GCA CCG CTG CAG ATC GCC GAC CAC ACC TGG CAG ATC GGC ACC
QPMAPLQIADHTWQIGT
171
GAG GAC CTG ACC GCG CTG CTT GTG CAG ACC CCC GAC GGC GCG GTG CTG CTC
EDLTALLVQT PDGAVLL
222
GAC GGC GGC ATG CCG CAG ATG GCC AGC CAC CTG CTG GAC AAC ATG AAG GCG
DGGMPQMASHLLDNMKA
273
CGT GGC GTG ACG CCT CGG GAT CTG CGG CTG ATC CTG CTC AGC CAC GCA CAC
RGVTPRDLRLI LLSHAH
324
GCC GAC CAT GCC GGA CCG GTG GCG GAG CTG AAG CGC CGT ACG GGC GCC AAA
ADHAGPVAELKRRTGAK
375
GTG GCG GCC AAC GCC GAA TCG GCG GTG CTG CTG GCG CGT GGC GGC AGC GAT
V A A N A E AVLLARGGSD
426
GAC CTG CAC TTC GGC GAT GGC ATC ACC TAC CCG CCT GCC AAT GCA GAC CGC
DLHFGDGITYPPANADR
477
ATC GTC ATG GAT GGT GAA GTG ATC ACG GTG GGC GGC ATC TTG TTC ACC GTG
IVMDGEVITVGGILFTV
528
CAC TTC ATG GCG GGG CAC ACC CCG GGC AGC AAC GCA TGG ACC TGG ACC GAT
HFMAGHTPGSTAWTWTD
579
ACC CGC AAT GGC AAG CCG GTG CGC ATC GCC TAC GCC GGC AGC CTG AGT GCA
TRNGKPVRIAYADSLSA
* Numbering of nucleotides is in accordance with Walsh et al(1994).
Grey boxed nucleotides indicate HirAI restriction site.
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Figure 9.8 Nucleotide and deduced amino acid sequence of a 561 bp
intragenic DNA fragment amplified by PCR from S. maltophilia
strains 37 (m-P-1 type 5) and 511 with bla^i specific primers
68*
GAG GCA CCG CTG CCA CAA CTG CGG GCC
EAPLPQLRA
120
CAG CCG ATG GCG CCG CTG CAG GTT GCC
QPMAPLQVA
171
GAG GAC CTG ACC GCG CTG CTG GTG CAG
EDLTALLVQ
222
GAT GGC GCA ATG CCA CAG ATG GCC GGT
DGAMPQMAG
273
CGC GGC GTG GCC CCG CAG GAC CTG CGA
RGVAPQDLR
324
GCC GAC CAC GCC GGC CCG GTC GCC GAG
ADHAG PVAE
375
GTG GCG GCC AAT GCA GAA ACG GCG GTG
VAANAETAV
426
GAC CTG CAC TTT GGC GAC GGC ATC ACC
DLHFGDGIT
477 C
ATC ATC ATG GAT GGT GAA GTG GTC ACG
I IMDGEVVT
528
CAC TTC ATG CCG GGG CAC ACC CCG GGC
HFMPGHTPG
579
ACC CGC GAT GGG AAG CCG GTG CGC ATC
TRDGKPVRI
TAT ACC GTG GAT GCG TCC TGG CTG
YTVDASWL
GAC CAC ACC TGG CAG ATC GGC ACC
DHTWQIGT
ACC GCC GAG GGC GCA GTA CTG CTG
TAEGAVLL
G
CAC CTG CTG GAC AAC ATG AAA CTG
HLLDNMKL
C
TTG ATC CTG CTT AGC CAT GCG CAT
LILLSHAH
CTC AAG CGT CGC ACC GGC GCG CAT
LKRRTGAH
CTG CTG GCG CGC GGC GGC AGC AAC
LLARGGSN
T
TAT CCG CCG GCC AGC GCC GAC CGC
YPPASADR
GTG GGC GGC ATC GCA TTC ACC GCG
VGGIAFTA
AGC ACC GCC TGG ACC TGG ACC GAC
STAWTWTD
GCC TAC GCC GAC AGC CTG AGT GCA
AYADSLSA
* Numbering of nucleotides is in accordance with Walsh et al.7 (1994).
A - Thymine (T) at position 391 is replaced by adenine (A), therefore, HinfI cannot
cleave the DNA at this site.
-Nucleotides in black type represent the sequence from 37, whereas green letters
indicate the nucleotide differences that occur in the sequence from strain 511
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Figure 9.9 Nucleotide and deduced amino acid sequence of a 561 bp
intragenic DNA fragment amplified by PCR from S. maltophilia
AK37454 (m-(3-l type 7) with bla^\ specific primers
68*
GAG GCA CCG CTG CCA CAG CTG CGG GCC TAC ACC GTG GAT GCC TCC TGG CTG
EAPLPQLRAYTVDASWL
120
CAG CCG ATG GCG CCG CTG CAG ATT GCC GAC CAC ACC TGG CAG ATC GGC ACC
QPMAPLQIADHTWQI GT
171
GAG GAC CTG ACT GCG CTG CTG GTG CAG ACC GCC GAG GGC GCA GTA CTG CTG
EDLTALLVQTAEGAVLL
222
GAT GGC GGC ATG CCG CAG ATG GCC AGC CAC CTC ATC AGC AAC ATG AAG GTG
DGGMPQMAGHLI SNMKV
273
CGC GGC GTG GCC CCG CAG GAC CTG CGA TTG ATC CTG CTC AGC CAT GCG CAT
RGVAPQDLRLI LLSHAH
324
GCC GAC CAC GCC GGC CCG GTC GCC GAG CTC AAG CGT CGA ACC GGC GCG CAT
ADHAGPVAELKRRTGAH
375
GTG GCG GCC AAT GCC GAA TCG GCG GTG CTG CTG GCG CGC GGC GGT AGC AAC
V A A N A E S AVLLARGGSN
426
GAC CTG CAC TTT GCC GAC GGC ATA ACG TAT CCG CCG GCC AGC GCC GAC CGG
DLHFADGITYPPASADR
477
ATC ATC ATG GAT GGT GAA GCG GTC ACG GTG GGC GGC ATC ACA TTC ACC GCG
I IMDGEAVTGGGITFTA
528
CAC TTC ATG CCA GGG CAT ACC CCG GGC AGC ACC GCC TGA ACC TGG ACC GAC
HFMPGHTPGSTAWTWTD
579
ACC CGC GAT GGC AAG CCG GTG CGC ATC GCC TAC GCC GAC AGC CTG AGC GCA
TRDGKPVRIAYADS LSA
* Numbering of nucleotides is in accordance with Walsh et al., (1994).
Grey boxed nucleotides indicate Hinfl restriction site.
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Figure 9.10 A comparison between the amino acid sequences
deduced from a 561 bp DNA fragment sequenced from seven
different S.maltophilia strains and the known amino acid sequences
from S.maltophilia strains 11D1275 and GN128733



























8 Amino acid residues conserved in all of the nine sequences are represented in black,
whereas red lettering indicates residues which differ from sequence to sequence.
* Indicates residues identified as being involved in the coordination of zinc ions or
substrate binding from the crystal structure of the metallo-(3-lactamase from S.
maltophilia IID1275 (Ullah et a/., 1998).
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9.8 Discussion
PCR with the intragenic primer set described (Section 9.3) has proved to be an
excellent technique for rapidly identifying the presence of metallo-P-lactamase genes
in S. maltophilia isolates, and for investigating the variation within the LI family of
enzymes at the molecular level.
It has been shown that the deduced 187 amino acid residues from m-P-types 1-5 and
7 share > 88.2% homology with one another and > 88.3% homology with the
metallo-P-lactamases sequenced from strains IID1275 and GN12873 (Table 9.3).
Therefore, the S. maltophilia metallo-P-lactamases are a family of related enzymes
differing by a few amino acids and these differences account for their diversity in pi
and subtle variations in substrate profiles. Figure 9.9 shows that the residues
proposed to be involved in the co-ordination of the two zinc ions bound at the active
site or substrate binding (Ullah ei at., 1998) are conserved within the amino acid
sequences of the different m-P-1 types, m-P-1 type 1 is the only exception to this. In
the sequence from S. maltophilia GEL (m-P-1 type 1) the aspartate (D) 184 residue
(numbering according to Ullah et a!1998) identified as a zinc ligand orientating
group (Ullah et a!, 1998) is replaced by glycine (G). The importance of this amino
acid substitution in terms of structure and function could only be determined in the
future by constructing a mutant m-P-1 type 1 with a single aspartate substitution in
place of glycine and then evaluating the kinetics of the mutant enzyme
It is interesting that the m-P-1 type 5 from strain 37 shares 100% identity with the
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187 amino acids deduced from metallo-(3-lactamase produced by strain 511 (Table
9.3). The metallo-(3-lactamases from these two strains have previously been shown
to have a similar substrate profile and pi value (6.8) and it has been speculated that
these could indeed be the same enzyme. Discrepancies have, however, been found
between the inhibitor profiles of these enzymes, for example 2mM nitroacetic acid
inhibits the metallo-|3-lactamase of strain 511, but does not inhibit m-(3-l type 5
(Payne et a/., 1994b). It is therefore, still possible that there are amino acid
differences between these two metallo-p-lactamases within the remaining residues
which make up the complete protein and have not been determined here, and these
differences may only be reflected in inhibitor profiles. Only further sequence
analysis would determine whether this is, in fact, the case. If, however, m-[3-l type 5
from strain 37, (originally identified in the UK (Payne et a/., 1994a)) and strain 511
(an Italian isolate (Felici el a/., 1993)) do encode metallo-P-lactamases identical in
amino acid sequence this leads on to the question - are some S. maltophilia metallo-
(3-lactamase types more prevalent than others9 A future study determining the
relative abundance of m-[3-i types amongst clinically isolated S. maltophilia from
different geographical areas would offer the answer to this question.
The genes blau and h/aS from S. maltophilia 1ID1275 and GN12873, respectively,
are known to translate to an unmodified protein that is 290 amino acids in length
(Walsh et a/., 1994; Sanschargrin et al., 1998). In this study, an intragenic stretch of
187 amino acids has been deduced by sequencing the PGR products from seven S.
maltophilia strains, however, for completeness it would be interesting to determine
the level of relatedness that exists between the remaining 103 residues. Section 9.6
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describes the design of primers outside the metallo-P-lactamase open reading frame,
but unfortunately, a PCR product could only be amplified from the positive control
(pUB8902). PCR with these intergenic primers appears to be more sensitive to the
amplification conditions. Three nucleotide differences also occur between the b/ciu
and blaS right hand intergenic primer sequences (Figure 9.3, start position 1407) and
therefore, to achieve success different PCR primers may be required. Nevertheless,
in the knowledge that the metallo-P-lactamases encoded by b/aL\ and b/aS share
91.4% homology over this 187 amino acid section of the protein and 88. 6%
homology over the entire protein (Sanschargrin et a/., 1998), it is highly probable
that the m-P-1 types 1-5 and 7 exhibit a similar degree of heterogeneity throughout
the complete protein as they do in the deduced 187 amino acid sequence.
From Table 9.3, the metallo-P-lactamases from nine S. maltophilia strains can be
divided into two groups The first group comprises the m-P-1 types from strains
GN12873, 37, 511 and A37454 which all share >95.2% homology with one another
but <91.4% homology with the second group made up of the enzymes from strains
IID1275, GEL, 0062, U152 and J2323. The 187 amino acid sequence determined
from the m-P-1 types from 11D1275, GEL, 0062, U152 and J2323 also share >95.2%
homology with one another (Table 9.3). Once again, only further sequence analysis
would establish if these two groupings were true. It would be interesting to study the
relatedness of these nine strains over the rest of the genome and determine whether
strains that have more closely related metallo-P-lactamases are also more closely
associated throughout the entire genome. S. maltophilia is at present the sole
member of the genus Sienoirophomotias and as molecular-based typing techniques
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become more routinely employed it is possible that speciation within the genus
Stenotrophomonas will undergo changes.
The heterogeneity exhibited by the S. maltophilia metallo-P-lactamases is by no
means a unique phenomenon. Considerable sequence variation is also known to
exist within other P-lactamase types such as at the ampC locus within the species C.
diversus and also C. jreundii (Jones et a/., 1994). Additionally, the chromosomal
molecular class A cephalosporinases (L2) that are coordinately expressed with the S.
maltophilia metallo-P-lactamases also appear to be a heterogeneous group of
enzymes (Payne et ah, 1994a; Pradhananga et a/., 1996). The heterogeneity of the




The main aims of this thesis have been to examine the role of (3-lactamases in
carbapenem-resistant strains from Japan and carbapenem-resistant A. veronii bv.
sobria isolated from Vellore, South India. In addition, the molecular heterogeneity
of the S. maltophilia metallo-(3-lactamases has been analysed.
10.2 The relevance of serine-based carbapenem-hydrolysing P-
lactamases
Assessing the problem of P-lactamases in carbapenem resistance is vitally important
for the implementation of therapeutic strategies. In the early 1990s, potent
carbapenemase activity had not been associated with a serine P-lactamase and it was
thought that metallo-P-lactamases would become the major resistance mechanism to
the carbapenems (Livermore, 1993b; Payne, 1993). In this thesis, a survey on
carbapenem-resistance mechanisms in 61 Japanese P. aeruginosa clinical isolates
has demonstrated that an association between a serine-based chromosomal
cephalosporinase and an alteration in outer membrane permeability was the most
prevalent mechanism of resistance amongst the strains studied (Section 3). Recently
the metallo-P-lactamase IMP-1 has been disseminating amongst clinically isolated P.
aeruginosa in Japan. However, in this study no IMP-1 metallo-P-lactamase was
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detected (Section 3.6 - 3.7) which implies that the occurrence of this enzyme is still
relatively rare in P. aeruginosa. Further studies on P. aeruginosa isolates from
Kuwait and Turkey have also demonstrated the widespread nature of a carbapenem
resistance mechanism which is a combination of a chromosomal class C (3-lactamase
and the loss of an imipenem-specific porin channel (R. Walker - unpublished data).
In recent papers from Japan emphasis is generally placed on the detection of IMP-1
in carbapenem-resistant isolates, and on occasion these reports have ignored or failed
to detail the carbapenem resistance mechanisms of non-IMP-1 isolates. In the
original Japanese report (Senda et a/., 1996a), 132 carbapenem resistant P.
aeruginosa strains were examined and 13% were found to carry the b/am? gene. The
carbapenem resistance mechanism in the remaining 87% was not determined and it is
highly probable that the resistance mechanism in many of these strains that were not
further investigated involved a cephalosporinase and a reduction in outer membrane
permeability.
Although it was initially thought that the metallo-(3-lactamases would be the most
common cause of carbapenem resistance, it is becoming increasingly evident that the
rise in the number of serine-based carbapenemases in clinical bacteria is an important
issue that must be addressed. The importance of the molecular class C (3-lactamase
in conferring carbapenem resistance as part of a two-component mechanism has been
emphasised in this thesis. The involvement of a class C cephalosporinase in
carbapenem resistance has also been identified in E. cloacae, C.freundii, P. retigerii,
P. mirabilis and recently K. pneumoniae (Section 1.10.1.2). In addition, serine-based
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molecular class A and D imipenem-hydrolysing enzymes in Acinelobacter species
are attracting much attention (Section 1.12.1). Furthermore, it has also been revealed
recently that the production of a molecular class A Sme-1 like carbapenemase in S.
marcescens is not such a rare event as originally thought (Section 1.12.1).
It is important to remember that most common P-lactamases have a serine-based
catalytic mechanism and it seems reasonable to assume that some of these enzymes
will adapt themselves to include the carbapenems in their substrate profile. This
scenario has most recently been illustrated in a report by Dorai-John et al., (1998) on
the identification of a novel putative molecular class C enzyme that efficiently
hydrolyses imipenem. This is unlike previously reported class C cephalosporinases
that can only feebly hydrolyse imipenem, although this is sufficient to confer
carbapenem resistance in a less permeable background.
In Section 3.9 it was shown that the imipenem MICs in carbapenem resistant P.
aeruginosa from Japan were all less than the breakpoint for resistance when
imipenem MICs were determined in the presence of BRL42715. BRL42715 is a
good inhibitor of molecular class A, C and D P-lactamases in vitro, and it is
unfortunate that this compound cannot be applied clinically. A general serine P-
lactamase inhibitor in combination with a P-lactam could possibly be important in
overcoming the problem of serine based carbapenemases. Currently many molecular
class A and D p-lactamases can be targeted using clavulanic acid, sulbactam or
tazobactam, there are, however, no molecular class C P-lactamase inhibitors.
221
10.3 The significance of metallo-P-lactamases
Although the importance of serine P-lactamses in carbapenem resistance is beginning
to be realised, the metallo-P-lactamases do still present a threat to the efficacy of the
carbapenems as postulated by Payne (1993) and Livermore (1993b). The emergence
in Japan of the broad-spectrum plasmid mediated P-lactamase IMP-1 in a variety of
clinically important bacteria, including K. pneumoniae is probably one of the most
significant events in terms of metallo-p-lactamase mediated resistance. Recent
findings indicate that the isolation of b/amp containing strains is still increasing (Ito
el al., 1997), however, one consolation is that, as yet, this enzyme has still not been
reported outside of Japan. Although IMP-1 has been described in common bacterial
pathogens, as already illustrated in the introduction of this thesis (1.11.1.5), many of
the metallo-P-lactamases that have been identified, to date, are often found in
bacteria of considerably less clinical importance.
10.4 The significance ofAeromonas carbapenemases
Aeromonas species, some of which produce metallo-P-lactamases, are considered to
be infrequent pathogens although their ability to cause infection has been reported
increasingly in the past few years (Wilcox and Jones 1995). The role of metallo-
carbapenemases in conferring resistance has been rather unclear, as most species that
produce a carbapenem-hydrolysing metallo-P-lactamase remain susceptible to the
carbapenems under standard sensitivity testing conditions (104cfu). This thesis has
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reported the identification of two carbapenem resistant A. veronii bv. sobria strains
tested with a conventional inoculum (104cfu), that were subsequently found to have
derepressed expression of a novel carbapenemase (Table 5.1 and Section 5.5). In
Table 5.2 it was shown that unless there are at least 106cfu of bacteria present the
inducible carbapenemase does not afford A. veronii bv. sobria with protection
against imipenem, thus the number of bacteria present and the amount of metallo-p-
lactamase produced is crucial to the manifestation of carbapenem resistance. It has
been suggested that at the site of infection bacterial concentrations are likely to be
larger than that used in conventional susceptibility testing, although this is perhaps
debatable (Rossolini el al., 1995). Currently carbapenem resistant A. veronii bv.
sobria are not a problem clinically, however, if they do pose a problem in the future,
possibly as a consequence of greater reliance on the carbapenems, it is most likely
that it will be caused by the selection of derepressed mutants. Therefore, care should
be taken in the choice of agents, particularly for invasive Aeromonas infections
because of the potential to select for derepressed mutants that are generally not only
hyper-producers of a carbapenemase but also of a penicillinase and cephalosporinase.
Agents such as gentamicin, or the fluoroquinolone ciprofloxacin have been
previously recommended for the treatment of serious Aeromonas infection (Bakken
el al., 1988).
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10.5 The P-lactamases of carbapenem-resistant A. veronii bv. sobria
strain 13
In this thesis, the P-lactamases ofA. veronii bv. sobria strain 13 have been examined
in detail by applying several different techniques such as ion exchange
chromatography, PCR and gene cloning. It appears that like many Aeromonas
species A. veronii bv. sobria 13 produces three chromosomally encoded P~
lactamases. These P-lactamases include a novel carbapenemase AVS-1, a
penicillinase named AVS-2 and a third P-lactamase AVS-3 that is possibly related to
previously reported Aeromonas cephalosporinases. The gene cloning and sequence
analysis of the AVS-2 penicillinase demonstrated that this enzyme is closely related
(>95.8% amino acid homology) to the molecular class D penicillinases AsbBl and
AmpS identified in a strain of A. jandaei and A. veronii bv. sobria, respectively
(Table 8.3) (Rasmussen et al., 1994a; Walsh et ah, 1995b). Class D penicillinases
appear to be ubiquitous throughout the Aeromonas genus and have been shown to be
linked to a two component cre-like operon that is involved in the regulation of
Aeromonas P-lactamases (Alksne and Rasmussen, 1997; Niumsup et al., 1997).
10.6 The novel AVS-1 carbapenemase
The novel carbapenemase AVS-1 was found to possess several unusual properties
including an atypical pi value and substrate and inhibitor profiles, when compared
with previously reported Aeromonas carbapenemases (Sections 5 and 6). The
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employment of an imipenem substrate based modification after IEF (Section 5.7)
proved invaluable in initially identifying the ability of the AVS-1 P-lactamase to
hydrolyse nitrocephin efficiently in addition to imipenem, an attribute not previously
described for the Aeromonas carbapenemases. Purification of the AVS-1 P-
lactamase (Section 6) further demonstrated the unusual properties of this enzyme,
including its ability to hydrolyse ampicillin and cephaloridine, its resistance to the
metallo-P-lactamase inhibitor EDTA (lOOmM) and its insensitivity to variations in
zinc sulphate concentrations. The Aeromonas metallo-P-lactamases CphA and ImiS
exhibit a very narrow substrate profile, with a marked preference for carbapenems
and are inhibited by EDTA (Rossolini el a/., 1996). The P-lactamase AVS-1 was
also found to be sensitive to the serine P-lactamase inhibitors clavulanic acid,
tazobactam and sulbactam, although it has already been speculated that these
inhibitors could be acting as competitive substrates (Section 6.9), because these
compounds are known to be hydrolysed by some metallo-P-lactamases. Both ImiS
and CphA are known to hydrolyse BRL42715, however, hydrolysis of these other
serine P-lactamase inhibitors has not been reported (Matagne et al., 1995, Walsh et
al., 1996).
The arguments for the AVS-1 carbapenemase being encoded by a metallo-P-
lactamase gene identified in both strain 13 and 99 have been put forward in Section
7.6. The metallo-P-lactamase gene, although not sequenced in its entirety (27
nucleotides could not be determined at the 5' end of the gene), was found to be
closely related (>95% amino acid homology) to the previously identified Aeromonas
metallo-P-lactamases CphA, CphA2 and ImiS (Table 7.2). These results suggested
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that if the metallo-|3-lactamase gene does encode the AVS-1 enzyme then there are
only a few amino acids that could possibly account for the extended substrate
spectrum and the unusual inhibitor profile of this AVS-1 carbapenemase.
Only two amino acids (lysine 49 and asparagine 206) were identified from the
sequence of the metallo-P-lactamase gene from A. veronii bv. sobria 13 and 99 as
being possibly close to the enzyme active site (Section 7.5) and therefore, these may
be the important amino acid substitutions. It should also be pointed out that these
residues were identified by aligning the metallo-P-lactamase sequence identified in
both strain 13 and 99 with the sequences of the metallo-P-lactamases from B. fragilis
(CcrA3) and B. cereus (P-lactamase II) which function optimally with two zincs,
unlike the Aeromonas metallo-P-lactamases which are known to function at their
maximum with only one zinc. The difference in the requirement for zinc between
these enzymes suggests that Aeromonas enzymes are radically different from CcrA3
and P-lactamase II, thus residues important in catalysis in CcrA3 and P-lactamase II
are not necessarily the same in Aeromonas metallo-P-lactamases. The importance of
individual residues in the Aeromonas metallo-P-lactamase will only be made clearer
when the crystal structure of an Aeromonas metallo-P-lactamase has been resolved
and from site-directed mutagenesis studies.
Although arguments for the probable metallo-P-lactamase origin of the AVS-1 P-
lactamase have been reasoned in Section 7, the cloning of this carbapenemase is
ultimately required to confirm whether it is truly related to previously identified
Aeromonas metallo-P-lactamase. The strategies employed in this study in an attempt
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to clone AVS-1 have been unsuccessful (Section 8). A possible alternative cloning
strategy could involve preparing a genomic DNA library from A. veronii bv. sobria
13, preparing colony blots of the library and hybridising these blots with a probe
consisting of the metallo-P-lactamase encoding PCR product amplified from strain
13. (3-Lactamase extracts prepared from any hybridisation positive clones could be
analysed by IEF to determine whether they encode a metallo-P-lactamase with the
same pi as AVS-1 (that is 5.84).
10.7 Stenotrophomonas maltophilici metallo-P-lactamases
Although the relevance of Aeromonas metallo-P-lactamases in conferring
carbapenem resistance has been uncertain, in contrast the S. maltophilici metallo-p-
lactamases are known undoubtedly to cause imipenem and meropenem resistance.
Permeability is thought to play a part in S. maltophilia carbapenem resistance,
however, the production of the metallo-P-lactamase, whether inducible or
derepressed, is known to account for high level resistance (Akova et a/., 1991). S.
maltophilia isolates are known to produce a variety of LI-type metallo-P-lactamases
that can be differentiated from one another biochemically. In this study, 561 bp
intragenic DNA sequences of metallo-P-lactamases from six S. maltophilia strains
have been determined from PCR products (Section 9). A comparison of the 187
deduced amino acid sequences of the six metallo-P-lactamases with one another and
with the same region encoded by the blciu and blas metallo-P-lactamase genes from
S. maltophilia IID1275 and GN12873 has revealed that these enzymes are all closely
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related to one another (>88.8% homology - Table 9.3). These enzymes all differ
from one another at a few amino acid positions that have generally not been reported
as residues known to be important in enzyme catalysis and these changes account for
the differences in pi and substrate and inhibitor profiles (Section 9.7). Metallo-(3-
lactamase heterogeneity is a feature not only between bacteria of different genera but
also between strains of the same species and this is exemplified by S. maltophilia
metallo-(3-lactamases. Work in this thesis also suggests that biochemical
heterogeneity can be a feature of the Aeromonas metallo-(3-lactamases, but at the
molecular level, this is probably caused by minor amino acid substitutions.
Investigating metallo-(3-lactamase heterogeneity is important clinically for future
drug development. The S. maltophilia metallo-P-lactamase heterogeneity study
described here, is helpful in identifying whether recognised active site residues are
conserved, which is essential when designing new antibiotics or inhibitors. Gene
sequence data also reveal residues that may be responsible for substrate profile
differences and may result in clinical failure in a strain that possesses one type of
enzyme but not another.
10.8 Overcoming metallo-P-lactamase mediated carbapenem
resistance
Although the role of metallo-P-lactamases in conferring resistance, particularly in
Aeromonas has not always been clear cut, metallo-enzymes such as IMP-1 can pose
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a clinical problem and there is a need for new drug strategies against these enzymes.
The monobactam aztreonam is unlike most other P-lactams in that it remains stable
in the presence of zinc carbapenemases. There are, however, draw backs to using
such an agent, specifically the fact that several of the metallo-P-lactamase producing
bacteria can additionally produce chromosomal cephalosporinases which, when
hyperproduced, can destroy aztreonam.
Designing new agents to overcome metallo-P-lactamase mediated resistance may
involve devising more stable carbapenems by altering their side chain substituents.
An alternative approach would be to discover or design effective inhibitors against
metallo-p-lactamases that can be administered in combination with a P-lactam. The
latter, however, may prove to be difficult to achieve because of the heterogeneous
nature of the metallo-P-lactamase group as a whole. This potential problem has
recently been illustrated by Payne el al., (1997), where a series of mercaptoacetic
acid thiol esters were found to be good inhibitors of some metallo-P-lactamases but
completely ineffective against others. A continued effort to understand the catalytic
mechanisms and substrate binding of metallo-P-lactamases is thus important in the
rational design of effective inhibitors. In the mean time until new compounds
become available it is imperative that carbapenems, as with all antibiotics, should be
employed with extreme caution to keep the selection of carbapenemases at bay,
whether they be serine or metallo-based.
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